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h  Hour 
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spectrometry 
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LDA  Lithium diisopropylamide 
                                                                                                                               Abbreviations 
3 
 
LHS  Left hand side 
M  Molar 
Me  Methyl 
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Abstract 
The first chapter of this thesis discusses the biomimetic total synthesis of clivonine. Clivonine 
is a member of the Amaryllidaceae family of alkaloids and was isolated from the plant Clivia 
miniata Regel by Wildman in 1956. Barton first proposed the biosynthesis of the 
Amaryllidaceae alkaloids in 1958, hypothesising that the key diversifying step in the 
biosynthesis was an intramolecular phenolic oxidative coupling of a common precursor, 
norbelladine. However, it was not until 2 years later, in 1960, that Barton was able to account 
for the biosynthesis of the lycorenine class of the Amaryllidaceae alkaloids, the class in 
which clivonine is a member. He proposed that a ‘ring-switch’ must occur after the initial 
intramolecular phenolic oxidative coupling from a lycorine type progenitor to that of a 
lycorenine type skeleton. Our synthesis of clivonine demonstrates for the first time the 
synthetic interconversion between these two classes of compounds in a manner that can be 
considered biomimetic. 
The second chapter of this thesis details our synthesis of the acetonide protected derivative of 
cis-3,5-cyclohexadien-1,2-diol. The first section of this chapter highlights the importance of 
these types of molecules and reviews the previous syntheses of this compound. The second 
section then details the development of a five-step three-pot synthesis of this compound in an 
overall 50% yield starting from commercially available 1,3-cyclohexadiene. 
The final chapter of this thesis discusses the studies towards the development of a catalytic 
asymmetric retro-Cope elimination reaction. This chapter will first highlight recent advances 
that have been made towards the asymmetric hydroamination (AHA) reaction before 
reviewing the recent progress made towards expanding the scope of the retro-Cope 
elimination reaction. Finally, our proposed method of developing an asymmetric retro-Cope 
reaction will be outlined, along with details of preliminary studies focussed on the 
development of a suitable system with which the asymmetric retro-Cope elimination can be 
studied. 
Declaration 
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Chapter 1 – The Biomimetic Total Synthesis of Clivonine 
1.1. Introduction 
1.1.1. Amaryllidaceae Alkaloids 
The Amaryllidaceae alkaloids are a large class of nitrogen containing compounds isolated 
from the Amaryllidaceae herbaceous perennials such as the daffodil. The plants of the 
Amaryllidaceae consist of approximately 85 genera and 1100 species and to date over 500 
structurally diverse alkaloids have been isolated.1 These alkaloids can be categorised into 8 
skeletally distinct subclasses (Figure 1).2-3 
 
Figure 1: Subclasses of the Amaryllidaceae alkaloids. 
However with the large number of these alkaloids being isolated in the recent years the 
subgroups can now be extended up to 18.1 The structural classes relevant to this thesis have 
been highlighted above as the lycorenine and the lycorine classes. Clivonine is a member of 
the lycorenine class. 
Many of the Amaryllidaceae alkaloids exhibit interesting biological and medicinal properties 
such as anticancer, anti-inflammatory, antifungal and antiviral activity, making them popular 
targets for synthesis.4 The last 15 years has seen a large number of total syntheses of these 
natural products, and the isolation of many new alkaloids in this class.1-2,5-6 
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1.1.2. (+)-Clivonine (1) 
Clivonine (1) was first isolated by Wildman in 1956 from the plant Clivia miniata Regel 
(Figure 2).7 
 
Figure 2: Structure of clivonine (1) with atom and ring numbering. 
Wildman found the molecular formula of clivonine (1) to be 
C14H13(O2CH2)(NCH3)(OH)(COO) and proposed a structure for it based on homolycorine (2) 
(Figure 3). The presence of the lactone functionality was determined by the high solubility of 
clivonine (1) in a warm alkali solution. Treatment of the solution with acid allowed for 
relactonisation and the extraction of the hydrochloride salt into chloroform. The free base was 
then obtained upon neutralisation with sodium bicarbonate. A positive Labat test and IR 
absorptions at 2793 and 943 cm-1 provided evidence of the methylenedioxy group. It was 
placed in the 9, 10 position due to the very similar UV spectrum of the model compound 3 
(Figure 3). 
 
Figure 3: Structures of homolycorine (2), model compound 3 and tetrahydroclivonine (4). 
Clivonine (1) also appeared to be completely saturated as it absorbed no H2 unlike all the 
other lactonic alkaloids of the same family. After reduction of clivonine (1) with lithium 
aluminium hydride, tetrahydroclivonine (4) (Figure 3) was isolated. UV spectroscopy showed 
the disappearance of the carbonyl group and a titration with periodate confirmed the presence 
of a vicinal diol unit. From all this information Wildman was able to assign a tentative 
structure for clivonine which had the correct connectivity (i.e. cf. 1) but lacked 
stereochemical detail. It was not until 10 years later that Mehlis proposed the relative and 
absolute stereochemistry (Figure 4).8  
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Figure 4: Mehlis’ proposed structure of clivonine. 
Mehlis correctly predicted the cis relationship between the C5 and C5a protons based on 
evidence that the product of lithium aluminium hydride reduction underwent a rapid 
periodate cleavage when compared to compounds known to be epimeric at C5. However, the 
stereochemistry he predicted at C11b and C11c in relation to C5a was based on comparisons 
made between clivonine and other lactones of the same family, and was soon proved to be 
incorrect by Döpke and Jeffs.9 
Döpke and Jeffs undertook mass spectrometric studies of various lactone alkaloids and were 
able to confirm the basic structure found by Wildman.10-11 This was followed by detailed 1H 
NMR experiments on clivonine and its O-acetate derivate which led them to reassign the 
stereochemistry of clivonine.9-10 The spectra showed clear signals for the N-Me, 
methylenedioxy and the two aryl protons. By comparing the two spectra it was possible to 
assign the protons at δ 4.18 and 4.06 ppm as H5 and H5a respectively in clivonine (1) itself. 
This assignment was supported by a characteristic downfield shift of H5 to δ 5.35 ppm in the 
O-acetyl compound. The H5a signal in the O-acetyl compound shows as a double doublet 
with coupling constants of 3.0 and 12.5 Hz. Irradiation of H5 at δ 5.35 ppm removes the 
smaller coupling to give the H5a signal as a doublet, confirming the coupling constants as J5, 
5a = 3.0 Hz and J5a, 11b = 12.5 Hz. The coupling constant between H5 and H5a supports the cis 
relationship of the diol unit as proposed by Mehlis (cf. Figure 4). However, the large coupling 
constant between H5a and H11b suggests a trans diaxial relationship in contrast to the cis 
relationship previously suggested. From this data they proposed that there was a trans B:C 
ring fusion.  
By studying the 1H NMR spectrum of clivonine (1) the relationship of the H11b, H11c and 
H3a protons could also be assigned. The H11b signal at δ 3.23 ppm appears as a double 
doublet with coupling constants of 12.0 and 9.5 Hz. The coupling constant of 12.0 Hz is also 
observed for H5a at δ 4.09 ppm, which allowed the 9.5 Hz coupling constant to be assigned 
as J11b, 11c. The proton signal at δ 2.87 ppm assigned as the H11c proton showed apparent 
coupling constants of 9.5 and 5.8 Hz. The coupling constant of 9.5 Hz is reflected in the 
H11b signal which confirmed the trans H11b, H11c relationship. Following this, and 
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knowing H11c was axial, the coupling constant 5.8 Hz could be assigned as J11c, 3a, indicating 
the cis relationship of these protons. This was further confirmed by looking at the spectra of 
O-acetyl clivonine where H5 had been irradiated to show the ABX splitting pattern of 
methylene protons H3a and H4. Coupling constants were found to be J4α, 4β = 15.5 Hz, J4α, 3a 
= 3.5 Hz and J4β, 3a = 6.5 Hz, supporting the equatorial orientation of H3a. 
Döpke and Jeffs undertook chemical degradation studies on clivonine (1) to further confirm 
the stereochemical relationship assigned from the 1H NMR studies.9 Firstly a von Braun 
reaction on clivonine (1) was carried out by treatment with cyanogen bromide to give a single 
product assigned as bromide 5 by mass spectrometric and 1H spectroscopic NMR studies 
(Scheme 1). 
 
Scheme 1: Döpke and Jeffs' degradation of clivonine (1) by a von Braun reaction.9 Reagents and Conditions: i) 
CNBr, benzene, ∆. 
From studying the 1H NMR spectrum of bromide 5 the proton signal at δ 4.70 ppm with 
coupling constants of 2.5 and 11.5 Hz and the signal at δ 3.62 ppm with coupling constants of 
3.5 and 11.5 Hz could be assigned as H5a and H11b respectively. The downfield shift of H5a 
could be attributed to the new 1,3-diaxial interaction it experiences with the axial bromine at 
C11c. Irradiation of the proton signal at δ 4.82 ppm caused the collapse of the H11b signal to 
a doublet with a coupling constant of 11.5 Hz, allowing the signal at δ 4.82 ppm to be 
assigned as H11c. The smaller coupling of H11b could be assigned to J11b, 11c supporting the 
new cis orientation of these two protons. However, attempts to confirm the relative 
stereochemistry of H5 and H3a with further chemical transformations on bromide 5 were 
unsuccessful. A second degradation pathway was also explored in which clivonine (1) was 
transformed into the known compound α-dihydrohippeastrine (6) (Scheme 2). 
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Scheme 2: Döpke and Jeffs' degradation of clivonine (1) to dihydrohippeastrine (6).9 Reagents and Conditions: 
i) POCl3, py, RT. ii) KOH, EtOH, ∆. iii) H2SO4, ∆. iv) NH4OH. 
Treatment of clivonine (1) with phosphorus oxychloride gave the chloride 7, which when 
heated in a basic solution formed the alkoxide 8. SN2 displacement of the chlorine gave 
epoxide 9 which, under acidic conditions, afforded α-dihydrohippeastrine (6). As the relative 
and absolute stereochemistry of α-dihydrohippeastrine (6) had previously been assigned by 
the correlation of hippeastrine (10) with lycorine (11) (Figure 5)9,12, Döpke and Jeffs were 
able to confirm the absolute and relative stereochemistry of clivonine (1) as that depicted in 
Figure 2, page 7. 
 
Figure 5: Structures of hippeastrine (10) and lycorine (11). 
Shortly after Döpke and Jeffs had confirmed the relative and absolute stereochemistry of 
clivonine (1) its 13C NMR spectra was assigned by Gatti.13 In the lowfield region (> δ 90 
ppm) the methylenedioxy peak showed a characteristic resonance at δ 130 ppm, and the 
carbonyl carbon of the lactone moiety was assigned as the resonance at ~ 160 ppm. The aryl 
carbons were firstly distinguished between CH and C* by looking at the off resonance 
multiplicity, and the positions of the signals assigned by comparisons with model systems. In 
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the highfield region the N-Me peak was easily assigned as the quartet at δ 42-46 ppm. The off 
resonance decoupling only gave a rough separation of the aliphatic CH and CH2 groups and 
so single-frequency decoupled proton spectra were used. Firstly irradiation of H5, H5a and 
H11c resulted in the collapse of the 13C doublets at δ 68.5, 82.8, and 70.2 ppm respectively, 
allowing for the remaining two CH groups of C11b and C3a to be assigned as the strong 
signal at δ 34.0 ppm. Irradiation of the C4 CH2 signal showed coalescence of the two triplets 
at δ 31, therefore one of these signals must be from C4, the other being assigned as C3. The 
final methylene group of C2 could therefore be assigned as the signal at δ 53.9, due to 
deshielding by nitrogen. 
1.1.3. Irie’s Synthesis of Clivonine (1) 
The first and only synthesis of (±)-clivonine (1) prior to the work described in this thesis was 
achieved by Irie in 1973.14 The synthesis consists of 17 steps with an overall yield of 0.43% 
starting from piperonal (Scheme 3). 
 
Scheme 3: Irie’s synthesis of clivonine (1) part 1. Reagents and conditions: i) Ac2O, reflux, 4 h. ii) NaOH (aq). 
iii) Ac2O, reflux, 12 h. iv) MeOHdry, benzene. v) SOCl2, benzene, reflux, 1 h. vi) NaN3, water, acetone, 1 h. vii) 
Benzene. viii) MeOH, reflux. 
The synthesis starts with the cycloaddition of fumaric acid (12) and 3,4-
methylenedioxyphenyl allyl carbinol (13) in boiling acetic anhydride, which gives a mixture 
of stereoisomeric anhydrides 14a and 14b and small amount of anhydride 14c. Both 14a and 
14b were hydrolysed with NaOH followed by re-cyclisation to give the same trans-cis 
anhydride 14c. Treatment with methanol (1 equiv.) in benzene then gave the half esters 15a 
and 15b in a ratio of 7:3. Half ester 15a was converted to the acid chloride with thionyl 
chloride in benzene, which gave azide 16 after treatment with sodium azide. Curtius 
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rearrangement of azide 16 in refluxing benzene, followed by heating the resultant isocyanate 
in methanol gave urethane 17. The acid 18 obtained by hydrolysis of urethane 17 was 
subjected to the Arndt-Eistert homologation to form diazoketone 19 (Scheme 4). 
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H
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Scheme 4: Irie’s synthesis of clivonine (1) part 2. Reagents and Conditions: i) HCl(10%)/AcOH. ii) SOCl2, 
benzene, py, RT, 16 h then CH2N2 in ether, RT, 1 h. iii) Silver benzoate, Et3N, MeOH, 40 °C, 4 h. iv) 
HCl(10%)/AcOH. v) Ac2O, reflux, 2 h. vi) chloromethyl methyl ether, ZnCl, AcOH, RT, 16 h. vii) AgOAc, 
AcOH, Ac2O, RT, 5 h. viii) LiAlH4, ether. ix) OsO4, py, ether, RT, 2 d. x) Na2SO3, 50% aq EtOH, reflux, 4 h. 
xi) 3% H2SO4, H2O bath, 3 h. xii) MnO2, CHCl3, RT, 16 h. 
The diazoketone 19 then underwent a Wolff rearrangement after treatment with silver 
benzoate and triethylamine. These conditions are those reported in the 1979 full paper on this 
synthesis; the Wolff rearrangement reported in the 1973 communication using just silver 
oxide apparently gave irreproducible results.15 The homoester 20 was hydrolysed with 
hydrochloric acid in acetic acid, and treatment of the resultant acid with acetic anhydride 
gave the imide 21. The imide 21 was treated with chloromethyl methyl ether in acetic acid in 
the presence of zinc chloride. The chloro methyl product was then treated with silver acetate 
in acetic acid and acetic anhydride to give benzylic acetate 22. Acetate 22 was reduced to the 
amino alcohol with lithium aluminium hydride in ether and then oxidised with osmium 
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tetroxide which, following work-up with sodium sulfite, gave a mixture of diastereomeric 
triols (±)-tetrahydroclivonine (4) and (±)-tetrahydroclividine (23) in a 1:1 ratio. (±)-
Tetrahydroclividine (23) was crystallised from this mixture using acetone, whilst column 
chromatography on alumina of the mother liquor allowed for the separation of (±)-
tetrahydroclivonine (4). Treatment of these triols with dilute sulfuric acid followed by 
oxidation with manganese dioxide gave (±)-clivonine (1) and (±)-clividine (24). 
Characterisation was based upon comparison with an authentic sample of isolated (+)-
clivonine (1). 
1.1.4. Biosynthesis of the Amaryllidaceae 
Biosynthetically the Amaryllidaceae alkaloids are all derived from a common bis-phenol 
precursor, norbelladine (25) itself derived from tyrosine and phenylalanine (Scheme 5).  
HO
CO2
NH3
CO2
NH3
HO
HO
H
N
HO
Tyrosine
Phenylalanine
Norbelladine (25)
HO
NH2
O
HO
HO
 
Scheme 5: Biosynthesis of norbelladine (25). 
This concept was first proposed by Barton in 1957 when he hypothesised that the key 
diversifying step in the biosynthesis of many alkaloids arises from an intramolecular 
oxidative phenolic coupling. He used the alkaloids of the Amaryllidaceae to illustrate his 
ideas.16 Battersby subsequently showed the incorporation of both labelled tyrosine and 
phenylalanine into lycorine (11) (Scheme 6).17 When Narcissus plants were fed with DL-[2-
14C]tyrosine or Nerine bowdenii plants fed with DL-[3-14C]tyrosine the lycorine (11) isolated 
was radioactive at the C2 and the C3 positions respectively. This gave proof that tyrosine 
made up one portion of the carbon skeleton and also showed that the remaining carbon 
skeleton was not derived from tyrosine. When Nerine bowdenii plants were fed DL-[3-
14C]phenylalanine incorporation of the labelled atom was found solely at C7.  
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Scheme 6: Battersby’s feeding studies to show incorporation of tyrosine and phenylalanine during the 
biosynthesis of lycorine (11).17 
However, Barton’s theory was unable to account for the biosynthesis of the tazettine (26) and 
lycorenine (27) subclasses, which prompted him to originally suggest that an intermolecular 
phenolic coupling must occur for these classes of compounds.16 In 1960, however, Barton 
extended his hypothesis to include these structural classes, proposing that the key 
intramolecular coupling does occur, however, subsequently a bond must break in the 
haemanthamine (28) and lycorine type progenitor (29) to give the tazettine (26) and 
lycorenine type (30) carbon skeletons respectively following re-ring-closure (Scheme 7).18-19  
HO
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R
R1
H
OH  
Scheme 7: Barton’s proposed ‘Ring-Switch’ from a lycorine progenitor 29 to lycorenine type product 30 and 
haemanthamine (28) to tazettine (26).18-19 
From norbelladine (25) o,p-phenolic coupling and subsequent processing leads to a lycorine 
type structure (29), whilst a p,p-phenolic coupling and subsequent processing gives 
haemanthamine (28). Benzylic oxidation of these precursors gives lactamol 31 and 
haemanthidine (32). For the lycorenine series, bond cleavage is followed by a 180° rotation, 
and finally a second benzylic oxidation affords the lycorenine type structure (30) (Scheme 7). 
For the tazettine (26) series, after bond cleavage a 90° rotation occurs to give pretazettine 
(33). At this point it is necessary to highlight that until 1968 tazettine (26) was thought to be a 
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natural product. However, whilst undertaking some isolation experiments Wildman 
discovered that tazettine (26) was in fact the product of a intramolecular cross Cannizzaro 
rearrangement of the natural product pretazettine (33) (see Section 1.1.5.3. Biomimetic Ring-
Switch).20 
The biosynthetic link between haemanthamine (28), and tazettine (26) was supported by 
Wildman, when high yields of haemanthamine (28) were obtained from Sprekelia 
formosissima early in the flowering season, whilst yields of tazettine (26) where higher later 
in the season.21 Wildman then went on to demonstrate that this biosynthetic sequence of 
reactions leading from haemanthamine (28) to tazettine (26) via haemanthidine (32) do 
indeed occur in vivo by injecting tritiated [8-3H]haemanthamine (34) into the stems of the 
flowering plant Sprekelia formosissima. Samples taken over 90 days confirmed the sequence 
of events to give [8-3H]pretazettine, which upon isolation converted to [8-3H]tazettine (35) 
(Scheme 8). 
 
Scheme 8: Wildman’s biosynthetic conversion of [8-3H]haemanthamine (34) to [8-3H]tazettine (35).21 
Wildman also demonstrated the interconversion between the lycorine (11) and lycorenine 
(27) class using isotopic labelling studies.22 Thus, King Alfred daffodils were fed with tritium 
labelled [8-3H]norpluviine (36), and after 18 days the alkaloid [8-3H]lycorenine (37) was 
isolated with 79% of the specific molar activity of the original [8-3H]norpluviine (36) 
(Scheme 9). 
 
Scheme 9: Wildman’s biosynthetic conversion of [8-3H]norpluviine (36) to [8-3H]lycorenine (37).22 
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1.1.5. Synthetic Strategy and Project Aims 
The synthesis of our clivonine progenitor, lycorine-type iminium salt 38, is via a route 
analogous to that developed for the total synthesis of (+)-trianthine (39) by Oppolzer in 1994, 
utilising a retro-Cope elimination as a key step (Scheme 10).23  
 
Scheme 10: Oppolzer’s synthesis of (+)-trianthine (39)23. Reagents and Conditions: i) ArBr, Et2O/THF (5:3), n-
BuLi, -78 °C, 30 min, then 40, Et2O, -78 °C → 0 °C, 3 h, then Ac2O, 0 °C → RT, 30 min. ii) SMe2, THF, 
CuBr·SMe2, vinyl magnesium chloride, -30 °C, 30 min, then, acetate 41, -30 °C → RT, 4 h. iii) 9-BBN, THF, 
50 °C, 15 h, then H2O, NaOH (20% aq. soln.), H2O2 (30% aq. soln.), RT, 3 h. iv) DMSO, oxalyl chloride, 
CH2Cl2, -50 °C, 5 min, then Et3N, RT, 1.5 h. v) NH2OH·HCl, NaOAc·3H2O, Et2O, 78 °C, 17 h. vi) NaCNBH3, 
methyl orange, MeOH, MeOH/HClconc. (10:1), 2 h. vii) benzene, 80 °C, 70 h. viii) Raney-Ni, Et2O, RT, 5 h. ix) 
Eschenmoser’s salt, 40 °C, 15 h. x) AcCl, MeOH, RT, 11 h. 
Oppolzer’s synthesis of (+)-trianthine (39) begins with a stereospecific 1,2-addition of 1-
bromo-3,4-(methylenedioxy)benzene to enone 40, with concomitant trapping with acetic 
anhydride to give acetate 41. An anti SN2’ elimination of acetate 41 with vinyl magnesium 
bromide gave the trans-vinylcyclohexene 42 with inversion of the stereochemistry set up 
from the 1,2-addition. Hydroboration, followed by Swern oxidation gave the corresponding 
aldehyde, which was converted to the oxime and reduced to hydroxylamine 43. retro-Cope 
elimination of hydroxylamine 43 was performed in refluxing, degassed benzene for 70 h to 
give N-hydroxyl pyrrolidine 44, setting up the two final stereogenic centres in (+)-trianthine 
(39). Hydrogenolysis with Raney-Ni gave the pyrrolidine then Pictet-Spengler cyclisation 
with Eschenmoser’s salt, and finally acetonide deprotection gave (+)-trianthine (39) in an 
overall 24% yield over 10 steps.  
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As with Oppolzer’s (+)-trianthine (39) synthesis our synthesis of (±)-clivonine (1) starts with 
a stereospecific 1,2-addition of 1-bromo-3,4-(methylenedioxy)benzene to enone 40 followed 
by trapping with acetic anhydride to give acetate 41 (Scheme 11). 
 
Scheme 11: Retrosynthetic analysis for our clivonine (1) synthesis. 
The second key step is a stereospecific Ireland-Claisen rearrangement of acetate 41 to give 
acid 45. This reaction takes place with retention of the stereochemistry set up from the 1,2-
addition in contrast with the inversion of stereochemistry seen after the SN2’ elimination in 
the (+)-trianthine (39) synthesis (cf. Scheme 10). Functional group interconversions 
transform acid 45 into oxime 46 to which a Borch reduction is carried out to give 
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hydroxylamine 47. The retro-Cope elimination of hydroxylamine 47 to N-hydroxyl 
pyrrolidine 48, as with the (+)-trianthine (39) synthesis, is stereospecific and sets up the final 
two stereogenic centres in the natural product. After hydrogenolysis, a Bischler-Napieralski 
cyclisation is carried out on the corresponding formamide to give our clivonine progenitor 
iminium salt 38 [cf. a Pictet-Spengler cyclisation which is carried out in the (+)-trianthine 
(39) synthesis]. Finally a biomimetic ring-switch converts our lycorine type precursor, 
iminium salt 38, to that of a clivonine type product lactol 49 via lactamol 50. 
At the outset of the work described in this thesis, the above described synthesis had already 
been successfully carried through to the biomimetic ring switch step by a previous PhD 
student, Carles Giró Mañas [Spivey Group 2004-2008]. The final steps had been attempted 
and tentatively deemed to have been successful but, unfortunately, there was not enough 
material for conclusive characterisation and in any case the yields through these last key steps 
were very poor.24 Therefore the first aim of the project was to repeat the synthesis up to 
iminium salt 38, and to develop a robust method of purification of this key intermediate. 
Once purified the final steps were to be repeated in a reproducible manner to give (±)-
clivonine (1) which could be characterised in full. 
The following sections introduce some of the key reactions involved in this synthesis in order 
to place the work in correct context. 
1.1.5.1. The Ireland-Claisen Rearrangement. 
The Ireland-Claisen rearrangement was discovered by Ireland in 1972 and is a suprafacial, 
concerted [3,3]-sigmatropic rearrangement of a silyl ketene acetal derived from an allylic 
ester to give a 3,4-unsaturated acid.25 Ireland found that ester enolates formed according to 
the method developed by Rathke in 197126 underwent a Claisen reaction on warming.27 He 
found that when the lithium enolates were quenched with trimethylsilylchloride at –78 °C, 
the resultant silyl ketene acetals rearranged readily to give clean, stereocontrolled products 
with minimal competition from the competing aldol reactions. Although a small amount of C-
silylated product was generated under these conditions (2-6%), it was later shown that the use 
of tert-butyldimethylchlorosilane to quench the enolate gave predominately O-silylation.28 
The Ireland-Claisen rearrangement is a widely used reaction due to the predictability of the 
new double bond geometry and the stereochemistry around the new carbon carbon sigma 
bond formed. These predications can be made as it is known that the reaction proceeds 
through a chair like transition state. Whilst researching the stereochemical outcome of the 
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enolate formation Ireland found that when THF is used as the solvent the kinetically favoured 
Z-enolate was formed (Scheme 12).29-30 
 
Scheme 12: Formation of the kinetically favoured Z-lithium enolate leading to the E-silyl ketene acetyl. 
However when 23% HMPA was used as a co-solvent with THF the thermodynamically 
favoured E-enolate was found to be the major product. (Scheme 13). 
 
Scheme 13: Formation of the thermodynamically favoured E-enolate. 
The formation of the E-enolate when 23% HMPA is added is due to the solvation of the 
lithium ion of LDA with HMPA causing a breakdown of the 6 membered transition state. 
When the lithium is tightly coordinated to the ester carbonyl oxygen in the absence of HMPA 
the R group clashes with the bulky isopropyl group of LDA when in the axial position (i.e. 
1,3-diaxial strain) and so prefers to be positioned in the favoured equatorial position giving 
rise to the Z-enolate (cf. Scheme 12). Due to the breakdown in the interaction between 
lithium and the ester carbonyl oxygen in the presence of HMPA there is no unfavourable 
interaction between the R group and the LDA. The R group therefore prefers to be positioned 
in the axial position to avoid A1,2 strain with the OR1 group giving rise to the E-enolate. This 
predictable enolate geometry allows for the predication of the stereochemistry at the new 
carbon centre following Ireland-Claisen rearrangement (Scheme 14). 
 
Scheme 14: Prediction of the stereochemistry around the new sigma bond following an Ireland-Claisen 
rearrangement. 
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In addition, Ireland demonstrated that the ratio of (E):(Z)-lithium enolates was not always 
directly related in the ratio of the resultant silyl ketene acetyls, a kinetic resolution occurs. 
Ireland proved this, in the case of the reaction in THF/15% DMPU, by carrying out a series 
of competitive trapping experiments, showing that the (Z)-lithium enolates and corresponding 
(E)-silyl ketene acetals are significantly more reactive than the (E)-lithium enolates and (Z)-
silyl ketene acetals. This suggests that the initial ratio of the (E)- and (Z)-lithium enolates 
arises from a kinetically controlled enolisation (as described above), to which a kinetic 
resolution occurs with addition of a trapping agent (such as DMSO or excess ester) to 
selectively react with the (Z)-lithium enolate and increase the relative amount of the (E)-
lithium enolate formed.31 
Although the predictability of the reaction products is a useful tool, in our synthesis this 
aspect of stereocontrol is not important. The stereochemistry of the molecule is already set up 
from the 1,2-addition (cf. Scheme 11) and as the [3,3] sigmatropic rearrangement is 
suprafacial the stereochemistry at the new stereocentre must be retained. This reaction 
therefore sets up the correct stereochemistry for the subsequent retro-Cope elimination 
reaction (Scheme 15). 
 
Scheme 15: Ireland-Claisen rearrangement of acetate 41 to acid 45. 
1.1.5.2. The retro-Cope Elimination. 
The retro-Cope elimination was first discovered serendipitously by House in 1976 and later 
independently by Oppolzer in 1979 and can be described as a suprafacial concerted thermal 
cyclisation of an unsaturated hydroxylamine to its corresponding pyrrolidine or piperidine N-
hydroxyl or N-oxide derivatives, although recently intermolecular variants have been 
developed, see later.32 
House first reported this type of reaction when during attempts to synthesise 1,3-dioximes 51 
from the corresponding 1,3-diketones 52 a bicyclic side product of the structure 53 was 
isolated (Scheme 16).33 
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Scheme 16: House’s serendipitous discovery of the retro-Cope elimination.33 
House extended his investigations by synthesising simpler hydroxylamines and found them to 
cyclise smoothly when allowed to stand overnight or when heated on a steam bath. House 
proposed that the reaction proceeded via a radical mechanism (Scheme 17). 
 
Scheme 17: House’s proposed retro-Cope elimination mechanism via a radical process.33 
In 1978 Black and Doyle reported more examples of this reaction, demonstrating that 
terminally substituted alkenes failed to cyclise, even under forcing conditions (Scheme 18).34 
In this publication they also demonstrated that the addition of radical inhibitors such as 
hydroquinone, phenol and aniline did not affect the rate of cyclisation, casting doubt upon 
House’s predicated radical mechanism. 
 
Scheme 18: Black and Doyle’s examples of the retro-Cope elimination.34 
Oppolzer first came across the reaction in 1979 when he found that a hydroxylamine 
intermediate for his studies towards [1,3]-dipolar cycloadditions was not stable and 
underwent a facile retro-Cope elimination to the cyclic hydroxylamine.35 
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Although the discovery of the reaction was made in the mid 1970s it was not until the early 
1990s that Ciganek and Oppolzer separately proved the mechanism and demonstrated the 
synthetic utility of the retro-Cope elimination. 
Similarly to both House and Oppolzer, Ciganek first encountered the retro-Cope elimination 
serendipitously. When reacting 2,2-diphenyl-4-pentenal (54) with N-methylhydroxylamine 
the desired nitrone 55 was only isolated in 45% yield, the major product (51% yield) was 
found to be cyclised product N-hydroxyl pyrrolidine 56, the retro-Cope elimination product 
of hydroxylamine 57 (Scheme 19).36 
 
Scheme 19: Ciganek’s unexpected retro-Cope elimination.36 
Ciganek expanded on the scope of this reaction, firstly showing that both 5 and 6 membered 
N-oxides could be obtained from their corresponding hydroxylamines (Scheme 20).36-37  
 
Scheme 20: Ciganek expansion of reaction scope.36-37 
Following on from work carried out by Black and Doyle34 he also investigated the effect of 
substitution on the double bond, demonstrating that substrates with two distal substituents on 
the alkene cyclised very slowly. This suggested strongly that the radical mechanism 
originally proposed by House was incorrect, considering the radical intermediate should be 
stabilised by the two distal substituents. Ciganek proved that the reaction proceeded via a 
concerted mechanism by showing that O-deuterated hydroxylamine 58 gave a single, 
unassigned isomer of the corresponding product, N-oxide 59 (Scheme 21).36-37 
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Scheme 21: Ciganek’s O-deuterated experiment to show a concerted mechanism.36-37 
Oppolzer finally provided definite proof of a concerted, suprafacial mechanism by reacting 
both (E)- and (Z)-isomers of an arylhydroxylamine 60 to give single, assigned epimeric 
products (Scheme 22).23 
 
Scheme 22: Oppolzer’s experiments to prove the retro-Cope elimination mechanism.23 
Hydroxylamines 60a and 60b were heated in degassed benzene to yield the N-hydroxyl 
pyrrolidines 61a and 61b with no contamination by the opposite epimer. This supported 
Ciganek’s theory that the mechanism is concerted and proved it to be suprafacial. 
Most recently, the group of Beauchemin has extended the scope of the retro-Cope 
elimination reaction significantly by showing that intermolecular variants are possible. 
Details of this work will be reviewed in Chapter 3. 
As indicated previously, our synthetic strategy for the synthesis of clivonine (1) is closely 
related to the first total synthesis of (+)-trianthine (39) carried out by Oppolzer in 1994.23 
This synthesis constitutes a rare example of the synthetic utility of the retro-Cope elimination 
reaction (cf. Scheme 10). In our synthesis, attack of the hydroxylamine moiety must occur 
from the top face of the alkene, cis to the acetonide [unlike in the case of (+)-trianthine (39) 
where attack is anti to this group] to give the observed stereochemistry at the C11b and C11c 
centres (Scheme 23). 
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Scheme 23: retro-Cope elimination of hydroxylamine 47 to N-hydroxyl pyrrolidine 48. 
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This facial selectivity is ensured by the two carbon chain linking the hydroxylamine to 
cyclohexene ring A which is sufficiently short to only allow attack to give a cis-fused 
indolizidine ring system. In other words, the stereocentre at C3a set up by the Ireland-Claisen 
rearrangement also dictates the two stereocentres established in the subsequent retro-Cope 
elimination. These two newly formed stereocentres are also set up with the correct 
stereochemistry required in clivonine (1) after the biomimetic ring-switch. 
1.1.5.3. Biomimetic Ring-Switch 
The biomimetic ring-switch is the final sequence of steps in our envisaged synthesis and 
allows for the conversion of the lycorine-type precursor lactamol 50 into the clivonine-type 
product lactol 49 (Scheme 24). 
 
Scheme 24: Biomimetic ring-switch of lactamol 50 to lactol 49. 
As discussed previously (Section 1.1.4, Biosynthesis of the Amaryllidaceae) this type of 
interconversion was first proposed by Barton in 1960, and since then biosynthetic 
interconversions between Amaryllidaceae alkaloid classes has been studied extensively.19,21-22  
Biomimetically, the interconversion between the 6-hydroxy-5,10b-ethanophenthridine and 
the [2]benzopyrano[3,4-c]indole ring systems has already been documented.38-40 Wildman 
has demonstrated the biomimetic conversion of haemanthidine (32) to tazettine (26) by 
treatment with methyl iodide followed by dilute base. (Scheme 25).41  
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Scheme 25: Wildman’s biomimetic conversion of haemanthidine (32) to tazettine (26).41 Reagents and 
Conditions: i) MeI, aq. NaOH. 
Chapter 1                                                                                        Total Synthesis of Clivonine 
25 
 
It was proposed by Wildman that the biomimetic ring-switch was followed immediately by 
an intramolecular hydride shift. This proved to be correct as determined by carrying out the 
interconversion of 6-hydroxycrinamine-6,11-d2 (62) to criwelline-8-d2 (63) (Scheme 26).
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Scheme 26: Wildman’s synthesis and interconversion of 6-hydroxycrinamine-6,11-d2 (62) to criwelline-8-d2 
(63).42 Reagents and Conditions: i) MnO2. ii) CrO3, DMF, H2SO4. iii) LiAlD4, THF. iv) MeI, acetone. v) Dilute 
base.  
Wildman synthesised the deuterated compound 62 by taking 6-hydroxycrinamine (64) and 
firstly oxidising the bridgehead hydroxyl group to the corresponding ketone with manganese 
dioxide, oxidising the lactamol to the corresponding lactam with acidic chromium trioxide in 
DMF containing a trace of sulfuric acid and then reducing this ketolactam with lithium 
aluminium deuteride. The resulting 6-hydroxycrinamine-6,11-d2 (62) was treated with methyl 
iodide to give the methiodide which underwent the ring switch on treatment with dilute base.  
Further studies on the mechanism of the Cannizzaro-type rearrangement following ring-
switch were carried out in the haemanthamine (28) to pretazettine (33) to tazettine (26) 
series.20 Wildman showed that the mechanism for the rearrangement of pretazettine (33) to 
tazettine (26) was that of an intramolecular Cannizzaro-type rearrangement (Scheme 27). 
 
Scheme 27: Wildman’s mechanism for the rearrangement of pretazettine (33) to tazettine (26).20 
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The driving force of the rearrangement is the release of the ring strain of the trans B-D fused 
ring system in pretazettine (33) to give the aldehyde intermediate 65. Hydride shift to give the 
ketone 66 followed by an intramolecular crossed-Cannizzaro reaction with subsequent 
hemiketal formation gives the less strained cis B-D fused ring system of tazettine (26). 
Wildman followed this up with synthetic studies to prove that pretazettine (33) is the original 
natural product and not tazettine (26).43 
Biosynthetically, the interconversion between the lycorine class (cf. 11) and the lycorenine 
class (cf. 27) has been demonstrated by Wildman (cf. Scheme 9, Section 1.1.4). Synthetically, 
Mizukami has achieved the overall conversion of a lycorine-type ring system to a clivonine-
type one via a von Braun degradation. Thus, α-dihydrocaranine (67) was converted to 
clivonine-type product 68 by treatment with cyanogen bromide in boiling benzene (Scheme 
28).44 
 
Scheme 28: Mizukami’s conversion of α-dihydrocaranine (67) to clivonine-type product 68. 44 Reagents and 
Conditions: i) CNBr, benzene, reflux, 3 h.  
Following on from Mizukami’s work Kotera achieved the synthetic conversion of diacetyl-
lycorine (69) into hippeastrine (10) (Scheme 29).45 
 
Scheme 29: Kotera’s conversion of diacetyl-lycorine (69) into hippeastrine (10).45 Reagents and conditions: i) 
CNBr, benzene, reflux, 3 h. ii) 5% EtOH/KOH, RT, 3 h. iii) 3% HCl (aq), reflux, 1 h. iv) 85% formic acid, 37% 
formalin, reflux, 6 h. v) Ac2O, py. vi) CrO3, py, RT, 24 h. 
Kotera used the same von Braun degradation conditions as Mizukami to give two ring opened 
products 70 and 71. Further synthetic manipulation of compounds 70 and 71 gave 
hippeastrine (10). 
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Wildman also attempted to effect the biomimetic interconversion of a lycorine derivative to a 
hippeastrine derivative. Thus, he converted diacetyl-lycorine (69) to diacetyl-7-oxolycorine 
(72) and then attempted a lactam half-reduction to give hemiacetal 73 which would was 
hoped to undergo the desired ring switch on treatment with methyl iodide.22 Wildman was 
however unable to find suitable conditions for the final reduction to access hemiacetal 73 or 
effect the ring-switch (Scheme 30). 
 
Scheme 30: Wildman’s attempt to convert diacetyl-lycorine (69) to hemiacetal 73.22 Reagents and Conditions: 
i) KMnO4. 
Our synthesis of clivonine (1) shows for the first time the biomimetic interconversion 
between the lycorine (11) and lycorenine (27) classes of Amaryllidaceae alkaloids, 
supporting for the first time the biosynthetic hypothesis demonstrated by Barton 50 years 
ago.46 
1.2. Results and Discussion 
1.2.1. Synthesis of (±)- and (+)-Enone 40 
The first target molecule synthesised was enone 40 (Scheme 32), which was accomplished 
using two methods. The first route started from meso-diol 74 and furnished the racemic 
product whilst the second route started with halo-diol 75 or 76 to provide the 
enantiomerically pure product. Diols 74, 75 and 76 are obtained from the microbial oxidation 
of benzene or the respective halobenzene by the bacteria Pseudomonas putida (Scheme 31). 
 
Scheme 31: Microbial oxidation of arenes. 
The first stable cis-cyclohexadienediol was isolated by Gibson in 1968, and since then many 
compounds of these type have been obtained in this way.47-49 
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The first route explored was the synthesis of (±)-enone 40 via the Borchardt-Hudlicky route 
(Scheme 32).50-52 
 
Scheme 32: Synthesis of (±)-enone (40) via the Borchardt-Hudlicky route. Reagents and Conditions. i) DMP 
(6.0 equiv.), pTsOH·H2O (0.2 equiv.), CH2Cl2, 0 ºC, 1 h, 77%. ii) m-CPBA (1.0 equiv.), CH2Cl2, 0 ºC → RT, 16 
h. iii) Pd2(dba)3 (10 mol%), DPPE (20 mol%), m-CBA (~ 1.0 equiv.), THF, RT, 2.5 d, 64% (over two steps). 
The first step was the protection of meso-diol 74 using DMP and p-tolyl sulfonic acid to give 
acetonide 77 in 77% yield. Epoxidation of one of the double bonds of diene 77 
diastereoselectively on the face opposite to the acetonide was achieved using 1 equivalent of 
m-chloroperbenzoic acid (m-CPBA) to give epoxide 78. The subsequent palladium catalysed 
rearrangement gave (±)-enone 40 in 64% yield over the two steps from acetonide 77.  
The palladium catalysed rearrangement was developed by Banwell and Hudlicky whilst 
studying different transformations that could be achieved with compounds such as epoxide 
78. They found that when epoxide 78 was reacted with phthalimide in the presence of 
Pd(PPh3)4 two products were isolated, the expected syn-1,2-addition product, amino alcohol 
79 in 38% yield and a second product assigned as enone 40 in 45% yield (Scheme 33).52  
 
Scheme 33: Banwell and Hudlicky’s reaction of epoxide 78 with phthalimide.52 Reagents and Conditions: i) 
phthalimide (1.0 equiv.), Pd(PPh3)4 (10 mol%), THF, 20 °C, 72 h. 
The isolated yield of enone 40 could be increased up to 70% using [Pd(DPPE)2], however 
rearrangement would only occur in the presence of phthalimide or benzoic acid.52 Giró 
Mañas showed that the reaction proceeded in good yield when m-chlorobenzoicacid (m-
CBA), the by product of the epoxidation, was used as the acid source.24 Therefore, the 
epoxide 78 was not isolated, and 1H NMR analysis was used to estimate the amount of m-
CBA in the reaction mixture; 66% on this occasion. The crude material was therefore 
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submitted to the palladium rearrangement conditions. The proposed mechanism for this 
rearrangement is outlined below (Scheme 34). 
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Scheme 34: Proposed mechanism for the palladium catalysed epoxide rearrangement.24 
The mechanism proposed for this process starts with the diastereoselective nucleophillic 
addition of Pd(0) to the vinyl epoxide at the C2 position to give a π-allyl palladium species on 
the same face as the acetonide. Subsequent palladium mediated 1,4 hydride transfer would 
then give an η-2 Pd(II) ketone intermediate which upon reductive elimination would give (±)-
enone 40. 
The second route explored was the synthesis of (+)-enone 40 via a modified Oppolzer-
Hudlicky route (Scheme 35).23,50,53 
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Scheme 35: Synthesis of (+)-enone 40 via the modified Oppolzer-Hudlicky route. Reagents and Conditions: i) 
DMP (6.0 equiv.), pTsOH·H2O (0.2 equiv.), CH2Cl2, 0 °C, 1-1.5 h, 80 96%, 81 97%. ii) TPP (0.7 mol%), O2, hν, 
CCl4, 0 °C, 2 h. iii) PS-thiourea (1.5 equiv.), CH2Cl2, 0 °C, 45 min – 1 h. iv) Ac2O (1.4 equiv.), DMAP (0.1 
equiv.), Et3N (1.5 equiv.), CH2Cl2, RT, 1 h, 65% from acetonide 80. v) Pd(PPh3)4 (2.5 mol%), TMDS (1.0 
equiv.), CH2Cl2, 45 °C, 22 h. vi) Et3N (1.05 equiv.), 45 °C, 1 h, 43%. 
Similarly to the first route discussed, the first step of the synthesis was acetonide protection 
of the chloro and bromo-diols 75 and 76 with DMP and catalytic p-tolyl sulfonic acid to give 
acetonides 80 and 81 in 96% and 97% yields respectively. Photooxidation of acetonides 80 
and 81 to give endoperoxides 82 and 83 was carried out in CCl4, with TPP as the 
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photosensitiser and was complete within 2-2.5 h for both substrates. However, as reported by 
Hudlicky, we found that the chloro and bromo-acetonides 80 and 81 were very susceptible to 
dimerisation via a Diels-Alder cyclisation when neat at RT or upon standing in solution for 
prolonged periods of time (Scheme 36).54 
 
Scheme 36: Diels-Alder dimerisation of acetonides 80 and 81. 
Due to this facile dimerisation the photooxidation had to be carried out at a relatively low 
concentration and kept at 0 °C throughout irradiation. It was found that the dimerisation of 
bromo acetonide 81 occurred more readily than chloro acetonide 80, therefore future 
reactions were only carried out on chloro acetonide 80. Due to the explosion hazard 
associated with endoperoxides, after irradiation the endoperoxide 82 was not isolated but was 
instead taken through to acetate 84 as a crude reaction mixture.  
Hudlicky has reported the reduction of endoperoxide 82 to hydroxyenone 85 with thiourea to 
proceed in a good yield.50 However, previous members of the Spivey group working on this 
chemistry found hydroxyenone 85 to be very sensitive to the thiourea reaction side products 
and to chromatography on silica gel. Giró Mañas attempted to solve this problem by in situ 
protection of hydroxyenone 85 as its acetate 84, however, this was not successful due to the 
insoluble nature of thiourea in non-alcoholic solvents. The development of a solid supported 
thiourea resin however allowed for the reduction of endoperoxide 82 to hydroxyenone 85 to 
be carried out in CH2Cl2. After filtration of the resin the solution could be treated directly 
with acetic anhydride, triethylamine and catalytic DMAP to give the more stable acetate 84 in 
85% yield from endoperoxide 82.24,53  
The thiourea resin was easily prepared by refluxing commercially available aminomethylated 
polystyrene 86 with isothiocyanate 87 in dry Et2O to form the desired thiourea functionalised 
resin 88 as confirmed by IR spectroscopy (Scheme 37). 
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Scheme 37: Synthesis of thiourea resin 88. Reagents and Conditions: i) Et2O, 35 °C, 24 h.
24,53 
Once the photooxidation of acetonide 80 to endoperoxide 82 was complete the reaction 
mixture was concentrated in vacuo and immediately re-dissolved in CH2Cl2. This solution 
was then added to a pre-swelled suspension of thiourea resin 88 in CH2Cl2 at 0 °C and stirred 
vigorously for 45 min, during which time full consumption of endoperoxide 82 was observed 
by TLC analysis. The reaction mixture was filtered and treated with acetic anhydride to give 
acetate 84 in 65% yield from acetonide 80 after purification (cf. Scheme 35). 
The final step towards (+)-enone 40 was the deacetoxylation of acetate 84, a reaction 
developed by Oppolzer for the total syntheses of (±)-α-lycorane and (+)-trianthine (39).23 
Treatment of acetate 84 with 1,1,3,3-tetramethyldisiloxane in the presence of Pd(PPh3)4 in 
refluxing CH2Cl2 for 22 h saw complete consumption of acetate 84, followed by 
isomerisation of the resultant β,γ-ketone to give exclusively (+)-enone 40 in 43% yield. This 
yield was not as high as expected [Giró Mañas isolated (+)-enone 40 in 78%24] however all 
efforts to improve the yield for this reaction were unsuccessful.  
The synthesis of clivonine (1) was attempted on both (+)- and (±)-enone 40. However, due to 
the limited amount of enantiomerically pure material obtained, the synthesis to give (+)-
clivonine (1) could not be completed. As the route to (±)-enone 40 was shorter (3 steps vs. 4 
steps) and higher yielding (50% from diol 74 vs. 27% from diol 75) in comparison to the 
route to (+)-enone the synthesis was completed using (±)-enone 40 to give (±)-clivonine (1). 
1.2.2. Synthesis of Oxime 46 
With (±)-enone 40 in hand, the first steps towards oxime 46 were to be 1,2-addition of 
lithiated aryl bromide 89 to give the Ireland-Claisen precursor, acetate 41. The Ireland-
Claisen rearrangement would then give acid 45 which would be methylated with 
diazomethane to give the methyl ester 90 (Scheme 38). This chemistry had been previously 
optimised by Giró Mañas.24 
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Scheme 38: Synthesis of methyl ester 90. Reagents and Conditions: i) t-BuLi (1.5 M, 2.05 equiv.), THF, -78 
°C, 1 h. ii) enone 40 (1.0 equiv.), THF, -78 °C, 2 h. iii) Ac2O (2.5 equiv.), 0 °C → RT, 16 h. iv) DIPA (1.75 
equiv.), n-BuLi (1.75 equiv.), THF, -78 °C, 30 min. v) TMSCl (3.0 equiv.), THF, -78 °C → 80 °C, 16 h. vi) 
Diazald (3.0 equiv.), KOH (3.5 equiv.), carbitol:water:Et2O (3:1:1), Et2O, 50 ºC, 16 h, 44% (over three steps 
from enone 40). 
Lithium halogen exchange on aryl bromide 89 with t-BuLi was carried out before adding (±)-
enone 40. The resultant alcohol was quenched with acetic anhydride to give acetate 41 which 
was taken through crude to the Ireland-Claisen rearrangement. Enone formation was achieved 
using LDA made in situ with diisopropylamine and n-BuLi, followed by subsequent enone 
trapping with freshly distilled TMSCl to give the silyl ketene acetyl. The reaction mixture 
was heated to 80 °C to allow for the rearrangement to give acid 45. Methylation with 
diazomethane made in situ by treatment of Diazald® with potassium hydroxide was then 
carried out to give methyl ester 90, in an overall yield of 47% over the three steps. 
The final steps of the synthesis of oxime 46 were the reduction of methyl ester 90 to aldehyde 
91, followed by oxime formation with hydroxylamine hydrochloride. When Giró Mañas 
conducted these experiments the reduction of methyl ester 90 to aldehyde 91 was achieved in 
one step using DIBAL-H in 84% yield.24 Following these conditions the reaction was carried 
out at -78 °C and 1.1 equivalents of DIBAL-H (1 M solution in hexanes) were used in order 
to prevent the over reduction to alcohol 92. However, after 3 h the reaction mixture was 
found to contain both aldehyde 91 and alcohol 92 in 40% and 15% yields respectively 
(Scheme 39). 
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Scheme 39: Reduction of methyl ester 90 with DIBAL-H. Reagents and Conditions: i) DIBAL-H (1 M, 1.1 
equiv), toluene, -78 °C, 3 h, 15% 92, 40% 91. 
In order to prevent the formation of the alcohol the reaction was repeated with extra care 
being taken to ensure the reactants and reaction mixture were kept at -78 °C at all times. 
Unfortunately, after 2 h TLC analysis of the reaction mixture showed that starting material, 
aldehyde 91 and alcohol 92 were all present. As the DIBAL-H reduction was proving to be 
difficult to achieve selectively, it was decided that to save time and material, it would be 
more productive to reduce methyl ester 90 to alcohol 92, then oxidise to give aldehyde 91 
(Scheme 40). Although this added one step to the synthesis it avoided the separation of the 
aldehyde from the alcohol by chromatography. 
 
Scheme 40: Reduction of methyl ester 90 to alcohol 92 followed by oxidation to aldehyde 91. Reagents and 
conditions: i) LiBH4 (2.0 M, 7.0 equiv.), THF, RT, 40 h, 86%. ii) DMSO (2.0 equiv), oxalyl chloride (2.2 
equiv.), NEt3 (3.0 equiv.), THF, -78 ºC. iii) Dess-Martin periodinane (3.0 equiv.), CH2Cl2, 0 ºC → RT, 23.5 h. 
Reduction of methyl ester 90 to alcohol 92 was achieved by the addition of 7 equivalents of 
lithium borohydride (2.0 M solution in THF) to a solution of methyl ester 90 in THF over 40 
h to afford alcohol 92 in 86% yield. The oxidation of alcohol 92 to aldehyde 91 was then 
explored. 
The Swern oxidation was our first choice due to the mild reaction conditions, and its 
selectivity for oxidation of alcohols to aldehydes without over oxidation to carboxylic acids. 
The DMSO and oxalyl chloride were premixed in THF at -78 °C before a solution of the 
alcohol in THF was added. The reaction mixture was allowed to stir at -78 °C for 1.5 h before 
triethylamine was added and the reaction mixture stirred at -78 °C and then warmed to RT for 
2.5 h. Surprisingly, by TLC and 1H NMR analysis no reaction had occurred and the starting 
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material was recovered. It is unclear why this reaction was not successful; however it was not 
explored any further. 
The Dess-Martin oxidation of alcohol 92 to aldehyde 91 was the second route investigated. 
Pleasingly, after just 1 h of stirring alcohol 92 with Dess-Martin periodinane in CH2Cl2 at RT 
100% conversion to aldehyde 91 was observed by 1H NMR. As aldehydes can be quite 
sensitive, aldehyde 91 was not purified at this stage and was taken onto the oxime formation 
step crude (Scheme 41). 
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Scheme 41: Formation of oxime 46 from aldehyde 91. Reagents and conditions: i) NH2OH·HCl (2.0 equiv.), 
NaOAc (2.5 equiv.), CH2Cl2, MeOH, RT, 1 h, 67% from methyl ester 90. 
Conversion of aldehyde 91 to oxime 46 was carried out by adding hydroxylamine 
hydrochloride and sodium acetate to a solution of aldehyde 91 in CH2Cl2. After 1 h of stirring 
the reaction showed no progress by TLC. When this reaction had been undertaken by Giró 
Mañas it was found that undesired products were formed when protic solvents such as 
methanol were used.24 However, these oxime forming reactions are normally carried out in 
such solvents due to the lack of solubility of NH2OH·HCl in aprotic solvents such as CH2Cl2. 
When a small amount of MeOH was added to the reaction mixture the complete formation of 
the product was seen after just 1 h stirring at RT. This is most likely due to a small amount of 
reagent being dissolved by the MeOH allowing the reaction to occur, finally giving oxime 46 
in 67% yield from methyl ester 90 after purification (1:1.2 cis:trans by 1H NMR, the 
stereoisomers have been separated for characterisation, however separation was not carried 
out routinely throughout the synthesis and oxime 46 was taken through subsequent steps as a 
mixture of stereoisomers). 
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1.2.3. Synthesis of Iminium Salt 38 
The next step towards synthesising our clivonine progenitor, iminium salt 38, was the Borch 
reduction of oxime 46 to give hydroxylamine 47.55 This was to be followed immediately by 
the retro-Cope elimination to give the N-hydroxyl pyrrolidine 48 (Scheme 42). 
 
Scheme 42: Conversion of oxime 46 to N-hydroxyl pyrrolidine 48. Reagents and Conditions: i) NaCNBH3 (2.0 
equiv.), HCl/MeOH (1:10), MeOH, 0 ºC → RT. ii) toluene, 80 ºC, 14 h. 
From work conducted previously by Giró Mañas it was anticipated that the Borch reduction 
of oxime 46 to hydroxylamine 47 would prove to be a delicate reaction.24 This reaction was 
attempted several times before a reproducible method was achieved (Table 1). 
Borch Reduction retro-Cope Elimination 
Entry Acid Purification of 
47 
Conc. of 47 in 
toluene  
Outcome 
1 HCl/MeOH 
(1:10) 
slow addition 
Flash 
Chromatography 
0.016 M Hydroxylamine 47 formed in 
52% yield. N-hydroxyl 
pyrrolidine 48 formed. However, 
not detected until further analysis 
of the 1H NMR was undertaken. 
2 HCl/MeOH 
(1:10) 
slow addition 
Flash 
Chromatography 
0.012 M Hydroxylamine 47 formed in 
53% therefore N-hydroxyl 
pyrrolidine 48 formed. However, 
not detected until further analysis 
of the 1H NMR was undertaken. 
3 HCl/MeOH 
(1:10) 
fast addition 
Flash 
Chromatography 
0.012 M No Product 
4 HCl/MeOH 
(1:10) 
fast addition 
Flash 
Chromatography 
0.011 M No Product 
5 HCl/MeOH 
(1:10) 
slow addition 
No Purification 0.015 M Quantitative formation of 
hydroxylamine 47, therefore N-
hydroxyl pyrrolidine 48 formed 
successfully. 
Table 1: Borch reduction followed by retro-Cope elimination attempts. 
Giró Mañas showed that the concentration of oxime 46 was very important to the success of 
the Borch reduction reaction and should be around 0.025 moldm-3.24 The reduction was 
carried out by dissolving oxime 46 and NaCNBH3 in dry methanol. To this solution a few 
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drops of methyl orange indicator were added and the resulting bright yellow solution cooled 
to 0 ºC. A solution of HCl in methanol (1:10 v/v) was added dropwise until an orange colour 
persisted and the reaction mixture stirred for 10 min at 0 ºC. After this time the reaction 
mixture was stirred at RT for 5 min during which time the yellow colour returned. The 
solution was cooled back to 0 ºC and further acid was added to restore the orange colour and 
the reaction mixture allowed to stir for a further 10 min. The reaction mixture was then 
warmed to RT, and the yellow/orange solution was neutralised with 2 M NaOH. After work-
up and purification by flash chromatography 1H NMR analysis showed that hydroxylamine 
47 had been formed in 52% yield (entry 1). The low yield was due to incomplete reduction of 
oxime 46 which was removed during purification. Hydroxylamine 47 was immediately 
dissolved in 10 mL toluene. The solution was degassed by a series of freeze-thaw cycles 
before being heated to 80 °C for 15 h. It was important that there was no water or oxygen 
present in the solution to prevent unwanted disproportionation and dimerisation reactions 
occurring. After this time the toluene was removed in vacuo and analysis of the resulting 
mixture by 1H NMR showed a 1:1.5 ratio of oxime 46 and a new product. The new product 
did not appear to be the desired N-hydroxyl pyrrolidine 48 by comparison with the 1H NMR 
spectra obtained by Giró Mañas, and it was assumed that the reaction had not been 
successful. It is proposed that oxime 46 arises through a disproportionation reaction between 
two molecules of hydroxylamine 47 to give oxime 46 and amine 93 (Scheme 43).  
 
Scheme 43: Proposed disproportionation reaction between two hydroxylamine molecules. 
The reaction was therefore repeated (Table 1, entry 2); this time more acid was added 
initially, in the hope that all oxime 46 would react. However, after work-up and purification 
hydroxylamine 47 was isolated in a comparable yield to the previous reaction. This product 
was subject to the retro-Cope elimination conditions. The 1H NMR spectrum of the crude 
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product mixture looked very similar to that of the previous reaction (entry 1) and it was again 
assumed the reaction had been unsuccessful. 
The Borch reduction was attempted a couple more times in order to increase the yield by 
faster addition of the acid, unfortunately, with no success (entries 3 and 4). After work-up the 
1H NMR spectra of the purified reactions did not correspond to the previous products of this 
reaction (entries 1 and 2). Both products were subject to the retro-Cope conditions, with 
addition of molecular sieves (entry 3) or degassing by purging with argon (entry 4). The 1H 
NMR analysis of the resultant mixtures after 16 h heating at 80 °C showed a mixture of 
compounds had formed, however column chromatography was not successful in isolating any 
expected product. The reaction was then attempted using neat acetic acid a procedure 
optimised within the Spivey group towards the total synthesis of lycorine.56 After work-up 
and submitting the crude reaction mixture to the retro-Cope elimination conditions, the 
outcome, as judged by inspection of the 1H NMR spectrum of the crude product mixture, was 
comparable to that of the previous reactions (entries 3 and 4). The results from these reactions 
suggested that too much acid was perhaps preventing the formation of hydroxylamine 47. 
Whilst experiments were being undertaken to optimise the Borch reduction the combined 
products of the first 2 reactions (entries 1 and 2) were re-analysed by 1H NMR spectroscopy. 
It was concluded that the discrepancies with respect to the spectra of Giró Mañas might 
simply be an artefact of differences in the concentrations at which the spectra were recorded. 
It was also decided that purification of hydroxylamine 47 after the Borch reduction might be 
the cause of the low yields obtained. The Borch reduction followed by the retro-Cope 
elimination was therefore repeated using conditions described for the first reaction (entry 5). 
Hydroxylamine 47 was formed in essentially quantitative yield and the crude product 
submitted to the retro-Cope elimination. The reaction was successful giving N-hydroxyl 
pyrrolidine 48 and a small amount of oxime 46 (1:0.25 by 1H NMR spectroscopy), no 
purification was undertaken and N-hydroxyl pyrrolidine 48 taken through the next steps 
crude. 
With the Borch reduction and the retro-Cope elimination reactions working reproducibly the 
final steps towards iminium salt 38 were carried out (Scheme 44). 
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Scheme 44: Conversion of N-hydroxyl pyrrolidine 48 to formamide 95. Reagents and conditions: i) Raney-Ni 
(excess), EtOH/H2O (10:1), H2, RT, 1-3 h, 90%. ii) acetoformic anhydride (3 equiv.), CH2Cl2, RT, 1-2 h, 31%. 
iii) Ethyl formate, 60 °C, 16 h, 99%.  
Raney-Ni hydrogenolysis in wet ethanol gave pyrrolidine 94 in 90% yield, followed by 
formylation on the crude product with acetoformic anhydride to give formamide 95 in 65% 
yield prior to purification. This was a lower yield than anticipated and it was suspected that 
this could be due to deprotection of the acetonide group in the acidic reaction conditions. The 
resultant diol would have been water soluble and therefore lost during the work-up. 
Purification by flash chromatography proved to be more difficult than expected due to co-
elution of the product with impurities on silica-gel and only a small amount of pure 
formamide 95 was eventually isolated in 34% yield. 
Due to the low yield and problems of purification encountered during the synthesis of 
formamide 95 a different method of formylation was investigated. Pleasingly, when 
pyrrolidine 94 was refluxed in ethyl formate for 16 h, almost quantitative conversion to 
formamide 95 was observed.57 The side product of this reaction is ethanol and the boiling 
point of ethyl formate is just 54 °C, therefore the side product an excess reagent could be 
removed in vacuo. This avoided the need for an aqueous work-up and further purification by 
column chromatography. In addition the mild, non-acidic reaction conditions meant that no 
loss of product was seen by acetonide deprotection. 
The final step in the synthesis of iminium salt 38 is the POCl3 mediated Bischler-Napieralski 
cyclisation of formamide 95, followed by acetonide deprotection with HCl (Scheme 45).  
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Scheme 45: Conversion of formamide 95 to iminium salt 38. Reagents and Conditions: i) POCl3 (1.5 equiv.), 
MeCN, 30 min, 85 °C. ii) 3 M HCl (excess), RT, 1 h. 
To a solution of formamide 95 in MeCN was added POCl3 dropwise and the resulting 
solution refluxed for 30 min. After this time, TLC showed consumption of all starting 
material and the reaction mixture was cooled to RT. Acetonide deprotection was then carried 
out in situ by the addition of aq. HCl (3 M) and allowing the solution to stir at RT for 1 h. 
Solvents were then removed in vacuo to yield iminium salt 38 as a dark orange oil. A 1H 
NMR spectrum of the product was comparable to that obtained by Giró Mañas confirming 
that the iminium salt 38 had been formed. No yield could be reported for this step at this 
stage as the crude product contained unquantified and inseparable phosphorus impurities. 
1.2.4. Purification of Iminium Salt 38. 
As indicated above, the iminium salt 38 contained phosphorus impurities from the POCl3 
used in the Bischler-Napieralski cyclisation. As iminium salt 38 is water soluble an aqueous 
work-up to remove the impurities could not be carried out, and due to the very polar nature of 
the molecule, the use of normal phase silica flash chromatography was not viable. In order to 
save material it was deemed appropriate to trial some purification methods with model 
iminium salt 96. The model compound was synthesised in two steps from commercially 
available 3,4-dimethoxy-N-methylphenethylamine (97) (Scheme 46). 
 
Scheme 46: Synthesis of model iminium salt 96. Reagents and conditions: i) ethyl formate (2.5 equiv.), 60 °C, 
16 h, quant. ii) POCl3 (1.5 equiv.), MeCN, 85 °C, 1 h. 
By simply refluxing 3,4-dimethoxy-N-methylphenethylamine (97) in ethyl formate, 
formamide 98 was formed in quantitative yield. The Bischler-Napieralski cyclisation was 
then carried out on formamide 98 and gave clean conversion to iminium salt 96 as judged by 
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analysis of its 1H NMR spectrum. With the model iminium salt 96 in hand, ion exchange 
chromatography was explored as a method for removing the phosphorus impurities. As the 
iminium salt is a positively charged molecule the ion exchange resin had to be negatively 
charged; this is known as cation exchange chromatography. A strong cation exchange (SCX) 
column was investigated first. These columns are available in pre-packed cartridges, and are 
made up of sulfonic acid groups bonded to silica (Figure 6). 
 
Figure 6: Diagram showing the interaction of a SCX column with iminium salt 96. 
The counter ion on the SCX column is replaced when a positively charged compound/ion of a 
higher affinity is passed down the column. Any uncharged molecules can be washed from the 
column with a suitable solvent. In our case it was envisaged that iminium salt 96 would stick 
to the column, replacing the H+ ion, and the uncharged phosphorus salts would be washed 
away.  
The crude iminium salt 96 was dissolved in methanol and loaded onto a 2 g SCX column. 
The column was then washed with copious amounts of methanol, and eluent fractions spotted 
on a TLC plate. The presence of compounds was monitored by viewing the plate under a UV 
lamp. Once no further impurities were seen to elute, aq. HCl (1.0 M → 3.0 M) was passed 
down the column, and again the eluent was monitored by TLC. The desired product eluted 
very slowly with 3 M HCl and finally concentrated HCl was required to elute the entire 
product. All the eluted fractions were collected and concentrated in vacuo. The 1H NMR 
spectrum of the initial MeOH fractions did not contain the iminium salt 96 but rather a 
phosphorus-containing compound as evidenced by several peaks in the 31P NMR spectrum of 
this fraction. The expected product was found to elute in the HCl aqueous fraction, this was 
confirmed by 1H NMR spectroscopy and mass spectrometry; the 31P NMR spectrum of the 
aqueous fraction showed that it contained no phosphorus. This outcome demonstrated that the 
method of cation exchange chromatography could in principle remove the phosphorus 
impurities. However, the use of concentrated HCl to remove iminium salt 96 from the column 
was not ideal, as it is possible that under such acidic conditions silica and/or binding agents 
may be stripped from the column. 
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It was decided that a weak cation exchange (WCX) column might be better suited to the 
purification of our iminium salt 96, and allow for the use of a weaker acid for elution of the 
compound. The WCX resin selected for use was a carboxylic acid bound (CBA) pre-packed 
column (Figure 7). 
 
Figure 7: Diagram showing the interaction of a CBA column with iminium salt 96. 
Initial attempts at purification with the CBA column using conditions similar to those used 
with the SCX column were not successful. It was clear that iminium salt 96 was not sticking 
to the column and was seen to elute when the column was washed with water in order to 
remove the impurities. These initial results determined that the pH of both the column and the 
sample were key parameters for this purification method to be successful. A CBA column is 
completely ionised at pH 6.8 or above58, however, in these initial attempts at purification the 
column was washed with deionised water with a pH of around 5-6. In order to exert greater 
control over the pH some buffers were tested. 
After some research into different types of buffers it was decided that an ammonium 
carbonate (NH4HCO3·NH2COONH4) buffer would be used. Ammonium carbonate is a 
volatile buffer that should avoid contaminating the purified product with any additional salts. 
A sample of iminium salt 96 was dissolved in a 0.01 M solution of the buffer previously 
basified to pH 8/9 with a 10% aqueous ammonia solution. After loading the sample onto the 
column (which had been pre washed with the buffer to ensure it was > pH 6.8) the column 
was washed with the buffer solution in order to remove the phosphorus impurities. The 
iminium salt 96 appeared to have stuck to the column and was eluted with 0.1 M HCl. This 
system proved to be successful, with the first fractions containing phosphorus but no iminium 
salt 96 by analysis of 1H and 31P NMR spectra. The later fractions contained iminium salt 96, 
free of phosphorus impurities. 
Having optimised this method for the purification of the model iminium salt 96 the method 
was applied to iminium salt 38. It was found that the purification method was successful on a 
20 mg scale, and that one column could be reused several times with complete removal of 
phosphorus impurities. This allowed for the purification of a sufficient quantity of iminium 
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salt 38 to allow investigations of the final steps of the synthesis. However, after removal of 
the aqueous media from iminium salt 38 by freeze drying it was clear that salts from the 
ammonium carbonate buffer where still present. These salts were therefore removed by 
reverse phase C18 chromatography, to give clean iminium salt 38. The yield for the final 
Bischler-Napieralski cyclisation could now be calculated as 42%. 
In summary the synthesis of iminium salt 38 from oxime 46 could be completed in five steps 
in a 30% overall yield, with solid phase chromatography at the last step being the only 
purification method used throughout the five steps.  
1.2.5. Biomimetic Ring-Switch. 
The three final steps of the synthesis were the conversion of iminium salt 38 to lactamol 50, 
methylation to induce the biomimetic ring-switch and then benzylic oxidation of lactol 49 to 
give (±)-clivonine (1) (Scheme 47). 
 
Scheme 47: Final steps of the synthesis of clivonine (1). Reagents and Conditions: i) Cs2CO3 sat. aq. sol. (0.77 
M, 1.3 equiv.), DMSO-d6/D2O (5:1), RT, 5-10 min. ii) MeI (2 equiv. sol. in DMSO-d6), RT, 5-10 min. iii) 
Fetizon’s (15 equiv.), toluene, 80 °C, 1 h, 32% over the three steps. 
The first of these steps was conversion of iminium salt 38 to lactamol 50. Giró Mañas found 
that using chemistry developed by Rozwadwoska59 and treating iminium salt 38 with NaOD 
in D2O/DMSO-d6 lead to the formation of lactamol 50 however, decomposition occurred 
very rapidly via a Cannizzaro type disproportionation under the reaction conditions. 
Successful conversion to lactamol 50 was achieved by using Dostal and Seckarova’s 
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conditions and treating iminium salt 38 with Na2CO3 in D2O/DMSO-d6.
60 Giró Mañas 
adapted these conditions and found that quantitative conversion to lactamol 50 could also be 
achieved using Cs2CO3 as the base.
24 
The first challenge was to repeat the reaction using the conditions developed by Giró Mañas 
to obtain lactamol 50 from iminium salt 38. As expected, this was by no means trivial (Table 
2). 
 
Entry Solvent Conditions (In a NMR 
Tube) 
Outcome (
1
H NMR) 
1 DMSO-d6 i) 10 equiv. Na2CO3 Decomposition 
2 DMSO-d6 i) 10 equiv. Cs2CO3 Decomposition 
3 DMSO-d6/D2O 2:1 i) Neutralisation (sat. 
aq. Na2CO3)  
ii) 10 equiv. Na2CO3 
Decomposition 
4 DMSO-d6/D2O 2:1 i) Neutralisation (sat. 
aq. Na2CO3)  
ii) 2 equiv. Na2CO3  
Decomposition 
5 DMSO-d6/D2O 2:1 i) Neutralisation (sat. 
aq. Cs2CO3)  
ii) 2 equiv. Cs2CO3 
Lactamol 50 observed (trace to clivonine 
(1)) 
6 DMSO-d6/D2O 5:1 Cs2CO3 aq. sol (0.77 M, 
1.3 equiv.) 
Quantitative conversion to lactamol 50 
(13% to clivonine (1)) 
Table 2: Attempts at the conversion of iminium salt 38 to lactamol 50. 
Initial attempts to convert iminium salt 38 to lactamol 50 with either Na2CO3 or Cs2CO3 were 
unsuccessful and only decomposition of lactamol 50 was observed (entries 1-4). It was 
decided that Cs2CO3 would be used as the base in future reactions, in the expectation that the 
higher solubility of CssCO3 in DMSO in comparison to Na2CO3 would increase the rate of 
lactamol 50 formation and allow for the use of less base (entry 5). After neutralisation of the 
sample with a saturated solution of Cs2CO3 in D2O and the addition of 2 equivalents of solid 
Cs2CO3 followed by sonication the 
1H NMR spectrum showed complete consumption of the 
iminium salt 38 and the presence of lactamol 50 (reactions were carried out in NMR tubes 
and conversion was monitored by the disappearance of the iminium methine proton at δ ~ 
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9.07 ppm and the appearance of a new peak at δ ~ 4.92 ppm corresponding to the lactamol 
methine proton). This crude material was carried through the two final steps of the synthesis, 
methylation (~ 25 equiv. MeI), followed by a change in solvent to toluene and benzylic 
oxidation with Fetizon’s reagent.61 However, after work-up only a trace of clivonine (1) was 
observed in the 1H NMR spectrum of the crude reaction mixture. Although only a small 
amount of the target product had been obtained, this result demonstrated that lactamol 50 had 
been formed. Quantitative conversion to lactamol 50 was achieved when a neutral solution of 
iminium salt 38 was treated with an aqueous solution of Cs2CO3 (0.77 M, 1.3 equiv.) (entry 
6). After methylation (~ 10 equiv. MeI) and oxidation (Fetizon’s reagent) clivonine (1) was 
isolated in 13% after purification by preparative TLC. This method could be carried out 
reproducibly to give a quantitative conversion of iminium salt 38 to lactamol 50 as judged by 
analysis of the 1H NMR spectra. 
It was assumed that the low yield (13%, cf. Table 2, entry 6) obtained for the synthesis of 
clivonine (1) after methylation and oxidation was due to the inefficiency of the benzylic 
oxidation of lactol 49 using Fetizon’s reagent. Therefore in an effort to optimise this step 
some different oxidation conditions were investigated (Table 3). 
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Entry Solvent Conditions Outcome 
1 DMSO-d6 EtOAc, 1.2 equiv. IBX  No Product 
2 DMSO-d6/D2O (5:1) Fremy’s Salt, K2NO(SO3)2, 2 equiv. Trace clivonine (1) 
3 THF/0.1 M HCl (4:1) MnO2, 2 equiv. then 1.1 equiv. SM 
Table 3: Alternative benzylic oxidation conditions. 
Research carried out by Moorthy has shown that IBX can be used to oxidise lactols to 
lactones.62 In light of this work, formation of lactamol 50 was carried out in DMSO-d6, 
followed by methylation (~ 10 equiv. MeI). The reaction mixture was then diluted with 
EtOAc and 1.2 equivalents of IBX added (entry 1). The reaction mixture was then heated to 
80 °C for 1 h, filtered and concentrated. Unfortunately, examination of the 1H NMR spectrum 
of the crude product showed no traces of clivonine (1). It was concluded that the desired 
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product was not isolated due to oxidation of the hydroxyl group as well as oxidation of lactol 
49.  
Fremy’s salt K2NO(SO3)2 is a single electron oxidant and has been shown to 
chemoselectively oxidise benzylic alcohols over saturated alcohols.63 Therefore after 
formation of lactamol 50 and methylation (~ 10 equiv. MeI) the crude reaction mixture was 
added to a solution of Fremy’s salt in a 5% aqueous Na2CO3 solution (entry 2). After 1 h 
stirring at room temperature a new spot had formed by TLC, however after work-up the 1H 
NMR spectrum of the crude reaction mixture showed only a trace of clivonine (1) had 
formed. 
Wildman has shown that solid MnO2 can be used for the benzylic oxidation of lycorenine 
(27).64 This oxidation was attempted on our substrate, however this time instead of forming 
lactamol 50 and treating with methyl iodide before oxidation, iminium salt 38 was treated 
directly with MnO2 in an acidic media (entry 3). It was envisaged that the iminium salt 38 
could undergo nucleophillic attack by water, and the resulting lactamol 50 would be 
protonated under the acid conditions. This would allow for the ring-switch to occur and with 
the presence of the MnO2 benzylic oxidation of the corresponding lactol to lactone would 
give NH-clivonine, methylation of which could then afford clivonine (1). Unfortunately, the 
iminium salt 38 was not reactive under these conditions and only starting material was 
recovered after stirring for 6 h at RT.  
As no improvement on the yield had been achieved by using different oxidants for the 
benzylic oxidation the methylation conditions were investigated next. Methylation had 
previously been carried out by the addition of an excess (10-25 equiv.) of methyl iodide 
directly into the solution of lactamol 50. As previously discussed, the quantitative formation 
of lactamol 50 was monitored by 1H NMR spectroscopy. The 1H NMR spectrum recorded 
after the addition of excess methyl iodide showed a complex mixture of products. At first it 
was assumed that this mixture was due to the labile nature of the lactamol 50, and that this 
compound was in equilibrium with aldehyde 99 and lactol 49 (see below). This notion was 
corroborated by the appearance of a singlet at δ ~ 10 ppm in the 1H NMR spectrum which 
was assigned as the carbonyl proton of aldehyde 99. However, it was quite possible that over 
methylation could have been occurring in the presence of such a large excess of methyl 
iodide. Various reactions were therefore carried out in order to improve the methylation step, 
in the hope to improve the overall yield through to clivonine (1) (Table 4). 
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Entry Solvent Conditions Outcome 
1 DMSO-d6/D2O 5:1 MeOTf (1.2 equiv.) No Product 
2 DMSO-d6/D2O 5:1 Me2SO4 (1.5 equiv.) No Product 
3 DMSO-d6 MeI (1.0 equiv. then 1.0 equiv) Trace 
4 DMSO-d6/D2O 5:1 MeI (0.5 equiv. then 0.5 equiv.) 27% clivonine (1) 
5 DMSO-d6/D2O 5:1 MeI (1.0 equiv.) 27% clivonine (1) 
6 DMSO-d6/D2O 5:1 MeI (2.0 equiv.) 32% clivonine (1) 
Table 4: Conditions for methylation. 
The use of alternative methylating reagents such as methyl triflate and dimethyl sulfate 
(entries 1 and 2) afforded no clivonine (1) after subsequent benzylic oxidation with Fetizon’s 
reagent. When 1.0 equivalent of a methyl iodide solution in DMSO-d6 was added to a 
solution of lactamol 50 the 1H NMR spectrum showed complete consumption of lactamol 50 
and the formation of a mixture of what appeared to be two compounds. One of the products 
was tentatively assigned as aldehyde 99 on the basis of the appearance of a singlet at δ ~ 9.5-
10 ppm and a N-methyl singlet at δ ~ 2.3 ppm. Pleasingly after oxidation and purification by 
preparative TLC clivonine (1) was isolated in 27% yield. This was slightly improved when 2 
equivalents of methyl iodide were added to lactamol 50 and clivonine (1) was isolated in 32% 
yield from iminium salt 38. Further improvement of the yield was not possible due to the 
formation of what appeared to be the quaternised salts after methyl iodide addition.  
In conclusion, the biomimetic ring-switch of our lycorine type precursor, iminium salt 38 had 
been achieved to give (±)-clivonine (1) in 32% yield. This series of reactions was 
reproducible and allowed for the isolation of enough (±)-clivonine (1) for full 
characterisation. The spectroscopic data that we obtained for (±)-clivonine (1) matched what 
was reported for the natural material (Figure 8).9,13  
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Figure 8: 
1H NMR spectrum of (±)-clivonine (1) (400 MHz, CDCl3). 
Additionally a single-crystal X-ray structure determination was carried out on its 
hydrochloride salt, which confirmed the correct structure had been obtained after the 
biomimetic ring-switch (Figure 9). 
 
Figure 9: Molecular structure of the hydrochloride salt of (±)-clivonine (1) as determined by single-crystal X-
ray crystallography. 
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1.3. Conclusions and Future Work 
The main aim of this project was to complete the total synthesis of clivonine (1) via a 
biomimetic ring-switch from lycorine type precursor iminium salt 38. The initial challenge 
was to repeat the synthesis of iminium salt 38 which had been previously developed by Giró 
Mañas, and once completed to develop a method of purification. This was achieved by the 
use of a CBA weak cation exchange column followed by C18 reverse phase chromatography. 
This gave us access to clean iminium salt 38 which could be used for the optimisation of the 
final biomimetic ring-switch.  
The second challenge was the optimisation of the biomimetic ring-switch, steps tentatively 
achieved by Giró Mañas. This challenge was successfully completed allowing for the 
isolation of clivonine in 32% over the three steps from iminium salt 38. This synthesis has 
shown experimentally for the first time the conversion of a lycorine-type structure to that of a 
clivonine type structure in a biomimetic fashion, confirming synthetically the biosynthetic 
pathway first proposed by Barton in 1960. 
The total synthesis of lycorine (11) via a retro-Cope elimination is currently being 
undertaken within the Spivey group. Once this total synthesis has been completed, the 
conditions optimised for the biomimetic ring-switch will be used to then synthesise 
hippeastrine (10) directly from lycorine (11). This chemistry should also assist with planned 
investigations into the interconversion between these alkaloids during the life cycle of the 
Amaryllidaceae. 
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Chapter 2 – Synthesis of meso-Diol 74 
2.1. Introduction 
2.1.1. Importance and Synthetic Utility of meso-Diol 74 and Derivatives 
The starting material for our total synthesis of clivonine was meso-diol 74, obtained from the 
microbial oxidation of benzene (cf. Chapter 1, Section 1.2.1).46 Gibson first proposed that 
meso-diol 74 was an intermediate in the oxidation of benzene to catechol by the bacterium 
Pseudomonas putida in 1968.47 He later showed that it was possible to isolate the meso-diol 
intermediates during the oxidation of benzene and toluene by a mutant strain of Pseudomonas 
putida (P. Putida 39/D).65 The area of microbial oxidation of arenes has been highly 
researched, with access to many monocyclic and fused aromatic diols having been 
established.48,66 
However, it was not until the 1980’s that the synthetic utility of such compounds was realised 
in industry and academia.67 The use of these types of compounds has been reviewed 
previously on several occasions.48,67-69 Therefore this section will only highlight some 
selected examples of the synthetic use of meso-diol 74 and its derivatives.  
Imperial Chemical Industries (ICI) demonstrated the first industrial use of meso-diol 74, with 
their synthesis of poly(p-phenylene) (100) (Scheme 48).70-71 
RO OR RO OR
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n
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Scheme 48: ICI’s synthesis of poly(p-phenylene) (100).70-71 
Polymerisation of protected meso-diol 74 in the presence of radical initiators gave the 
polymer 101, which was heated at high temperatures to affect aromatisation to give poly(p-
phenylene) (100). It was found that the methyl carbonate protecting group was the most 
effective, due to the decomposition of the resulting methyl carbonic acid into methanol and 
carbon dioxide after aromatisation at high temperature.71 This chemistry has been developed 
further by Grubbs who has used transition metal catalysis to ensure 1,4-linked products are 
obtained selectively in high yields.72-73 
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After ICI’s synthesis of poly(p-phenylene) (100) Ley was the first organic chemist to 
demonstrate the application of compounds such as meso-diol 74 in natural product synthesis, 
with his synthesis of (±)-pinitol (102) (Scheme 49).74 
 
Scheme 49: Ley’s synthesis of pinitol (102).74-75 Reagents and Conditions: i) BzCl (2.2 equiv.), DMAP (1.8 
mol%), py, 0 °C → RT, 16 h. ii) m-CPBA (90%, 1.2 equiv.), CH2Cl2, pH 8 phosphate buffer, RT, 22 h. iii) 
CSA·H2O (14 mol%), CH3Cl, MeOH, RT, 22.5 h. iv) Et4NOAc·4H2O (0.25 equiv.), 
tBuOOH (70% aq. sol., 1.6 
equiv.), OsO4 (0.18 mol%), acetone, 0 °C → RT, 3 d. v) Et3N/MeOH/H2O (1:5:1), RT, 3 h. 
The synthesis began with meso-diol 74 derivative dibenzoate 103. Epoxidation with m-CPBA 
gave predominately anti epoxide 104 (the syn epoxide was isolated in 17% yield). 
Regioselective ring opening of anti epoxide 104 with methanol gave dibenzoate 105. Finally, 
dihydroxylation with catalytic osmium tetroxide followed by hydrogenation gave (±)-pinitol 
(102) in an overall 61% yield.74 Ley went on to synthesise both (+)-pinitol (102) and (-)-
pinitol (102) by separating the enantiomers of the menthoxyacetic ester of (±)-dibenzoate 105 
before subsequent oxidation and hydrogenation.75 
Since Ley’s synthesis of pinitol (102) many groups have used meso-diol 74 and derivatives 
thereof for the synthesis of natural and biologically important products. One such group of 
compounds that are often synthesised starting from meso-diol 74 are the conduritols. The 
conduritols are an important class of compounds that possess interesting biological and 
medicinal properties such as antibiotic, antileukemic and glycosidase inhibitory effects 
(Figure 10).76 
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Figure 10: Structure of conduritols A-F.77 
Of this group of compounds only conduritol A and conduritol F have been isolated as natural 
products, making this group of compounds appealing synthetic targets. Over the last 20 years 
many racemic and asymmetric syntheses of the conduritols and conduramines (compounds 
where one of the hydroxyl groups of the corresponding conduritol has been replaced by an 
amine) and their analogues have been published.48,69,76-78 
A recent example is Balci’s synthesis of bromo conduritol-C (106) (Scheme 50).79 
 
Scheme 50: Balci’s synthesis of bromo conduritol-C (106).79 Reagents and Conditions: i) O2, TPP, hν, CH2Cl2, 
RT. ii) Br2 (1.1 equiv. in hexane), CHCl3, 0 °C, 1.5 h. iii) DMSO, 20 min. iv) NaBH4 (1.9 equiv.), THF, 0 °C, 4 
h. v) Ac2O, H2SO4, RT, 12 h. vi) NH3 gas, MeOH, 30 min, RT, 2 h. 
Photooxidation of meso-diol 74 derivative acetonide 77 was carried out to give endoperoxide 
107 in 95% yield. Treatment of endoperoxide 107 with bromine gave dibromide 108 which 
underwent rearrangement in a solution of DMSO, followed by spontaneous HBr elimination 
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to give bromoketone 109. Hydride reduction with NaBH4, gave bromodiol 110 which was 
subject to acetate protection in the presence of acid to give tetraacetate 111. Finally, 
deprotection with NH3 in methanol afforded the desired bromo conduritol-C (106) in an 
overall 48% yield. 
Studer has also demonstrated the use of acetonide 77 during the development of a Cu(I) 
catalysed enantioselective nitroso Diels-Alder reaction, and has employed this method for the 
asymmetric synthesis of (-)-peracetylated conduramine A-1 (112) (Scheme 51).80 
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Scheme 51: Studer’s synthesis of (-)-peracetylated conduramine A-1 (112).80 Reagents and Conditions: i) 2-
nitrosopyridine (1 equiv.), [CuPF6(MeCN)4] (10 mol%), Walphos-CF3 (10 mol%), CH2Cl2, -86 °C → -20 °C, 18 
h. ii) [Mo(CO)6] (1.2 equiv.), NaBH4 (1.3 equiv.), MeOH/H2O (10:1), 65 °C, 10 h. iii) DMF, TBSCl (1.4 
equiv.), im (2.9 equiv.), RT, 24 h. iv) CH3MgCl (1.2 equiv.), methyl chloroformate (3.0 equiv.), RT, 12 h. v) 
MeOTf (1.1 equiv.), 0 °C, 12 h. vi) NaOH (2 M, excess), MeOH, 50 °C, 6 h. vii) AcCl (15.0 equiv.), NaI (15.0 
equiv.), MeCN, 65 °C, 40 h. 
The enantioselective nitroso Diels-Alder reaction of acetonide 77 with 2-nitrosopyridine was 
carried out using [CuPF6(MeCN)4]/Walphos-CF3 as the catalyst to give the cycloadduct 113 
in 99% yield and 93% ee. Cleavage of the N-O bond with subsequent TBS protection of the 
resultant hydroxyl group gave the amino alcohol 114 in 91% yield. Treatment of the amino 
alcohol 114 with methyl magnesium chloride followed by methyl chloroformate gave the 
carbamate 115. Removal of the N-(2-pyridyl) group from carbamate 115 was achieved by N-
methylation of the pyridyl group with MeOTf followed by hydrolysis of the pyridinium salt 
with NaOH. Finally, cleavage of the acetonide and carbamate groups followed by acetyl 
protection gave (-)-peracetylated conduramine A-1 (112) in an overall 40% yield. 
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The groups of Pipersberg, Wood and Balci have also made use of the Diels-Alder reaction of 
acetonide 77 with a range of dienophiles towards the synthesis of natural or biologically 
active products.68,81-83 Burnell has also studied the Diels-Alder reaction of acetonide 77 with 
all carbon and azo dienophiles, investigating the facial selectivity observed in such 
reactions.84 There are many more instances in which derivatives of meso-diol 74 have been 
used in synthesis85-86 and to provide industrially relevant materials87, highlighting the 
importance of these types of compounds. 
Meso-diol 74 is available to buy commercially, sourced from the microbial oxidation of 
benzene as described above. However, it is expensive, and due to its instability cannot be 
stored as a solid, even at temperatures below 0 °C.67 For this reason, non-enzymatic syntheses 
of meso-diol 74 have been developed. 
2.1.2. Previous Syntheses of meso-Diol 74 Derivatives 
Yang developed the first chemical synthesis of meso-diol 74 derivative acetonide 77 in 1982 
starting from 1,4-cyclohexadiene (116) (Scheme 52).88-89 
 
Scheme 52: Yang’s synthesis of acetonide 77.88-89 Reagents and Conditions: i) Br2, CHCl3, -78 °C. ii) aq. 
KMnO4, buffered (MgSO4) EtOH/H2O, -5 °C for 5.5 h, then -15 °C for 15 h. iii) DMP (excess), H
+ (catalytic). 
iv) DBU (3.6 equiv.), benzene, reflux, 6 h. 
1,4-Cyclohexadiene (116), available commercially or from the Birch reduction of benzene, 
was subject to a low temperature bromination forming dibromide 117, which precipitated out 
of solution preventing double bromination occurring. Dihydroxylation of the remaining 
double bond with potassium permanganate gave dibromo diol 118, which was treated with an 
excess of DMP and catalytic acid to give dibromo acetonide 119. Finally bis elimination of 
HBr using DBU as a base in refluxing benzene for 6 h gave acetonide 77 in an overall yield 
of 26% over 4 steps.  
Johnson has reported that the dihydroxylation step of the above described synthesis can be 
improved by using osmium tetroxide and NMO instead of potassium permanganate to give 
acetonide 77 after acetonide protection and bis-elimination in an overall yield of 87% from 
benzene.90 Although interestingly, all subsequent reports of the use of this sequence of 
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reactions have cited Yang’s work and reported yields comparable to his original report, 
including Giró Mañas in our group (see below). 
Mereyala has used myo-insitol (120) for the synthesis of meso-diol 74 derivative 
cyclohexylidene 121 (Scheme 53).91 
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Scheme 53: Mereyala’s synthesis of cyclohexylidene 121.91 Reagents and Conditions: i) ethoxycyclohexene, 
pTsOH (catalytic), DMF, 100 °C, 2 h. ii) PPh3 (3.0 equiv.), I2 (3.0 equiv.), im (3.0 equiv.), toluene, reflux, 6 h. 
iii) pTsOH (catalytic), CH2Cl2, 0-5 °C, 4 h. iv) PPh3 (3.0 equiv.), I2 (3.0 equiv.), im (3.0 equiv.), toluene, reflux, 
1 h. 
The first step of the synthesis was treatment of myo-insitol (120) with ethoxycyclohexene to 
give a mixture of acetals 122, 123 and 124. Acetals 123 and 124 were taken forward and 
treated with triphenyl phosphine, iodide and imidazole in refluxing benzene which resulted in 
the elimination of the trans-diol group to give the corresponding cyclohexene acetals 125 and 
126. Deprotection of the trans-cyclohexylidine group to furnish diols 127 and 128, followed 
by a second trans-diol elimination under the same conditions gave cyclohexylidene 121 in an 
overall yield of 24% over 4 steps.  
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Fabris has also utilised myo-insitol (120), for the synthesis of meso-diol 74 derivative 
acetonide 77 (Scheme 54).92 
 
Scheme 54: Fabris synthesis of acetonide 77.92 Reagents and Conditions: i) DMP, pTsOH (catalytic), DMSO, 
120 °C. ii) MsCl (5.0 equiv.), DMAP (5 mol%), py, 0 °C→RT, 16 h. iii) KI (7.7 equiv.), NMP, 120 °C, 10 Torr, 
1 h. iv) Zn/Cu couple (12.0 equiv.), 120 °C, 24 h, then 20 Torr, 145 °C. 
Acetonide protection of the cis diol unit of myo-insitol (120) to give tetrol 129, followed by 
mesylation of the remaining hydroxyl groups provided tetramesylate 130. Elimination of the 
two mesylated trans-diol groups to give acetonide 77 was achieved using a zinc/copper 
couple at high temperature in NMP. Fabris found that the quality of the zinc/copper couple 
was important in order to obtain good yields of acetonide 77. The product was removed from 
the zinc salts by distillation at 145 °C at 20 Torr. Isolation of acetonide 77 was then achieved 
after work-up by careful distillation under reduced pressure to afford the desired product in 
yields between 48-60%. The overall synthesis of acetonide 77 was complete in 3 steps with 
an overall yield of 36%. 
Due to problems that were encountered within the group when attempting to repeat the 
synthesis of acetonide 77 reported by Yang and modified by Johnson, and the seemingly 
difficult final step of the Fabris synthesis we have developed an alternative synthesis of 
acetonide 77 from 1,3-cyclohexadiene (131). 
2.1.3. Synthetic Strategy and Project Aims 
Our proposed synthesis of acetonide 77 starts with the photooxidation of 1,3-cyclohexadiene 
(131) to give endoperoxide 132. Rearrangement of endoperoxide 132 with CoTPP should 
then give the syn bis-epoxide 133. Bis ring opening of bis-epoxide 133 with a bromide source 
should then give dibromo diol 134 which upon acetonide protection, should furnish 
dibromide 135. Finally, bis-elimination of HBr from dibromide 135 would be expected to 
afford acetonide 77 (Scheme 55). 
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Scheme 55: Our proposed synthesis of acetonide 77. 
Photooxidation of dienes with singlet oxygen (1O2) is a reaction that has been carried out 
many times within the group and the formation of endoperoxide 132 from 1,3-
cyclohexadiene (131) has previously been achieved in good yields.53 At the outset of this 
work, the rearrangement of endoperoxide 132 with CoTPP to give bis-epoxide 133 had also 
been carried out within the group and had been shown to be successful by analysis of the 1H 
NMR spectrum of the product, however isolation of bis-epoxide 133 had suffered from low 
yields. Opening of the bis-epoxide 133 with CuBr2 to give dibromodiol 134 had also been 
achieved on a small scale, however, as with the isolation of bis-epoxide 133, only low yields 
of the desired product had been obtained. The first aim of the project, therefore, was to 
develop a method of accessing scalable amounts of dibromodiol 134. The final step of our 
synthesis is bis-elimination of dibromide 135 to give acetonide 77. This step had been 
attempted within the group, but again with little success. The second aim of this project, 
therefore, was to optimise the bis-elimination conditions in order to isolated adequate 
quantities of acetonide 77 for future syntheses. 
2.1.3.1. Co(II)TPP Rearrangement of Endoperoxides to syn bis-Epoxides 
The chemistry of bicyclic endoperoxides (e.g. endoperoxide 132) has been studied 
comprehensively over the past 20 to 30 years.93 Thermolysis and photolysis of unsaturated 
endoperoxides, formed from the reaction of the corresponding diene with 1O2, to give syn bis-
epoxides (e.g. bis-epoxide 133) are common reactions for these types of compounds.93-94 An 
early example of this chemistry was shown by Masheshwari in 1970 with the photolysis of 
the natural product ascaridole (136) to the corresponding bis-epoxide 137 (Scheme 56).95 
 
Scheme 56: Masheshwari’s photolysis of ascaridole (136) to bis-epoxide 137.95 
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However, it has been shown that the thermolysis and photolysis reactions of some 
unsaturated [n.2.2] bicyclic endoperoxides result in the formation of epoxyketones in addition 
to the expected bis-epoxides. The epoxyketone readily undergoes rearrangement to the 
corresponding hydroxyenone in the presence of acid, base or silica gel and is often not 
isolated.95-96 For example, both thermolysis and photolysis reactions of endoperoxide 132 
results in the formation of both bis-epoxide 133 and epoxyketone 138 of which the latter 
readily rearranges to give hydroxyenone 139 (Scheme 57).95-96  
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Scheme 57: Thermolysis or photolysis reactions of endoperoxide 132 to bis-epoxide 133 and hydroxyenone 
139.95-96 
The mechanism for the formation of both bis-epoxide 133 and epoxyketone 138 start with the 
initial cleavage of the O-O bond of endoperoxide 132 to give the diradical species 140, 
followed by the cyclisation of one of the oxygen radicals with the double bond to give the 
monoepoxide 141. At this point two different routes are followed, either monoepoxide 141 
undergoes a second cyclisation to give bis-epoxide 133 (path A, Scheme 58) or a 1,2-
hydrogen atom shift occurs to give the epoxyketone 138 (path B, Scheme 58).96 
 
Scheme 58: Mechanisms of bis-epoxide 133 and epoxyketone 138 formation.96 
Carless has shown that a number of endoperoxides undergo thermolysis and photolysis 
reactions to give a mixture of bis-epoxides and epoxyketones in varying ratios dependant on 
the substrate structure.96 An interesting example demonstrating this variation in product ratio 
involves the thermolysis and photolysis of tert-butyl substituted endoperoxides 142 and 143 
(Scheme 59). 
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Scheme 59: Carless’ thermolysis and photolysis reaction of tert-butyl endoperoxides 142 and 143.96 
When cis tert-butyl endoperoxide 142 was subject to thermolysis or photolysis reactions the 
major product was epoxyketone 144 and the ratio of this product to bis-epoxide 145 was 
approximately 7:3. However, when trans tert-butyl endoperoxide 143 underwent thermolysis 
or photolysis under identical conditions a complete switch in the ratio of the products was 
observed with bis-epoxide 146 being the major product and with the ratio of bis-epoxide 146 
to epoxyketone 147 being approximately 8:2. Carless proposed that the difference in ratio of 
the products was due to conformational differences between the two substrates (Scheme 60). 
 
Scheme 60: Carless’ rationale for the formation of epoxyketone 144 and bis-epoxide 146 based on 
conformational analysis.96 
From the conformations depicted above it can been that in monoepoxide 148 the radical on 
the carbon atom is adequately aligned with the axial proton for the 1,2-hydrogen atom shift to 
occur to give epoxyketone 144. Whereas for monoepoxide 149 the oxygen radical is now in 
the axial position set up for the ring closure to give bis-epoxide 146.96 
In 1980 Foote discovered that cobalt(II) tetraphenylporphyrin (CoTPP) could be used as a 
catalyst for the selective rearrangement of endoperoxides to bis-epoxides at low temperature, 
circumventing the formation of epoxyketones.97 He showed that this is the case for a number 
of substrates, including unsaturated [n.2.2]bicyclic endoperoxides. For example, when 
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endoperoxide 132 was treated with CoTPP (1-5 mol%) at -10 °C bis-epoxide 133 was 
isolated in 74% yield in comparison to 39% yield for thermolysis and 27% yield for 
photolysis (Scheme 61). 
 
Scheme 61: Foote’s rearrangement of endoperoxide 132 with CoTPP vs. photolysis and thermolysis.97 
A mechanistic rationale for this selectivity has been postulated by Balci. He suggests that 
because CoTPP is capable of cleaving the O-O bond of the endoperoxide by electron transfer 
at low temperature, there is not sufficient energy for the 1,2-hydrogen atom shift to occur to 
give the epoxyketones, therefore bis-epoxides are the only products obtained.98 Balci has 
demonstrated that this is the case for a number of unsaturated [n.2.2]bicyclic endoperoxides 
(Scheme 62).99 
 
Scheme 62: Balci’s reactions of endoperoxides with CoTPP.99 
The CoTPP rearrangement of endoperoxides to bis-epoxides has been applied to the synthesis 
of some interesting natural products that possess syn bis-epoxide moieties. For instance, the 
synthesis of (+)-crotepoxide (150) and (+)-boesenoxide (151) completed by Shing in 1998 
(Scheme 63).100 
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Scheme 63: Shing’s Synthesis of (+)-crotepoxide (150) and (+)-boesenoxide (151).100 Reagents and Conditions: 
i) O2, TPP (0.1 mol%), CCl4, hν, 5 h. ii) CoTPP (0.4 mol%), CHCl3, 0 °C, 3 h. iii) pyridinium fluoride (3 drops 
for a 0.1 mmol scale reaction), THF, RT, 12 h. iv) Et3N (2.0 equiv.), DMAP (catalytic), Ac2O (1.1 equiv.), 
CH2Cl2, RT, 12 h. v) Et3N (2.0 equiv.), DMAP (catalytic), BzCl (1.2 equiv.), CH2Cl2, RT, 12 h. 
The key intermediate for the synthesis of (+)-crotepoxide (150) and (+)-boesenoxide (151) 
was diene 152. This compound was synthesised from (-)-quinic acid in 13 steps with an 
overall yield of 17%. Photooxidation of diene 152 with 1O2 and TPP in CCl4 gave 
endoperoxide 153 in 79% yield. Treatment of endoperoxide 153 with CoTPP gave the bis-
epoxide 154 in a quantitative yield. The final steps were de-silylation to give alcohol 155 
followed by protection of the hydroxyl group with acetic anhydride or benzoyl chloride to 
give (+)-crotepoxide (150) and (+)-boesenoxide (151) respectively. 
The total synthesis of (+)-crotepoxide (150) described above follows a very similar route to 
that published by White in 1976 (Scheme 64).101 
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Scheme 64: White’s synthesis of (±)-crotepoxide (150).101 Reagents and Conditions: i) O2, hematoporphyrin, 
py, hν, RT. ii) hν OR py, ∆. iii) Ac2O, Na2CO3. iv) 1,2-dichloroethane, BHT, reflux. 
During the synthesis, White found that when hydroxy endoperoxides 156 and 157, obtained 
from the photooxidation of diene 158, were subject to thermolysis or photolysis reactions 
only hydroxyenone 159 was formed, presumably via the corresponding epoxyketone (cf. 
Scheme 57). White also found, however, that the desired bis-epoxide 160 could be isolated 
from the thermolysis of diacetyl endoperoxide 161 in 24% yield [cf. Shing achieved a very 
similar transformation in 100% yield using CoTPP, Scheme 63], whereas diacetyl 
endoperoxide 162 gave only an aromatised product 163. Bis-epoxide 160 was then converted 
into (±)-crotepoxide (150) by hydrogenolysis of the benzyl group followed by benzolyation 
of the resultant hydroxyl group.  
By comparing the syntheses of (±)- and (+)-crotepoxide (150) carried out by White and Shing 
respectively, the advantage of using CoTPP for the rearrangement of endoperoxides to bis-
epoxides in synthesis over the traditional photolysis or thermolysis reactions is evident [27% 
yield vs. 100% yield].  
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Other transition metal complexes such as those based on Ru(II) and Pd(II) have also been 
shown to effect the rearrangement of endoperoxides to bis-epoxides. In particular, Noyori has 
demonstrated that RuCl2(PPh3)2
102 and PdCl2(PPh3)4
103 are efficient for this purpose: (Scheme 
65). 
 
Scheme 65: Noyori’s rearrangement of endoperoxide 132 with Ru(II) and Pd(II) complexes.102-103 
In light of this extensive precedent, we were confident that conditions could be found to 
achieve this transformation in our proposed synthesis. 
2.2. Results and Discussion. 
2.2.1 Synthesis of Dibromodiol 134 
The first challenge of this project was the optimisation of the synthesis of dibromo diol 134 
from 1,3-cyclohexadiene (131) (Scheme 66). 
OO
O
O
Br
Br
OH
OH
131 132 133 134
i) ii)
iii)
iv)
 
Scheme 66: Synthesis of dibromo diol 134. Reagents and Conditions: i) O2, TPP (2.0 mol%), CCl4, hν, 0 °C, 2 
h. ii) CoTPP (2.0 mol%), CCl4, RT, 2.75 h. iii) O2, PS-CoTPP (2.0 mol%), MeCN, 0 °C, 21 h. iv) LiBr (1.6 
equiv.), CuBr2 (3.2 equiv.), MeCN, RT, 1 h. 
It is well known that photosensitisers such as tetraphenylporphyrin (TPP), although necessary 
for the successful formation of singlet oxygen, can be hard to remove from the desired 
products after the reaction is complete. One option to overcome this problem is to use solid 
supported photosensitisers; these polymer supported photosensitisers can then be removed 
from the product by filtration after the reaction has come to completion. Griesbeck has 
developed a solvent-free process of photooxidation addressing this issue along with other 
problems associated with photooxidations.104-105 He has achieved this by adsorbing TPP non-
covalently into polystyrene beads cross-linked with divinylbenzene. This is done by swelling 
the polystyrene beads in an appropriate solvent, adding a catalytic amount of TPP (0.06 
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mol%) followed by evaporation of the excess solvent. The substrate is then added to the 
beads in a minimum amount of ethyl acetate and the solvent evaporated again. The resulting 
solid is then covered with a petri dish and irradiated with a sodium lamp or a halogen lamp 
with no cooling or addition of oxygen to the system. The desired product can then be washed 
off the polymer beads with ethanol. Griesbeck has shown that this method of photooxidation 
has been successful with a range of substrates with comparable yields to what was obtained 
upon photooxidation under conventional methods.104-105 
As we had previously experienced issues with the removal of TPP from products after 
photooxidation during the synthesis of (+)-enone 40 (cf. Chapter 1, Section 1.2.1), 
Griesbeck’s method was an appealing option for our synthesis. We also envisaged that 
CoTPP could be used as the photosensitiser for our photooxidation of 1,3-cyclohexadiene 
(131) to endoperoxide 132, this would then allow for in situ rearrangement of endoperoxide 
132 to bis-epoxide 133. 
The PS-CoTPP was prepared following the method described by Griesbeck.105 CoTPP (0.06 
mol%) in CH2Cl2 was added to a slurry of polystyrene beads in CH2Cl2. To this slurry was 
added 1,3-cyclohexadiene (131) and the slurry transferred to a petri dish and excess solvent 
allowed to evaporate. When the resin was dry it was covered loosely with a watch glass and 
irradiated with a 300 W lamp for 1.5 h. After this time analysis of the 1H NMR spectrum 
showed a 1:1 ratio of endoperoxide 132/bis-epoxide 133. The beads were therefore swollen in 
CH2Cl2 and stirred for a further 6 h, after this time complete conversion of endoperoxide 132 
to bis-epoxide 133 was observed by TLC and 1H NMR analysis. However bis-epoxide 133 
was isolated in just 15% yield. The boiling point of 1,3-cyclohexadiene (131) is 80 °C, 
therefore it is possible that evaporation of the starting material had occurred under the 
reaction conditions resulting in the low yield. It was also considered that bis-epoxide 133 
could have a low boiling point, and therefore the product could have been lost on isolation. 
Notwithstanding the low yield obtained, this reaction did demonstrate that CoTPP could work 
as an effective photosensitiser. 
In order to prevent loss of material during the reaction it was decided that the reaction should 
be run in solution. This would allow the temperature of the reaction to be lowered to 0 °C 
which would hopefully minimise the loss of the volatile starting material and intermediates. 
The ideal solvent was found to be MeCN, as the PS-CoTPP beads could be swollen in this 
solution without leaching of the CoTPP from the polystyrene. Thus, PS-CoTPP was prepared 
as previously described, this time without the addition of the 1,3-cyclohexadiene (131). The 
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dry resin was then swollen in MeCN and cooled to 0 °C before 1,3-cyclohexadiene (131) was 
added and the reaction mixture irradiated for 4 h with a constant flow of oxygen passing 
through the reaction mixture. After this time TLC analysis showed the reaction mixture 
contained both endoperoxide 132 and bis-epoxide 133 and the reaction mixture was allowed 
to stir at RT under N2. After 17 h endoperoxide 132 was still present by TLC analysis and a 
further 0.12 mol % CoTPP and CH2Cl2 had to be added before complete conversion to bis-
epoxide 133 was observed. Due to the expected low boiling point of bis-epoxide 133 the 
reaction mixture was filtered and the resin washed with MeCN and the solution treated 
directly with CuBr2. After 4 h bis-epoxide 133 had been completely converted to dibromo 
diol 134 by TLC and 1H NMR analysis. As we were unsure on the physical properties of 
dibromo diol 134, acetonide protection was carried out before isolation. Treatment of the 
crude solution of dibromo diol 134 with DMP and catalytic p-tolyl sulfonic acid gave 
dibromide 135 in 1 h by TLC analysis. Unfortunately, after attempted isolation by flash 
chromatography dibromide 135 could not be separated from unknown impurities and in any 
case the impure dibromide 135 was obtained in just a 20% yield. 
The low yield was again attributed to loss of material during the photooxidation. Therefore 
the reaction was repeated and this time a Teflon cap fitted to the flask, no oxygen was passed 
through the reaction mixture and the irradiation time shortened to avoid loss of material. The 
catalyst loading of CoTPP adsorbed onto polystyrene was increased to 0.6 mol% to facilitate 
full conversion of endoperoxide 132 to bis-epoxide 133. After irradiation for 1 h the reaction 
mixture was stirred at RT for 17.5 h after which full conversion to bis-epoxide 133 was 
observed by TLC analysis. The reaction mixture was filtered, treated with CuBr2 for 3.5 h to 
give dibromo diol 134, followed by acetonide protection with DMP and catalytic p-tolyl 
sulfonic acid. However, dibromide 135 was not isolated from the reaction mixture after 
purification by flash chromatography, instead dibromo diol 134 was isolated in 14% yield as 
a white crystalline solid, along with another crystalline side product in 44% yield. The 
structure of the side product was determined as dibromide 164 by comparison with literature 
data and as well as a single crystal X-ray structure determination that was carried out on the 
compound (Figure 11).106 
    
Figure 11: Molecular structure of bromide 164 as determined by single crystal X-ray crystallography. 
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Originally it was suspected that the dibromide 164 had been formed by a reaction between 
dibromo diol 134 and Cu(I) or Cu(II). However, after some experimentation it was deduced 
that dibromide 164 was the product of the reaction of 1,3-cyclohexadiene (131) with CuBr2. 
During these studies it was discovered that dilithium tetrabromocuprate (Li2CuBr4)
107, 
formed by premixing LiBr and CuBr2 in MeCN at 0 °C and warming to RT before being 
added to a solution of bis-epoxide 133, could effect the ring opening of bis-epoxide 133 with 
slightly better yields than CuBr2. This reagent also proved to be easier to remove by aqueous 
work-up in comparison to CuBr2 and was therefore used in all future reactions. The large 
amount of dibromide 164 isolated from the reaction demonstrated that full conversion of 1,3-
cyclohexadiene (131) to endoperoxide 132 had not been achieved. We now also knew that 
dibromo diol 134 was a solid and could be isolated before acetonide protection. Therefore, a 
series of reactions were carried out in order to monitor the conversion of 1,3-cyclohexadiene 
(131) to endoperoxide 132 and therefore increase the yield of dibromo diol 134 (Table 5). 
 
Entry PS-CoTPP Conversion to 
endoperoxide 132 
Conversion to bis-
epoxide 133  
Conversion to 
diol 134 
1 0.6 mol% 1.5 h, 100% a 84 h, 85% b 36% 
2 0.6 mol% 12 h, 100% b 28 h, 54% b - 
3 1.0 mol% 12 h, 100% b 37.5 h, 50% b - 
4 2.0 mol% 6 h, 100% b 15 h, 100% b 67% 
Table 5: Conversion of 1,3-cyclohexadiene (131) to dibromo diol 134. a monitored by GC. b monitored by 1H 
NMR. 
In order to minimise loss of starting material, all reactions were run in flasks sealed with suba 
seals. The Ps-CoTPP beads were swollen in MeCN and purged with O2 for 10 min before the 
addition of 1,3-cyclohexadiene (131). In order to increase the yield by ensuring all of the 
starting material had been converted to endoperoxide 132 a reaction was run and monitored 
by GC (entry 1). After 1.5 h irradiation a peak corresponding to the endoperoxide 132 was 
present in the GC chromatogram, and no peaks were observed for 1,3-cyclohexadiene (131). 
The irradiation was therefore stopped and the reaction mixture allowed to stir at RT. After 84 
h a maximum conversion of 85% to bis-epoxide 133 was observed by 1H NMR analysis and 
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the reaction mixture was filtered. Bis-epoxide 133 was then treated with a solution of 
Li2CuBr4 in MeCN and dibromo diol 134 isolated by flash chromatography in 36% yield 
along with a small amount of dibromide 164. The low yield was attributed to incomplete 
conversion to endoperoxide 132, due to 1,3-cyclohexadiene (131) not being consistently 
detected by GC. It was therefore decided that 1H NMR analysis would be a better method for 
monitoring the progress of the reaction. The reaction was repeated and complete conversion 
of starting material to endoperoxide 132 was achieved after 12 h irradiation (entry 2). 
However after irradiation was stopped the conversion of endoperoxide 132 to bis-epoxide 
133 was not complete after 28 h, with a maximum of 54% conversion observed. In order to 
increase the conversion of endoperoxide 132 to bis-epoxide 133 a reaction was run using 1.0 
mol% CoTPP adsorbed onto PS (entry 3). Endoperoxide 132 formation was achieved after 12 
h, but again complete conversion to bis-epoxide 133 was not observed with a maximum of 
50% conversion after 37.5 h. Finally the reaction was run using 2.0 mol% CoTPP adsorbed 
onto PS (entry 4), where conversion to endoperoxide 132 was seen after 6 h irradiation and 
100% conversion to bis-epoxide 133 seen after 15 h stirring at RT. Filtration of the reaction 
mixture and treatment with a solution of Li2CuBr4 in MeCN gave dibromo diol 134 in 67% 
yield after purification. 
Despite the good result obtained for the conversion of 1,3-cyclohexadiene (131) to dibromo 
diol 134 using 2.0 mol% PS-CoTPP this yield could not be reproduced: incomplete 
conversion to bis-epoxide 133 sometimes occurred. Due to the irreproducible results obtained 
using PS-CoTPP and the quantity of PS necessary (5-10 g PS for 14 mg CoTPP), the 
synthesis of dibromo diol 134 was carried out in solution (Table 6). 
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Entry Conditions Scale 
(mmol) 
Conversion to 
endoperoxide 132 
Conversion to bis-
epoxide 133  
Conversion to 
diol 134 
1 CoTPP (2 mol%), 
MeCN 
1.05 8 h, 92% 23.5 h, 23% N/A 
2 CoTPP (2 mol%), 
CCl4 
1.05 Not observed 19 h, 85% 54% 
3 CoTPP (2 mol%), 
CCl4 
5.25 Not observed 26 h, 70% 66% 
4 TPP (2 mol%), 
CCl4 then CoTPP 
(2 mol%) 
5.25 5.5 h, 100% 2.5 h, 100% 68% 
5 TPP (2 mol%), 
CCl4 then CoTPP 
(2 mol%) 
10.5 2 h, 100% 2.75 h, 100% 64% 
Table 6: Conversion of 1,3-cyclohexadiene (131) to dibromo diol 134. 
Whilst the reaction run in MeCN was not successful (entry 1), the reaction run in CCl4 saw 
85% conversion to bis-epoxide 133 after 19 h irradiation (entry 2). It was noted that in this 
reaction the endoperoxide 132 was not observed at any point by 1H NMR analysis during the 
reaction. After treatment with a solution of Li2CuBr4 in MeCN dibromo diol 134 was 
obtained in 54% yield as well as a trace of dibromide 164. In order to check if the yield was 
reproducible the reaction was repeated on a larger scale (5.25 mmol vs. 1.05 mmol, entry 3). 
After 26 h irradiation a maximum of 70% conversion of 1,3-cyclohexadiene (131) to bis-
epoxide 133 was observed by 1H NMR analysis. The reaction mixture was treated with a 
solution of Li2CuBr4 in MeCN to give dibromo diol 134 in 66% yield and dibromide 164 in 
13% yield after purification. Due to the slow conversion of 1,3-cyclohexadiene (131) to bis-
epoxide 133 using CoTPP as the photosensitiser it was decided that TPP would be used as the 
photosensitiser for the photooxidation to endoperoxide 132, CoTPP could then be added after 
photooxidation to form bis-epoxide 133. The photooxidation was therefore carried out with 2 
mol% TPP in CCl4 and pleasingly full conversion of starting material to endoperoxide 132 
was observed after 5.5 h irradiation (entry 4). CoTPP (2 mol%) was then added to the 
reaction mixture and after 2.5 h complete conversion to bis-epoxide 133 had occurred by 
TLC analysis. Treatment of the crude bis-epoxide 133 with a solution of Li2CuBr4 in MeCN 
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gave dibromo diol 134 in 68% yield after purification. Finally, the reaction was repeated on a 
larger scale (10.5 mmol vs. 5.25 mmol, entry 5). Full conversion to endoperoxide 132 was 
observed after 2 h irradiation, CoTPP (2 mol%) was added to give bis-epoxide 133 in a 
further 2.75 h. Treatment with a solution of Li2CuBr4 in MeCN then gave dibromo diol 134 
in 64% yield after purification. 
In conclusion, a quick, scalable, one pot approach has been optimised for the synthesis of 
dibromo diol 134 from 1,3-cyclohexadiene (131) in good yields. 
2.2.2. Bis-Elimination of Dibromide 135 
With a route optimised for the synthesis of dibromo diol 134 acetonide protection to give 
dibromide 135 could be carried out on a reasonable scale to access enough material for the 
bis-elimination reaction to be studied (Scheme 67). 
 
Scheme 67: Acetonide protection of dibromo diol 134. Reagents and Conditions: i) DMP (6.0 equiv.), 
pTsOH·H2O (0.2 equiv.), CH2Cl2, 0 °C, 2 h, 88%. 
A single crystal X-ray structure determination to was carried out on dibromide 135 to confirm 
the relative stereochemistry obtained after the opening of bis-epoxide 133 (Figure 12). 
 
Figure 12: Molecular structure of dibromide 135 as determined by single crystal X-ray crystallography. 
With plenty of dibromide 135 in hand work was carried out to optimise the bis-elimination to 
give acetonide 77 (Table 7). 
 
 
 
Chapter 2                                                                                                Synthesis of meso-Diol 
69 
 
 
Entry Reagents Solvent Temp  
(° C) 
Time  Outcome (
1
H NMR) 
Product Phenol SM 
1 DBU (6 equiv.), TBAI 
(0.2 equiv.)   
MeCN 150 a 6 min 1 0.45 0 
2 DBU (4 equiv.), TBAI 
(0.2 equiv.) 
MeCN 85 16 h 1 1 0 
3 DBU (4 equiv.), TBAI (1 
equiv.) 
Toluene 45 5 h 0 0 1 
4 DBU (4 equiv.), TBAI (1 
equiv.) 
Et2O 45 5 h Trace 0 1 
5 DBU (4 equiv.), TBAI (1 
equiv.) 
CH2Cl2 45 5 h 0.15 0 1 
6 DBU (4 equiv.), TBAI (1 
equiv.) 
THF 45 5 h 1 0 1.9 
7 DBU (4 equiv.), TBAI (1 
equiv.) 
MeCN 45 5 h 1 0 2.3 
8 DBU (4 equiv.), TBAI (1 
equiv.) then DBU (4 
equiv.) 
MeCN 45 24 h 1 0 0.3 
9 DBU (4 equiv.), TBAI (1 
equiv.) then DBU (4 
equiv.) 
THF 45 24 h 1 0 0.5 
10 DBU (20 equiv.) TBAI 
(2 equiv.) 
MeCN 45 4 h 1 0 0 
Table 7: bis-Elimination for the conversion of dibromide 135 to acetonide 77. a Microwave irradiation. 
The initial reaction was carried out in MeCN, using DBU as the base under microwave 
irradiation (entry 1). It was gratifying to see that all the starting material had been consumed 
by TLC analysis after just 6 min irradiation and acetonide 77 was present by analysis of the 
1H NMR spectrum. However, there was a significant amount of an aromatic product. It was 
concluded that this aromatic product was due to the decomposition of the desired product, 
under the reaction conditions, to give phenol, seen in the 1H NMR spectrum as the DBU salt. 
In order to prevent the formation of phenol the reaction was run under conventional heating 
(entry 2). After 16 h at 85 °C the 1H NMR spectrum of the crude reaction mixture was very 
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similar to that obtained from the previous reaction. This time, however, the ratio of phenol 
present was higher, suggesting that both temperature and reaction time were important 
parameters to be controlled in order to prevent decomposition of the desired product.  
As elimination reactions are known to be solvent dependent it was deemed appropriate at this 
point in the optimisation process to conduct a small solvent screen (entries 3-7). The reaction 
time was shortened to 5 h and the conversion of starting material to product analysed by 1H 
NMR spectroscopy. The amount of TBAI was increased from 0.2 equivalents to 1.0 
equivalents as it was thought that this might increase the rate of elimination allowing for 
shorter reaction times. The results show that little or no reaction occurred in toluene or Et2O 
(entries 3 and 4), and a 15% conversion was observed after 5 h in CH2Cl2 (entry 5). MeCN 
and THF proved to be the best solvents with conversions of 31 and 35% respectively (entries 
6 and 7). It was encouraging to see that the starting material was being converted to the 
product without the formation of phenol when the reactions were run at 45 °C. Therefore the 
reaction was repeated in MeCN and THF (entries 8 and 9), this time the reactions were 
monitored and allowed to heat for 20 h. After this time starting material remained and so a 
further 4 equivalents of DBU were added and the reactions allowed to heat for a further 4 h. 
After this time a 77% conversion was observed in MeCN and a 67% conversion in THF.  
The optimal reaction conditions at this juncture appeared to be using MeCN as the solvent 
and >8 equivalents DBU at 45 °C. The reaction was repeated using these conditions, this time 
using 20 equivalents of DBU and 2 equivalents of TBAI (entry 10). After 4 h no starting 
material was present by GC analysis, however the product was only isolated in 58% yield. 
This was disappointing as by 1H NMR and TLC analysis full conversion to the product had 
occurred without the formation of any phenol. The reason for the low yield was concluded to 
be the low boiling point of acetonide 77 (70 °C, 5 Torr108). 
In order to overcome this problem it was thought that the use of different protecting groups 
on dibromo diol 134 could lead to products with higher boiling points after the bis-
elimination, and therefore allow for a higher yield of the isolated product (Scheme 68). 
 
 
Chapter 2                                                                                                Synthesis of meso-Diol 
71 
 
 
Scheme 68: Synthesis of benzoyl and t-butyldiphenylsilyl protected dibromides 166 and 167. Reagents and 
Conditions: i) BzCl (2.2 equiv.), DMAP (0.1 equiv.), py, 0 °C→RT, 17 h. ii) TBDPSiCl (2.2 equiv.), im (4.4 
equiv.), DMF, RT, 3.25 h. iii) (20 equiv.), TBAI (2 equiv.), MeCN, 45 °C, 4 h. 
The alternative protecting groups chosen were the benzoyl and t-butyldiphenylsilyl groups as 
these would give protected meso-diols 103 and 165 which are known solid compounds with 
melting points of 90.5-91.5 °C and 115-116 °C respectively.75 The benzoyl protection was 
successful giving dibenzoyl ester 166 in 77% yield after purification, however the silyl 
protection to give disilane 167 was not successful and only starting material was recovered. 
With dibenzoyl ester 166 in hand the bis-elimination was attempted. After 17 h at 45 °C in 
MeCN the TLC of the crude reaction mixture showed no starting material was present. 
However, the 1H NMR spectrum of the crude reaction mixture showed no expected product. 
After separation of the major components in the crude reaction mixture by chromatography, 
mass spectrometric and 1H NMR analysis showed mainly aromatic products, suggesting the 
reaction had been successful but decomposition of the product had occurred. The reaction 
was repeated, however, after just 1 h of heating the 1H NMR spectrum of the crude reaction 
mixture showed only a mixture of starting material and aromatic products. This established 
that the benzoyl derivative 103 was even more sensitive to decomposition than the acetonide 
77. 
Another route explored in order to establish a yield for the bis-elimination was to perform an 
in situ Diels-Alder reaction on acetonide 77. These reactions were attempted with a 
previously synthesised batch of acetonide 77 (Scheme 69). 
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Scheme 69: Diels-Alder reactions of acetonide 77 with various dieneophiles.109-110 Reagents and conditions: i) 
H2O, 25 ºC, 21 h. ii) DBU (20 equiv.), TBAI (2.0 equiv.), MeCN, 45 °C, 17 h. iii) toluene, 25 ºC, 21 h. iv) DBU 
(20 equiv.), TBAI (2.0 equiv.), MeCN, 45 °C, 17 h.  v) toluene, 110 ºC, 21 h. vi) DBU (20 equiv.), TBAI (2.0 
equiv.), MeCN, 45 °C, 17 h. 
The Diels-Alder reaction of DMAD110, nitroso benzene110 and methyl acrylate111 with 
acetonide 77 were all successful in the absence of DBU and TBAI. However, when the 
reactions were carried out in MeCN at 45 ºC in the presence of DBU and TBAI either starting 
material or no desired products were recovered from the reaction. This was most likely due to 
the fact that DBU also reacted with the dienophiles preventing the desired reaction occurring. 
As it was planned that the Diels-Alder reaction would take place in situ, this route was not 
explored any further due to the reactivity of DBU with the dienophiles. 
As acetonide 77 had been synthesised previously from the protection of meso-diol 74 
obtained commercially from the microbial oxidation of benzene (cf. Chapter 1, Section 1.2.1) 
in good yield it was decided that issues with isolation of the desired product were due to the 
scale of the reaction being carried out (i.e. milligram scale vs. gram scale). Therefore the 
reaction was repeated on a larger scale (Table 8). 
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Entry Reagents Solvent Scale Time Temp. (°C) Isolated Yield 
1 DBU (10 equiv.), 
TBAI (2 equiv.) 
MeCN 1.34 g 3 h 45 56% 
2 DBU (10 equiv.), 
TBAI (2 equiv.) 
CH2Cl2 1.53 g 2 h 45 83% 
Table 8: Large scale bis-elimination of dibromide 135 to acetonide 77. 
The first larger scale reaction was carried out with 10 equivalents of DBU and 2 equivalents 
TBAI in MeCN (N.B. 10 equivalents of DBU were used instead of 20 equivalents due to 
issues faced previously with incomplete removal of DBU after an aqueous work-up, entry 1). 
After 3 h at 45 ºC the reaction was complete by TLC and GC analysis. After an aqueous 
work-up, Et2O was removed by distillation at 45 ºC. In order to remove the MeCN, MeOH 
was added to form an azeotrope with MeCN and distilled at 75 ºC to give acetonide 77 in 
56% yield. It was thought that the yield of isolation could be improved further by running the 
reaction in CH2Cl2 instead of MeCN, as it was found that some product was lost when the 
distillation temperature had to be increased in order to remove the MeCN. The reaction was 
repeated on a similar scale in CH2Cl2 (entry 2), and after 2 h at 45 ºC GC analysis showed 
complete conversion to acetonide 77. After work-up and removal of CH2Cl2 by distillation at 
55 ºC acetonide 77 was isolated in 83% yield. 
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2.3. Conclusions 
The first aim of this project was the synthesis of dibromo diol 134. The issue faced with this 
synthesis was the low boiling points of the starting material, 1,3-cyclohexadiene (131) and 
the intermediate bis-epoxide 133. This was overcome, firstly by ensuring the reaction vessel 
was purged with oxygen before the addition of 1,3-cyclohexadiene (131) and the 
photooxidation carried out at 0 °C in a sealed flask. Secondly, the procedure for converting 
1,3-cyclohexadiene (131) to dibromo diol 134 via endoperoxide 132 and bis-epoxide 133 was 
achieved using a one-pot procedure, avoiding the need to isolate bis-epoxide 133. This one-
pot procedure was accomplished in two ways, firstly by using CoTPP, adsorbed onto 
polystyrene or in solution, acting as the photosensitiser for the photooxidation of 1,3-
cyclohexadiene (131) to endoperoxide 132 and as the catalyst for converting endoperoxide 
132 to bis-epoxide 133. However, a quicker and more scalable approach was developed using 
TPP as the photosensitiser to convert 1,3-cyclohexadiene (131) to endoperoxide 132, 
followed by CoTPP addition to give bis-epoxide 133, and finally treatment with a preformed 
solution of Li2CuBr4 gave dibromo diol 134 in 64-68% yield in approximately 6 h. 
The second aim of the project was to optimise the bis-elimination of dibromide 135 to give 
the desired acetonide 77. The main issue faced with this step was the low boiling point of the 
desired product, and the facile decomposition of the product at high temperatures to give 
phenol. These matters were overcome, firstly by running the reaction at 45 °C and secondly 
conducting the reaction on a reasonable scale in CH2Cl2 allowing the solvents to be removed 
by distillation. Acetonide 77 was isolated in 83% yield. 
In conclusion, the synthesis of acetonide 77 from commercially available 1,3-cyclohexadiene 
(131) has been achieved in a 5 step, 3 pot synthesis with an overall yield of 50%. 
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Chapter 3 – Studies Towards an Asymmetric retro-Cope 
Elimination Reaction 
3.1. Introduction 
3.1.1. Recent Advances in the Asymmetric Hydroamination (AHA) Reaction 
Amines are an extremely important class of compounds within all aspects of chemistry, with 
many biologically important and natural products containing amine functionalities. The 
hydroamination of alkenes and alkynes has become a very important reaction for the 
formation of C-N bonds and comprises the reaction between the N-H of an amine and an 
unsaturated C-C bond in an inter- or intramolecular fashion (Scheme 70).112 
 
Scheme 70: General inter- and intramolecular hydroamination reactions.113 
The hydroamination reaction is an atom economic process making it a very appealing 
reaction for the formation of nitrogen containing compounds. Although the hydroamination 
of alkenes is a thermodynamically allowed process most reactions require a catalyst for the 
reaction to occur, for the following reasons:113 
 The electrostatic repulsion between the nitrogen lone pair and the electron rich π bond 
of the alkene as they come together to react results in a high activation barrier. 
 A [2+2] addition between the N-H and the C=C double bond is orbital symmetry 
forbidden and is unfavourable due to the difference in energy between the alkene π 
bond and the N-H σ bond. 
 Due to the negative enthalpy of the reaction, the activation barrier cannot be 
overcome by heating the reaction, as the equilibrium is then shifted towards the 
starting materials. 
Over the last 10 years there has been a significant rise in the amount of research being 
conducted towards the development of efficient catalysts for the hydroamination reaction112, 
with much focus being directed towards the development of asymmetric hydroamination 
(AHA) reactions.113 A variety of different catalysts have been used to effect this 
Chapter 3                                                             Asymmetric retro-Cope Elimination Reaction 
76 
 
transformation, including ones based on rare earth metals, transition metals, and main group 
metals. The hydroamination reaction was reviewed comprehensively by Müller and Beller in 
1998 and more recently by Müller and Hultzsch in 2008.112,114 Additionally, the AHA 
reaction has been reviewed by Hultzsch113,115 and more recently by Schulz116 and Chemler.117 
This section will highlight some recent examples of intramolecular AHA reactions. 
Hultzsch and Livinghouse have shown independently that rare earth metal binaphthalate 
complexes of lanthanum, scandium, yttrium and lutetium are efficient catalysts for the AHA 
reaction.118-119 Livinghouse’s yttrium bis(thiolate) complexes have catalysed the AHA 
reaction in good yields with enantioselectivities of up to 87% ee (Table 9).118 
 
Entry R
1
, R
2
, R
3
 Time (h) Yield (
1
H NMR) ee (%) 
1 H, H, H 8 > 95% 81 
2 Me, H, H 9 > 95% 87 
3 Me, Ph, H 3 > 95% 82 
4 H, H, Me 30 > 95% 69 
Table 9: Selected examples of Livinghouse’s AHA reaction.118 
Using the yttrium catalyst shown, Livinghouse has reported that the reaction of gem dimethyl 
containing substrates are complete within 3 and 9 h in 87% and 82% ee respectively (entries 
2 and 3). He has also shown that N-alkylated substrates (entry 4) are successfully cyclised, 
albeit with a longer reaction time of 30 h and a slightly lower enantioselectivity of 69% ee. 
Hultzsch has reported that his 3-3’-bis(trisarylsilyl)-substituted binaphthalate rare earth metal 
complexes can catalyse the AHA reaction in good yields and enantioselectivities (Table 
10).119 
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Entry R
1
, R
2
, R
3
 Catalyst/(mol%) Temp. (° C) Time (h) Yield (%) ee (%) 
1 H, H, H (R)-3-Lu/(5) 22 16.5 93 90 
2 Me, H, H (R)-2-Lu/(2) 22 27.5 94 69 
3 Ph, H, H (R)-2-Sc/(2) 25 0.6 94 95 
4 -(CH2)4-, H, H (R)-2-Sc/(2) 25 6 97 85 
5 Me, Ph, H (R)-2-Sc/(2) 100 72 91 72 
6 H, H, Me (R)-3-Sc/(2) 60 44 93 53 
Table 10: Selected examples of Hultzsch’s AHA reaction.119 
Hultzsch’s scandium and lutetium complexes were able to catalyse the AHA reaction in high 
yields, within reasonable time scales and at moderate temperatures for most substrates 
studied. The highest enantioselectivities of 85-95% ee were obtained with substrates in the 
absence of terminal alkene or nitrogen substituents (entries 1, 3 and 4) with the exception of 
the gem dimethyl substrate, of which a lower, 69% ee was reported (entry 2). Substrates with 
terminally substituted alkenes underwent the reaction in good yields and enantioselectivities 
of up to of 72% ee, however the reaction temperature had to be increased up to 100 °C (entry 
5). N-alkylated substrates gave the desired products in good yields, however with a lower 
enantioselectivity of 53% ee (entry 6). 
As demonstrated by Livinghouse and Hultzsch, rare earth metal complexes are effective 
catalysts for the AHA reaction. However, these complexes are often extremely air and 
moisture sensitive and consequently the use of a glove box is often required to set up and run 
these reactions.115 Therefore the development of catalysts based on more stable transition 
metal complexes has become an important area of research. 
Group 4 metals have been studied and have been shown to act as efficient catalysts for the 
AHA reaction.112,115-117 Schafer has reported that impressive enantioselectivities of up to 93% 
ee can be obtained with her chiral neutral zirconium amidate complexes (Table 11).120 
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Entry R Time (h) Yield (%) ee (%) 
1 Me 3 80 93 
2 -(CH2)4- 5 91 88 
3 -(CH2)5- 3 96 82 
4 -CH2CHCH2 4.5 88 74 
Table 11: Selected examples of Schafer’s AHA reaction.120 
Schafer’s zirconium complex can catalyse the AHA reaction of a simple test substrate in just 
3 h with a 93% ee (entry 1), the highest ee value obtained for this particular substrate to date 
[cf. 87% ee for Livinghouse’s catalyst and 69% ee for Hultzsch’s catalyst]. Other substrates 
bearing a gem dialkyl group have reacted successfully under these reaction conditions with 
good enantioselectivities of 74-88% ee being obtained (entries 2-4). However, no examples 
of substrates without a gem dialkyl group have been reported with this catalyst. 
Taking a step towards expanding the substrate scope of this reaction, Buchwald has recently 
demonstrated the use of dialkylbiaryl phosphine ligands in the rhodium catalysed AHA 
reaction (Table 12).121 
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Entry R Ar L Temp. (° C) Time (h) Yield (%) ee (%) 
1 Ph C6H5 9 50 24 90 83 
2 Ph 2-CH3C6H4 9 50 24 91 88 
3 Me 2-CH3C6H4 9 70 20 75 62 
4 H 2-CH3C6H4 8 70 20 50 86 
5 H 4-ClC6H4 8 70 20 63 85 
6 H 4-CO2MeC6H4 8 70 20 61 83 
Table 12: Selected examples of Buchwald’s AHA reaction.121 
Buchwald demonstrated that the AHA reaction would proceed in good yields and with good 
enantioselectivities at reasonable temperatures when using binaphthyl ligand L9 with gem 
diphenyl substituted substrates (entries 1 and 2). However, the enantioselectivity dropped to 
62% ee when a gem dimethyl group replaced the gem diphenyl group (entry 3). He reported 
that L8 was a superior ligand with substrates in the absence of a gem dialkyl group and was 
able to obtain the desired products in 83-86% ee, albeit in slightly lower yields (entries 4-6). 
These examples also demonstrate that aryl chlorides (entry 5) and esters (entry 6) are stable 
to the reaction conditions, leading to products that are available to further modifications. 
Buchwald also showed that the protecting group on the nitrogen (cf. Ar = 2-CH3C6H4) could 
be removed from the products of the AHA reaction by catalytic transfer hydrogenation in 
high yields (92%), to give the corresponding N-H pyrrolidines. 
The examples described above demonstrate the high level of research being undertaken in the 
field of AHA, with a variety of different catalysts able to obtain the desired products in high 
yields and enantioselectivities. However, despite this recent progress the AHA reaction still 
requires the development a general catalyst that can provide high yields and 
enantioselectivities for a broad range of substrates. 
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3.1.2. Recent Advances in the retro-Cope Elimination Reaction 
As discussed in Chapter 1, in the context of our use of this reaction as a key step in the 
synthesis of (±)-clivonine (1), the retro-Cope elimination is the suprafacial concerted thermal 
cyclisation of an unsaturated hydroxylamine to its corresponding pyrrolidine or piperidine N-
oxide or N-hydroxyl derivative. It constitutes a possible alternative reaction to the direct 
hydroamination of alkenes, as described above, for the formation of new C-N bonds (Scheme 
71, cf. Section 1.1.5.2) 
 
Scheme 71: A general retro-Cope elimination reaction. 
The retro-Cope elimination was reviewed comprehensively by Cooper and Knight in 2004, 
where they highlighted the scope and limitations of this reaction.32 Experimental evidence 
presented by Black and Doyle and independently by Ciganek has demonstrated that when the 
alkene is terminally substituted the cyclisation does not occur or is extremely slow (cf. 
Chapter 1, Section 1.1.5.2, Scheme 18).34,37 Ciganek also showed that whilst 6-membered N-
oxides could be obtained from their corresponding hydroxylamines, 3-, 4- or 7-membered N-
oxides could not be synthesised.37 There is also evidence that secondary hydroxylamines 
undergo cyclisation faster than that of the corresponding primary hydroxylamines.32,37 
Recently the group of Beauchemin have significantly expanded the scope of the retro-Cope 
elimination reaction and have developed an intermolecular variant. This section will review 
the work carried out by Beauchemin over the last 2-3 years. 
Since many retro-Cope elimination reactions have been carried out using secondary 
hydroxylamines, the first intermolecular retro-Cope elimination reaction developed by 
Beauchemin was of alkynes with aqueous hydroxylamine (Table 13).122-123 
 
 
 
 
Chapter 3                                                             Asymmetric retro-Cope Elimination Reaction 
81 
 
 
Entry Alkyne Conditions Yield (%) 
1 R1 = Ph, R2 = H A 87 
2 R1 = 4-OMeC6H4, R
2 = H A 83 
3 R1 = 4-FC6H4, R
2 = H Aa 71 
4 R1 = 3-MeC6H4, R
2 = H A 75 
5 R1 = n-C6H13, R
2 = H B 86 
6 R1 = R2 = Ph C 71 
7 R1 = Ph, R2 = Me B 53 
8 N
 
Aa 73 
9 
 
B 72 
10 R3O
3  
R3 = H, Bn, Piv, PMB 
B 91, 98, 90, 98 
11 R3
R3
HO
 
R3 = H, Me, Ph 
D,B,B 89, 75, 63 
Table 13: Selected examples of Beauchemin’s intermolecular retro-Cope elimination reaction with alkynes.122-
123 A = alkyne (1 equiv.), aq. NH2OH (2.5 equiv.), dioxane (1 M), sealed tube, blast shield, 113 °C, 16-18 h; B = 
i-PrOH (1 M), 140 °C, microwave, 5-10 h; C = reflux condenser, 140 °C, dioxane (2 M), 38-40 h; D = 110 °C, 
i-PrOH, (2 M), 70 h, sealed tube. a 2 M in dioxane 
After some experimentation Beauchemin found that by heating phenylacetylene and aqueous 
hydroxylamine in dioxane (1 M) at 113 °C in a sealed tube the desired oxime was obtained in 
87% yield with only a 5% yield of the anti-Markovnikov product being isolated (entry 1). He 
then went onto show that these optimised conditions were successful with a range of alkynes 
containing various aryl substituents (entries 2-4). More challenging substrates such as 1-
octyne (entry 5) and disubstituted alkynes (entries 6 and 7) reacted more efficiently when i-
PrOH was used as the solvent and the reaction heated to 140 °C under conventional heating 
or microwave irradiation. Finally, Beauchemin demonstrated that the reaction was successful 
with alkynes bearing a pyridyl group (entry 8) and also free and protected hydroxyl groups 
(entries 10 and 11). 
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Having developed a successful procedure for the intermolecular retro-Cope elimination of 
alkynes with aqueous hydroxylamine, Beauchemin explored this new method with selected, 
activated alkenes (Table 14).122-123 
 
Entry Alkene NH2OH 
(equiv.) 
Temp. (° C) Yield (%, A + B) Ratio (A:B) 
1 
 
2 95 99 1:2.2 
2 
 
10 95 65 7.1:1 
 
 
    
3a 
3b 
3c 
3d 
X = CH2 
X = CH2 
X = O 
X = NBoc 
2 
10 
2 
2 
95 
95 
95 
95 
98 
49 
95 
48 
1:1.5 
14:1 
1.9:1 
> 20:1 
4 
 
2 95 55 > 20:1 
5  2 140 39 2.2:1 
6 
 
2 95 30 > 20:1 
7 
 
2 115 13 > 20:1 
Table 14: Selected examples of Beauchemin’s intermolecular retro-Cope elimination reaction with alkenes.122-
123 a aq. NH2OH (x equiv.), alkene (1 equiv.), i-PrOH (5 M), sealed tube, blast screen, 24-48 h. 
Initial experiments with norbornene and aqueous hydroxylamine demonstrated that the choice 
of solvent was very important for the success of this reaction. Whilst conditions used for the 
reaction of aryl alkynes (cf. Table 13, entries 1-4) resulted in almost no conversion of starting 
material, the reaction run in alcoholic solvents appeared to be more successful. After some 
optimisation it was found that heating norbornene and aqueous hydroxylamine in i-PrOH (5 
M) at 95 °C in a sealed tube for 14 h gave a near quantitative yield of a mixture of primary 
and secondary hydroxylamines A and B (entry 1). Interestingly, Beauchemin reported that 
when 10 equivalents of aqueous hydroxylamine were used in the reaction compared to 2 
equivalents the major product was the primary hydroxylamine A (entries 2 and 3b). Using his 
optimised conditions Beauchemin demonstrated that the intermolecular retro-Cope 
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elimination was successful with a range of alkenes. Strained and hindered bicyclic alkenes 
lead to the selective formation of the primary hydroxylamines (entries 3d and 4). Styrene and 
other vinylarenes lead to the desired hydroxylamine products under the reaction conditions, 
however, in lower yields (entries 5-7).  
Beauchemin noted that since the reaction of aqueous hydroxylamine with alkenes gave a 
mixture of primary and secondary hydroxylamines A and B, the primary hydroxylamine A 
must be reactive under the optimised conditions to undergo a second retro-Cope elimination 
to form the secondary hydroxylamine B. Therefore, reactions were carried out in order to 
extended the intermolecular retro-Cope elimination of alkenes with N-alkylhydroxylamines 
(Table 15).123 
 
Entry Alkene R
2
 Conditions Yield (%) 
1 
 
Cy A 83 
2 
 
Bn A 90 
3 
 
sec-butyl A 63 
4 
 
norbornane A 78 
5  Bn B 58 
6 
 
Bn B 54 
7 
 
Bn B 36 
Table 15: Selected examples of Beauchemin’s intermolecular retro-Cope elimination with N-
alkylhydroxylamines and alkenes.123 A = alkene (2 equiv.), hydroxylamine (1 equiv.), NaCNBH3 (1 equiv.), n-
PrOH (0.6 M), sealed tube, 110 °C, 18 h. B = alkene (2 equiv.), hydroxylamine (1 equiv.), NaCNBH3 (1 equiv.), 
n-PrOH (0.6 M), sealed tube, 140 °C, 14-18 h. 
Initial attempts to react N-cyclohexylhydroxylamine with norbornene resulted in the isolation 
of the corresponding cyclohexanone oxime of N-cyclohexylhydroxylamine as the major 
product. However, after some experimentation Beauchemin found that n-PrOH was the 
optimal solvent for the reaction. He also conducted an additive screen and discovered that the 
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addition of 1 equivalent of NaCNBH3 in the reaction prevented the oxidation of the 
hydroxylamine to its corresponding oxime. He did, however, show with control experiments 
that the NaCNBH3 was inhibiting the oxidative process yielding the oxime, instead of simply 
reducing the oxime back to the hydroxylamine, as this process requires the presence of acid 
(cf. Borch reduction55, Chapter 1, Section 1.2.3). Under the optimised conditions the reaction 
of N-cyclohexylhydroxylamine with norbornene afforded the desired product in 83% yield 
(entry 1). These reaction conditions were then employed to study the reaction of norbornene 
with various N-alkylhydroxylamines, with good yields being obtained for different alkyl 
substituents (entries 2-4). Finally, the scope of the reaction with respect to the alkene was 
investigated and N-benzylhydroxylamine was reacted with a range of vinylarenes in 
reasonable yields (entries 5-7). Interestingly, when the vinylarenes were substituted with 
electron withdrawing groups (e.g. CF3) the anti-Markovnikov product was favoured.
123 
Beauchemin has also developed a tandem intermolecular retro-Cope elimination of N-
alkylhydroxylamines with alkenes followed by a [2,3]-Meisenheimer rearrangement to effect 
the cyclisation of difficult substrates. He has used an intramolecular variant of this 
methodology to synthesise the alkaloids coniine (168) and norreticuline (169) (Scheme 
72).124  
 
Scheme 72: Beauchemin’s synthesis of coniine (168) and norreticuline (169) via an intramolecular retro-Cope 
elimination.124 Reagents and Conditions: i) benzene (0.01 M), H2O (10 equiv.), sealed tube, 140 °C, 47%. ii) 
AcOH (10 M), Zn dust (20 equiv.), 55 °C, 4 h. iii) benzene (0.01 M), H2O (10 equiv.), sealed tube, 120 °C, 
54%. iv) AcOH/H2O (1:1), Zn dust (5.0 equiv.), RT, 1.5 h. v) BCl3 (4.4 equiv., 1.0 M soln. in CH2Cl2), CH2Cl2, 
-10 °C → 0 °C, 2 h, 45%. 
In addition to the synthesis of the alkaloids coniine (168) and norreticuline (169), 
Beauchemin has also synthesised the natural products pumiliotoxin C (170) and 2-epi-
pumiliotoxin C (171) via an intramolecular retro-Cope elimination (Scheme 73).125 
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Scheme 73: Beauchemin’s synthesis of pumiliotoxin C (170) and 2-epi-pumiliotoxin C (171).125 Reagents and 
Conditions: i) n-PrOH (0.15 M), H2O (10 equiv.), 180 °C, microwave irradiation, 5 h. ii) Zn/AcOH. 
For this synthesis Beauchemin initially attempted the retro-Cope elimination of 
hydroxylamines 172 and 173 under the conditions reported by Oppolzer for his synthesis of 
lycorane [C6H6 (0.01 M), 180 °C]
23, however, no cyclisation was observed. However, when 
the reaction was run in n-PrOH at 180 °C under microwave irradiation cyclisation of both C2 
epimers was observed to give cyclised hydroxylamines 174 and 175. The reason for the 
dramatic change in reactivity was proposed to be due to the fact that n-PrOH assists the 
proton transfer step between the amine N-oxide intermediate and the hydroxylamine product. 
This possible explanation will be examined further in the next section (Section 3.1.3). 
Following on from the intermolecular retro-Cope elimination of hydroxylamines with 
alkynes and alkenes, Beauchemin has also demonstrated that hydrazines can be used in the 
retro-Cope elimination with alkynes to give predominantly the anti-Markovnikov 
products.126 He has also shown that hydrazines can be used in an intramolecular retro-Cope 
elimination with alkenes to give 5- and 6-membered rings (Scheme 74).127 
 
Scheme 74: Beauchemin’s retro-Cope elimination reaction with hydrazines.126-127 
Finally, Beauchemin has also demonstrated that ketonitrones can be synthesised via the 
intermolecular retro-Cope elimination reaction of allenes with hydroxylamines (Scheme 
75).128-129  
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Scheme 75: Beauchemin’s synthesis of ketonitrones via the retro-Cope elimination.128-129 
This section has highlighted how the scope of the retro-Cope elimination has been extended 
over the past few years, and demonstrated the need for more research to be undertaken to 
further increase the utility of this reaction. 
3.1.3. Mechanistic Studies of the retro-Cope Elimination 
Beauchemin has undertaken detailed density functional theory (DFT) calculations in order to 
probe the mechanism of the retro-Cope elimination reaction, studying the nature of the 
transition states of the initial cyclisation and the proton transfer step.123 Beauchemin first 
mapped the potential energy characteristics of the reaction, determining the thermodynamic 
profiles of the reactions of alkenes and alkynes (Figure 13). 
      
Figure 13: Beauchemin’s potential energy profiles for the reaction of alkynes (LHS) and alkenes (RHS). 
(Images taken from ref 122). 
These results demonstrate that the activation barrier of the retro-Cope elimination reaction is 
very similar for both alkynes and alkenes. However, there is a large difference in the 
activation barriers for the proton transfer step. With alkynes the activation barrier of the 
proton transfer (PT) step is very similar to that of the initial cyclisation (IC) step (∆GPT = 
30.1 vs. ∆GIC = 30.1 kcal/mol for phenylacetylene). Whereas in the case of alkenes the 
intramolecular proton transfer step is rate limiting (∆GPT = 37.7 vs. ∆GIC = 32.0 kcal/mol for 
norbornene). This provides an explanation as to why the retro-Cope elimination reaction of 
alkenes carried out by Beauchemin were solvent dependant and only successful in protic 
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solvents (cf. Table 14 and Scheme 73), whereas the reaction of alkynes could be run in 
aprotic solvents such as dioxane (cf. Table 13). 
Beauchemin postulated that similarly to the intramolecular reaction the intermolecular retro-
Cope elimination would also be a concerted process (cf. Ciganek’s36 and Oppolzer’s23 
mechanistic studies Chapter 1, Section 1.1.5.2). In order to gain more insight into the 
mechanism he determined the transition state structures for several different alkenes and 
alkynes and in all cases the results showed the involvement of 5-membered, coplanar 
transition states corresponding to concerted processes.123 He then studied the transition state 
of the proton transfer step from the N-oxide intermediate to the hydroxylamine product, in 
order to demonstrate the importance of this step and to determine the reason for the positive 
effect on rates observed in protic solvents. Three possible proton transfer transition states 
were studied (Figure 14). 
 
Figure 14: The three transition states A, B and C for the proton transfer in the retro-Cope elimination as studied 
by Beauchemin.123 
The calculated energy of the intramolecular transition state A is high, due its 3-membered 
character. The bimolecular transition state B was calculated to have the lowest energy with 
the proton transfer occurring between the amine oxide and a protic species such as i-PrOH, 
explaining why some reactions react much better in protic solvents. An alternative transition 
state would be that of C, the N-oxide dimer. However, Beauchemin claimed that this 
transition state would be kinetically unlikely, it also did not account for the positive effects of 
the protic solvent. 
3.1.4. Project Aims 
The hydroamination of alkenes is an important reaction for the formation of new C-N bonds, 
with many recent advances being made towards the AHA reaction. However, as previously 
discussed, this reaction requires the use of a catalyst, and there remains to be a general 
catalyst available for the AHA for a broad range of substrates. The retro-Cope elimination 
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could be used an alternative to the hydroamination reaction for the formation of C-N bonds, 
one advantage being that this reaction does not require the use of a catalyst to proceed. 
Beauchemin has recently expanded the scope of the retro-Cope elimination reaction, 
however, in order for the retro-Cope elimination to compete with the hydroamination 
reaction an asymmetric variant needs to be developed. The main aim of this project, 
therefore, was to develop an asymmetric retro-Cope elimination reaction.  
The first step of the retro-Cope elimination is the reversible cyclisation to give the amine N-
oxide intermediate. An irreversible proton transfer then occurs to give the N-hydroxyl 
pyrrolidine product (Scheme 76). 
 
Scheme 76: Our proposed asymmetric retro-Cope elimination reaction. 
Beauchemin has demonstrated by experiment and DFT calculations that the rate determining 
step of the reaction is the proton transfer step, and that this step is facilitated by protic 
solvents such as i-PrOH. Theoretically, if a chiral proton source could catalyse the proton 
transfer step, a dynamic kinetic resolution process could be set up in which only one 
enantiomer of the amine N-oxide intermediate undergoes the proton transfer leading to 
enantiomerically enriched products (Scheme 76). 
The first aim of this project was to find a suitable system that could be used for the 
development of such an asymmetric retro-Cope elimination reaction. This system would be 
required to react at a reasonable rate, allowing for the reaction to be monitored by 1H NMR 
spectroscopy. To this end, the system would also require the starting material and product to 
have distinctive peaks in their 1H NMR spectra for simple, accurate analysis. Finally, the 
synthesis of suitable substrates needed to be designed so that analogues can be easily 
synthesised. 
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3.2. Results and Discussion 
3.2.1. Synthesis of Oximes 180a-180g 
In order to develop a suitable system to study the retro-Cope elimination reaction a robust 
route to a range of potential substrates of varying electronic demand needed to be established. 
The following route was developed for hydroxylamine 176a before being developed for the 
synthesis of other analogues (Scheme 77). 
 
Scheme 77: Synthesis of hydroxylamine 176a. Reagents and Conditions: i) NaNO2 (1.1 equiv.), DMF, 8 h, 
32%. ii) styrene (7.2 equiv.), Grubbs II catalyst (7 mol%), CH2Cl2, 45 °C, 21 h, 65%. iii) SmI2 (4.0 equiv., 0.1 
M in THF), THF/MeOH (2:1), 3 min. 
The first step of the synthesis was formation of 5-nitropent-1-ene (177) from commercially 
available 5-bromopent-1-ene (178) with sodium nitrite in DMF.130 The highest yield obtained 
for this reaction was just 32%, most likely due to the low boiling point of the product (82 °C, 
32 mmHg131). With 5-nitropent-1-ene (177) in hand the cross metathesis with styrene using 
Grubbs second generation catalyst was attempted following methodology developed by 
Parsons.130 Pleasingly, the reaction was successful to give nitroalkene 179a in 65% yield after 
purification (as an inseparable mixture of stereoisomers in a ratio of 0.14:1 cis/trans by 1H 
NMR analysis). The next step was the formation of hydroxylamine 176a from nitroalkene 
179a. This was first attempted directly using SmI2 (Scheme 77).
132 Thus, a solution of 
nitroalkene 179a in THF/MeOH (2:1) was cannulated into a solution of SmI2 (0.1 M in THF, 
4.0 equiv.) to which the colour immediately changed from dark blue to yellow. This 
suggested that there was oxygen in the substrate solution, however, after the addition of a 
further 4 equivalents of SmI2 solution the reaction mixture retained the blue colour. After 3 
min no starting material was present by TLC analysis and the reaction immediately quenched 
with a 10% aqueous sodium thiosulfate solution. The 1H NMR spectrum of the crude reaction 
mixture showed one major product had formed. A characteristic upfield shift, of the triplet of 
the CH2 group α to the nitrogen, from ~ δ 4.46 ppm to ~ δ 3.04 ppm was observed suggesting 
the reaction had been successful. However, it was not clear if reduction to hydroxylamine 
176a or over reduction to the corresponding amine had occurred. Separation of the major 
product by flash chromatography followed by IR analysis showed the presence of an OH 
peak, again suggesting the formation of hydroxylamine 176a had been successful. However, 
Chapter 3                                                             Asymmetric retro-Cope Elimination Reaction 
90 
 
when the reaction was repeated the 1H NMR of the crude reaction mixture showed two major 
products had been formed. Unfortunately, attempts to isolate any of the expected product by 
flash chromatography were not successful. 
As reactions with SmI2 are known to be capricious and difficult to scale-up, an alternative 
route to hydroxylamine 176a via oxime 180a was explored (Scheme 78). 
 
Scheme 78: Synthesis of hydroxylamine 176a via oxime 180a. Reagents and Conditions: i) BnBr (1.1 equiv.), 
KOH (1.35 equiv.), TBAI (15 mol%), THF, 25 ºC, 22 h, 61%. ii) NaCNBH3 (2.0 equiv.), MeOH/HCl (10:1), 
methyl orange, MeOH, 0 °C, 40 min, 91%. 
Following Carreira’s procedure, nitroalkene 179a was treated with 1.1 equivalents of benzyl 
bromide, 1.05 equivalents of KOH and 15 mol% of TBAI in THF at RT.133 After 6 h, a 75% 
conversion of nitroalkene 179a to oxime 180a was observed by 1H NMR analysis, therefore a 
further 0.3 equivalents of KOH were added and the reaction mixture allowed to stir for a 
further 16 h. After this time complete consumption of the starting material had been observed 
by TLC analysis and oxime 180a was isolated in 61% yield after purification (1:0.9 cis/trans 
by 1H NMR spectroscopy, stereoisomers were not separated and taken through to the next 
step as a mixture). As hydroxylamines can be unstable upon storage the final Borch 
reduction55 (cf. Chapter 1, Section 1.2.3) of oxime 180a to give hydroxylamine 176a was not 
carried out until immediately before the retro-Cope elimination reaction was to be run. 
With a successful route to oxime 180a achieved oximes 180b-180f were successfully 
synthesised using the same pathway (Scheme 79). 
 
Scheme 79: Synthesis of oximes 180b-180f. Reagents and Conditions: i) styrene (3.6-7.2 equiv.), Grubbs II 
catalyst (5-7.5 mol%), CH2Cl2, 45 °C, 18.5-30.5 h, 35-59%. ii) BnBr (1.1 equiv.), KOH (1.35 equiv.),TBAI (15 
mol%), THF, RT, 6-18.5 h, 44-68%. 
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Cross metathesis of 5-nitropent-1-ene (177) with the appropriate styrene gave nitroalkenes 
179b-179f in 35-57% yields. Treatment of the nitroalkenes 179b-179f with benzyl bromide, 
KOH and TBAI gave the oximes 180b-180f in 44-68% yields after purification (cis/trans 
ratios of the cross metathesis and the oxime formation reactions are detailed in the 
Experimental Section, Chapter 4). These substrates were selected for synthesis, as it was 
planned to investigate the influence of electron withdrawing and electron donating aryl 
substituents on the rate of the reaction, so as to identify a convenient substrate for catalyst 
development. 
Additionally, oxime 180g was prepared in two steps from 4-pentenal (181) in order to assess 
the influence of a terminal alkyl group on the rate of the retro-Cope elimination (Scheme 80). 
 
Scheme 80: Synthesis of oxime 180g. Reagents and Conditions: i) Grubbs II catalyst (4 mol%), CH2Cl2, 45 °C, 
3.25 h, 18%. ii) NH2OH·HCl (3.78 equiv.), NaOAc (4.7 equiv.), CH2Cl2, MeOH, RT, 1 h, 98%. 
The cross metathesis of 5-nitropent-1-ene (177) with 4-phenylbut-1-ene (182) was attempted 
but no reaction was observed under conventional heating. Microwave irradiation lead to the 
formation of the desired product, however, homocoupled species of both coupling partners 
were also formed. Gratifyingly, the cross metathesis of 4-phenylbut-1-ene (182) with 4-
pentenal (181)134 gave aldehyde 183, albeit in low yield. Treatment of aldehyde 183 with 
NH2OH·HCl and NaOAc (cf. Chapter 1, Section 1.2.2.) gave oxime 180g in 98% yield after 
purification (cf. Scheme 80). 
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3.2.2. retro-Cope Elimination Rate Studies 
With oximes 180a-180g in hand, studies of the rate of the retro-Cope elimination reaction 
could begin in order to find a suitable system to study the asymmetric retro-Cope elimination 
reaction. Firstly, the Borch reductions of oximes 180a-180d and 180g were carried out to 
give hydroxylamines 176a-176d and 176g in 86%-quantitative yields (Scheme 81). 
 
Scheme 81: Borch reduction of oximes 180a-180d and 180g to hydroxylamines 176a-176d and 176g followed 
by the retro-Cope elimination reactions to N-hydroxyl pyrrolidines 184a-184d and 184g. Reagents and 
Conditions: i) NaCNBH3 (2.0 equiv.), MeOH/HCl (10:1), Methyl orange, MeOH, 0 °C, 40 min, 86% - quant. ii) 
Solvent, RT → 40 °C → 60 °C. 
The Borch reductions were performed the same day or the day before the rate reactions were 
to be run. Once the hydroxylamine had been formed it was divided into three batches and 
dissolved in methanol, chloroform or toluene at a concentration of 0.014 M. Each reaction 
mixture was then degassed (freeze-thaw × 3) and allowed to stir at RT. Analytical samples 
were taken after 1.5 h and 3 h (N.B. for hydroxylamines 176a and 176b no sample was taken 
after 3 h at RT) and the samples analysed by 1H NMR spectroscopy. The reaction mixtures 
were then heated to 40 °C for 2.5 h before another sample was taken. Finally, the reaction 
mixtures were heated to 60 °C for 1 h and a final sample taken for analysis (Figure 15). 
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Figure 15: Graphs showing the rates of the retro-Cope elimination reaction of hydroxylamines 176a-d and g. 
From the data collected it was clear that the rate of cyclisation of hydroxylamine 176a, 
having the unsubstituted phenyl ring, was very similar to that of the methyl substituted (i.e. 4-
tolyl) analogue, hydroxylamine 176b, with 11-26% and 17-23% conversions to N-hydroxyl 
pyrrolidines 184a and 184b being observed respectively (graphs 1 and 2). Interestingly, when 
the phenyl group was substituted at the 4-position with an electron donating O-methyl 
substituent, hydroxylamine 176c, almost no reaction to give N-hydroxyl pyrrolidine 184c was 
observed in all three solvents (graph 3). However, a considerable amount of an unidentified 
side product did form when the reaction was run in methanol. Conversely, when the aryl 4-
substituent was the electron withdrawing CF3 group, hydroxylamine 176d, the reaction rates 
were significantly faster, with almost full conversion to N-hydroxyl pyrrolidine 184d being 
observed in all solvents (graph 4). Finally, the hydroxylamine 176g, having an alkyl 
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substituent at the distal end of the alkene, was unreactive under the reaction conditions, with 
no N-hydroxyl pyrrolidine 184g being observed in any solvent (graph 5). From these results it 
was decided that hydroxylamine 176c bearing the O-methyl substituent would be a good 
substrate for our envisaged development of an asymmetric retro-Cope elimination reaction, 
as hydroxylamine 176c was not reactive at low temperatures, but did start to cyclise 60 °C. 
This substrate would hopefully allow the screening of various additives without a background 
reaction interfering with possible catalyst activity.  
Towards this end, and in order to assess if the addition of a proton source would accelerate 
the rate of reaction, a second rate study was conducted, using hydroxylamine 176c as the 
substrate. This time the solvents used were methanol, toluene and toluene containing ~ 5 
equivalents methanol. Reactions were started at 60 °C and monitored every 2 h for a total of 
8 h (Figure 16). 
 
Figure 16: Graphs to show further rate reactions carried out on hydroxylamine 176c. *T + M = Toluene with ~ 
5 equiv. MeOH. **Data taken from graph 3, Figure 15. 
As with the previous rate studies carried out on this substrate (cf. graph 3, Figure 15) a 
significant amount of a side product was formed alongside N-hydroxyl pyrrolidine 184c when 
the reaction was run in methanol. This side product did not form when the solvent used was 
toluene, and pleasingly it was not observed in the presence of ~5 equivalents of methanol. 
The results show that there is a small increase in the rate of reaction when methanol was 
added to the reaction [60% conversion after 8 h vs.74% with the addition of methanol, graph 
6]. Finally, a reaction was carried out in toluene with ~5 equivalents of methanol following 
the same temperature profile as the first reaction rate study (graph 7, cf. graph 3, Figure 15). 
Disappointingly, there was no significant change in the reaction rate with the addition of 
methanol when compared to the results obtained in just toluene. Despite this result 
hydroxylamine 176c will be used for future studies, in which many other additives will be 
screened. 
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3.3. Conclusions and Future Work 
The first aim of this project was to synthesise and test substrates in order to establish a 
suitable system that could be used for the development of an asymmetric retro-Cope 
elimination reaction. This was achieved by synthesising a range of different hydroxylamines 
and studying the rate of reaction in different solvents at different temperatures. The results 
from these studies demonstrated that hydroxylamine 176c, containing an aryl group bearing 
an O-methyl substituent, was a suitable substrate for the purpose. We discovered that the 
retro-Cope elimination on this substrate would only occur at temperatures above 40 °C, this 
would allow us to screen various additives for catalytic activity without a background 
reaction occurring. 
With a suitable system for the development of an asymmetric retro-Cope elimination reaction 
achieved, the next step for the project will be testing various additives to act as a proton 
source in order to catalyse the proton transfer step. After completing this screening, hopefully 
an additive will have been identified that will catalyse our reaction and therefore allow testing 
of chiral additives to be undertaken. A recent review written by Stoltz has outlined the latest 
advances in enantioselective protonation.135 Although many of the enantioselective 
protonation procedures that have been developed to date have been designed for enolate 
protonation, this review demonstrates that there a number of chiral proton sources that may 
be suitable for our system (Figure 17). 
 
Figure 17: Examples of chiral protons sources used for enantioselective protonation.135 
The figure above shows some examples of chiral Brønsted acids that have been used 
successfully for the enantioselective enolate or decarboxylative protonation, that could be 
tested as possible enantioselective proton sources for our asymmetric retro-Cope elimination 
reaction.
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Overall Conclusions 
This thesis is comprised of three chapters, describing the research that has been undertaken 
within three different projects. The first of these chapters describes the biomimetic total 
synthesis of the Amaryllidaceae alkaloid clivonine. The key steps of the synthesis include an 
Ireland-Claisen rearrangement, a retro-Cope elimination and the biomimetic ring-switch of a 
lycorine type progenitor to that of a lycorenine type product. For the successful optimisation 
of the biomimetic ring switch step, a suitable method of purification of our key intermediate, 
iminium salt 38, was required. This was achieved with the use of solid phase, ion exchange 
chromatography, and allowed for the optimisation of the biomimetic ring-switch. Our 
synthesis of clivonine has shown for the first time a biomimetic interconversion of these two 
classes of compounds and has allowed for the corroboration of the biosynthetic pathway 
proposed for these alkaloids by Barton in 1960. 
The second chapter describes the synthesis of the acetonide 77, an extremely important 
synthetic building block and the starting material for our clivonine synthesis. This was 
achieved, firstly, by the development of a high yielding, scalable three step one-pot procedure 
for the synthesis of dibromo diol 134 from 1,3-cyclohexadiene (131). The synthesis was 
completed by optimising the bis-elimination of dibromide 135, to give acetonide 77 in an 
overall yield of 50% from 1,3-cyclohexadiene (131). 
Finally, the third chapter of this thesis describes the work carried out towards an asymmetric 
retro-Cope elimination reaction. The initial aim of this project was to establish a suitable 
system that could be used for the development of a catalytic asymmetric retro-Cope 
elimination reaction. This was achieved by synthesising a range of substrates and studying 
the effect of electron withdrawing and electron donating aryl substituents on the rate of the 
reaction. The results from this study revealed that hydroxylamine 176c bearing an O-methyl 
substituent would be the ideal substrate for the screening of additives for catalytic activity. 
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Chapter 4 – Experimental 
4.1. General Directions 
Solvents and reagents: Solvents were dried as follows: MeCN, CH2Cl2 and MeOH were 
distilled over CaH2, CH3Cl over MgSO4, THF and Et2O over Na-benzophenone ketyl and 
toluene over Na. Alternatively MeCN, CH2Cl2, THF, Et2O and toluene were dried and 
deoxygenated with a Pure-Solv 400 solvent purification system by Innovative Inc., USA. The 
moisture content of the solvents was monitored by Karl Fischer coulometric titration 
(Mettler-Toledo DL39). CCl4 was stirred over MgSO4 for 1 h. Acetic anhydride was distilled 
from K2CO3 under N2, m-CPBA was recrystallised from CH2Cl2 and stored in a plastic 
container at 4 °C and TMSCl was distilled from K2CO3 under N2. All other reagents were 
used as commercially supplied unless otherwise stated and handled in accordance with 
COSHH regulations.136 Photooxygenation: These reactions were performed in standard 
pyrex® round-bottom flasks and direct irradiation from a 300 W sunlamp (General Electric 
TSP-56RB). Chromatography: Flash chromatography was performed on silica gel (Merck 
Kieselgel 60 F254 230-400 mesh) according to the method of W.C. Still.
137 Thin layer 
chromatography (TLC) was performed on either aluminium or glass backed plates pre-coated 
with silica (Merck 0.2 mm, 60 F254) which were developed using standard visualising agents: 
ultra violet fluorescence (254 nm), KMnO4/∆ or vanillin/∆. Solid Phase Extraction (SPE) was 
carried out on weak cation exchange (WCX) carboxylic acid (CBA) pre-packed columns 
(Bond Elut, 2 g) and reverse phase on C18 pre-packed columns (Varian Megabond Elute).  
1
H NMR spectra: These were recorded at 400 or 500 MHz on a Bruker AV-400 or AV-500 
instrument. Chemical shifts (δH) are quoted in parts per million (ppm) referenced to the 
appropriate residual solvent peak, with the abbreviations s, d, t, q, p and m denoting singlet, 
doublet, triplet, quartet, pentet and multiplet respectively. 13C NMR spectra: These were 
recorded at 100 or 125 MHz on a Bruker AV-400 or AV-500 instrument. Chemical shifts 
(δC) are quoted in parts per million (ppm) referenced to the appropriate residual solvent peak, 
with the abbreviations s, d, t, and q denoting C, CH, CH2 and CH3 respectively. Infra red 
spectra: These were recorded as thin films or as solids on PerkinElmer Spectrum 100 Series 
spectrometer. Only selected absorbencies (νmax) are reported.  Mass spectra: Low resolution 
and high resolution spectra were recorded on a VG Prospec spectrometer, with molecular 
ions and major peaks being reported. Intensities are given as percentages of the base peak. 
HRMS values are valid to 5 ppm. Melting points: Analyses were carried out using a Khofler 
hot stage and are uncorrected.  
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4.2. Experimental for Chapter 1 
cis-2,3-(Isopropylidenedioxy)cyclohexa-4,6-diene (77)
51
 
 
To a stirred solution of meso-diol 74 (9.77 g, 87.3 mmol) in CH2Cl2 (150 mL) at 0 °C was 
added DMP (64.4 mL, 523.8 mmol) and pTsOH·H2O (0.83 g, 4.4 mmol) and the resultant 
mixture stirred at 0 °C for 1 h. After this time the reaction mixture was quenched with NaOH 
(1 M, 100 mL) and stirred at RT for 10 min, until two clear phases had formed. The phases 
were separated, the organic phase was washed with H2O (2 × 100 mL) and the aqueous phase 
was extracted further with CH2Cl2 (2 × 100 mL). The combined organic phases were washed 
with brine (100 mL), dried over Na2SO4, filtered and concentrated in vacuo to give acetonide 
77 as a pale yellow oil (10.23 g, 77%); Rf 0.83 (petrol/EtOAc, 1:1);
 1H NMR (400 MHz, 
CDCl3): δ 1.38 (3H, s, CH3), 1.40 (3H, s, CH3), 4.64 (2H, m, C2H and C3H), 5.88 (2H, m, 
C1H and C4H), 5.98 (2H, m, C5H and C6H); 
13C NMR (100 MHz, CDCl3): δ 24.69 (q), 26.70 
(q), 70.32 (2 × d), 104.56 (s), 123.71 (2 × d), 125.26 (2 × d); IR νmax (neat): 694, 872, 1027, 
1045, 1159, 1208, 1238, 1370, 1381, 2886, 2935, 2986, 3045 cm -1; m/z (CI+) 322 
[(2M+NH4)
+, 25%], 305 [(2M+H)+, 10%], 170 [(MNH4)
+, 85%]; HRMS (CI+) calcd. for 
C18H25O4 [(2M+H)
+] 305.1753, found 305.1751 (∆ -0.6 ppm). 
(5S*, 6S*)-Di-O-isopropylidenecyclohex-2-ene-1-one (40)
52
 
 
To a stirred solution of acetonide 77 (9.16 g, 60.2 mmol) in CH2Cl2 (25 mL) at 0 °C was 
added dropwise a solution of m-CPBA (10.4 g, 60.2 mmol) in CH2Cl2 (100 mL). After 
stirring for 17 h at RT, the reaction mixture was concentrated in vacuo to yield a white solid 
which was re-dissolved in THF (50 mL). In a separate, dry flask wrapped in aluminium foil, 
Pd2(dba)3 (5.5 g, 6.0 mmol) was added to a stirred solution of diphenylphosphino ethane 
(DPPE) (4.8 g, 12.1 mmol) in THF (50 mL). After stirring for 20 min at RT the solution 
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containing crude epoxide 78 was cannulated into that of the Pd(0). After stirring for 66 h at 
RT the reaction mixture was concentrated in vacuo to yield a dark brown solid which was 
partitioned between NaHCO3 (sat. aq., 150 mL) and EtOAc (150 mL), the phases were 
separated and the aqueous phase extracted further with EtOAc (5 × 100 mL). The combined 
organic phases were dried over Na2SO4, filtered and concentrated in vacuo. The crude 
residue was purified by FC (SiO2, petrol/Et2O, 2:1→1:1→1:2) to give (±)-enone 40 as a pale 
yellow solid (6.5 g, 64%). m.p. 68-72 °C (Et2O/pentane) [Lit., 87.0-88.0 °C (Et2O/hexane)]
52; 
Rf 0.4 (petrol/Et2O, 1:2); 
1H NMR (400 MHz, CDCl3): δ 1.30 (3H, s, CH3), 1.36 (3H, s, 
CH3), 2.76 (1H, app ddt, J = 20.0, 5.2, 2.5, C4HH), 2.85 (1H, app ddt, J = 20.0, 4.9, 1.5, 
C4HH), 4.25 (1H, d, J = 5.0, C6H), 4.59 (1H, app tt, J = 5.0, 1.5, C5H), 6.08 (1H, ddd, J = 
10.3, 2.5, 1.5, C2H), 6.80 (1H, m, C3H); 
13C NMR (100 MHz, CDCl3): δ 25.90 (q), 27.36 (q), 
27.67 (t), 72.81 (d), 75.40 (d), 109.11 (s), 128.15 (d), 146.33 (d), 196.30 (s); IR νmax (neat): 
1072, 1220, 1241, 1374, 1664, 2983 cm -1; m/z (CI+) 186 [(MNH4)
+, 100%]; HRMS (CI+) 
calcd. for C9H13O3 [(MH)
+] 169.0865, found 169.0863 (∆ -1.0 ppm).  
(2S, 3S)-1-Chloro-2,3-di-O-isopropylicyclohex-4,6-diene (80)
138
 
 
To a stirred solution of diol 75 (1.0 g, 6.85 mmol) in CH2Cl2 (30 mL) at 0 °C was added 
DMP (5.1 mL, 41.1 mmol) and pTsOH·H2O (0.26 g, 1.37 mmol) and the resultant mixture 
stirred at 0 °C for 1.5 h. After this time the reaction mixture was quenched with NaOH (1 M, 
15 mL) and the mixture allowed to stir for 10 min until two clear phases formed. The phases 
were separated, the organic phase was washed with H2O (2 × 20 mL) and the aqueous phase 
was extracted further with CH2Cl2 (3 × 20 mL). The combined organic phases were washed 
with brine (50 mL), dried over Na2SO4, filtered and concentrated in vacuo to give acetonide 
80 as a pale yellow oil (1.22 g, 96%); 1H NMR (400 MHz, CDCl3): δ 1.41 (3H, s, CH3), 1.42 
(3H, s, CH3), 4.63 (1H, d, J = 8.8, C2H), 4.76 (1H, dd, J = 8.8, 3.6, C3H), 5.89 (1H, dd, J = 
9.6, 3.6, C4H), 5.94 (1H, d, J = 9.6, 5.8, C5H), 6.09 (1H, d, J = 5.8, C6H); m/z (CI
+) 204 
[{M(35Cl)NH4}
+, 100 %], 206 [{M(37Cl)NH4}
+, 35 %]. 
(2S, 3S)-1-Bromo-2,3-di-O-isopropylicyclohex-4,6-diene (81)
138
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To a stirred solution of diol 76 (5.0 g, 26.18 mmol) in CH2Cl2 (80 mL) at 0 °C was added 
DMP (19.3 mL, 157.1 mmol) and pTsOH·H2O (1.0 g, 5.2 mmol) and the resultant mixture 
stirred at 0 °C for 1 h. After this time the reaction mixture was quenched with NaOH (1 M, 
75 mL) and the mixture allowed to stir for 10 min until two clear phases formed. The phases 
were separated, the organic phase was washed with H2O (2 × 50 mL) and the aqueous phase 
was extracted further with CH2Cl2 (3 × 100 mL). The combined organic phases were washed 
with brine (100 mL), dried over Na2SO4, filtered and concentrated in vacuo to give acetonide 
81 as a pale yellow oil (5.84 g, 97%); 1H NMR (400 MHz, CDCl3): δ 1.41 (3H, s, CH3), 1.42 
(3H, s, CH3), 4.71 (2H, m, C2H and C3H), 5.85 (1H, dd, J = 9.6, 6.1, C5H), 5.99 (1H, app d, J 
= 9.6, C4H), 6.32 (1H, d, J = 6.1, C6H); m/z (CI
+) 231 [{M(79Br)H}+, 100 %], 233 
[{M(81Br)H}+, 97 %]. 
(1R, 4R, 5R, 6S)-1-Chloro-7,8-dioxa-5,6-di-O-isopropylidenebicyclo[2.2.2]oct-2-ene 
(82)
50
 
 
A stirred solution of acetonide 80 (1.0 g, 5.38 mmol) and TPP (23 mg, 0.7 mol%) in CCl4 
(200 mL) was cooled to 0 °C and irradiated with a 300 W lamp whilst bubbling oxygen 
through the solution for 2 h. After this time the reaction mixture was concentrated in vacuo 
and the crude endoperoxide 82 taken onto the next step without any further purification. 1H 
NMR (400 MHz, CDCl3): δ 1.32 (3H, s, CH3), 1.34 (3H, s, CH3), 4.44 (1H, d, J = 7.0, C6H), 
4.67 (1H, dd, J = 7.0, 4.6, C5H), 4.89 (1H, app t, J = 5.1, C4H), 6.46 (1H, d, J = 8.6, C2H), 
6.56 (1H, dd, J = 8.6, 6.0, C3H). 
(1R, 4R, 5R, 6S)-1-Bromo-7,8-dioxa-5,6-di-O-isopropylidenebicyclo[2.2.2]oct-2-ene 
(83)
50
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A stirred solution of acetonide 81 (4.5 g, 19.5 mmol) and TPP (84 mg, 0.7 mol%) in CCl4 (50 
mL) was cooled to 0 °C and irradiated with a 300 W lamp whilst bubbling oxygen through 
the solution for 2 h. After this time the reaction mixture was concentrated in vacuo and the 
crude endoperoxide 83 taken onto the next step without any further purification. 1H NMR 
(400 MHz, CDCl3): δ 1.33 (3H, s, CH3), 1.36 (3H, s, CH3), 4.60 (1H, dd, J = 7.2, 1.2, C6H), 
4.67 (1H, dd, J = 7.2, 4.3, C5H), 4.96 (1H, ddd, J = 5.9, 4.3, 1.2, C4H), 6.49 (1H, dd, J = 8.7, 
5.9, C2H), 6.62 (1H, app dt, J = 8.7, 1.3, C3H). 
Polystyrene-bound N-methyl-thiourea (88)
24
 
 
Aminomethylated resin 86 (25 g, 22.5 mmol, 0.9 mmol g-1) was swelled in Et2O (200 mL) for 
20 min before a solution of isothiocyanate 87 (1.8 g, 24.8 mmol) in Et2O (20 mL) was added 
via cannula. The resultant suspension was heated to 40 °C for 24 h. After this time the 
reaction mixture was cooled, filtered, washed with Et2O (400 mL) and dried under high 
vacuum to yield thiourea resin 88 as a pale yellow solid (26 g, 97%, 0.84 mmol g-1); IR νmax 
(KBr): 748, 1025, 1112, 1491, 1560, 2923, 3025, 3250, 3394. See Appendix 1 for loading 
level calculations. 
(4R, 5S, 6S)-4-O-Acetoxy-5,6-di-O-isopropylidenelcyclohex-2-ene-1-one (84)
23
 
 
A solution of endoperoxide 82 (0.88 g, 4.04 mmol) in CH2Cl2 was added via cannula to a 
pre-swelled suspension of thiourea resin 88 (7.2 g, 6.05 mmol, 0.84 mmol g-1) in CH2Cl2 
(100 mL) at 0 °C and the resultant suspension stirred for 30 min. After this time complete 
consumption of endoperoxide 82 was observed by TLC analysis. The reaction mixture was 
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filtered and the resin washed with CH2Cl2 (100 mL) and the resultant solution immediately 
sealed and put under an atmosphere of N2. To this solution was added a solution of DMAP 
(45.3 mg, 0.40 mmol), Et3N (0.85 mL, 6.06 mmol) and freshly distilled Ac2O (0.54 mL, 5.66 
mmol) in CH2Cl2 (5 mL) and the reaction mixture allowed to stir at RT for 1 h. After this 
time the reaction mixture was quenched with NaHCO3 (sat. aq., 100 mL), and the phases 
separated. The aqueous phase was extracted further with CH2Cl2 (3 × 100 mL), the combined 
organic phases were washed with brine (100 mL), dried over Na2SO4 and concentrated in 
vacuo. The crude residue was purified by FC (SiO2, petrol/Et2O, 7:1→5:1→4:1→3:1→2:1) 
to give acetate 84 as a pale yellow oil (597 mg, 65%); 1H NMR (400 MHz, CDCl3): δ 1.38 
(6H, s, 2 × CH3), 2.11 (3H, s, OCH3), 4.43 (1H, d, J = 5.8, C6H), 4.50 (1H, ddd, J = 5.8, 3.3, 
1.3, C5H), 5.58 (1H, m, C4H), 6.18 (1H, dd, J = 10.3, 1.4, C2H), 6.77 (1H, ddd, J = 10.3, 4.0, 
1.3, C3H); m/z (EI
+) 226 [(M)+•, 10%]. 
(5S, 6S)-Di-O-isopropylidenecyclohex-2-ene-1-one (40)
23
 
 
A solution of acetate 84 (0.5 g, 2.2 mmol) in CH2Cl2 (25 mL) was degassed (freeze-thaw × 
3). To this solution was added Pd(PPh3)4 (64 mg, 2.5 mol%) and TMDS (0.4 mL, 2.21 mmol) 
and the resultant mixture heated to 44 °C for 21 h in the dark. After this time Et3N (0.32 mL, 
2.32 mmol) was added and the mixture heated for a further 1 h at 44 °C. The reaction mixture 
was quenched with H2O (50 mL), the phases were separated and the aqueous phase extracted 
further with CH2Cl2 (3 × 25 mL). The combined organic phases were washed with brine (50 
mL), dried over Na2SO4, filtered and concentrated in vacuo. The crude residue was purified 
by FC (SiO2, petrol/Et2O, 4:1→3:1→2:1→1:1→1:2) to give (+)-enone 40 as a pale yellow 
solid (159 mg, 43%); Spectroscopic data as above but enantiomerically pure; [α]20D   + 93.4 (c 
= 1.000, MeOH), [Lit., [α]20D   + 107.5 (c = 1.000)]
23. 
(3aS
*
,5S
*
,6R
*
)-5,6-Di-O-isopropylidene-3-[(methoxycarbonyl)methyl]-1-(3,4-
methylenedioxyphenyl)cyclohex-1-ene (90)
46
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To a solution of 1-bromo-3,4-(methylenedioxy)benzene 89 (4.49 mL, 37.46 mmol) in THF 
(85 mL) at -78 °C was added tert-BuLi (48.75 mL, 1.5 M solution in hexanes, 73.12 mmol) 
dropwise. After stirring for 30 min at -78 °C, a solution of enone 40 (6.0 g, 35.67 mmol) in 
THF (85 mL) was slowly added via cannula. The reaction mixture was stirred for 2 h at -78 
°C, then allowed to warm to 0 °C over 45 min. Freshly distilled Ac2O (8.40 mL, 89.18 mmol) 
was then added to the reaction mixture and the solution allowed to warm to RT over 14 h. 
The reaction mixture was partitioned between NaHCO3 (sat. aq., 200 mL), the phases were 
separated and the aqueous phase extracted further with Et2O (4 × 100 mL). The combined 
organic phases were dried over Na2SO4, filtered and concentrated in vacuo to give acetate 41 
(~ 12 g); 1H NMR (400 MHz, CDCl3): δ 1.34 (3H, s, CH3), 1.56 (3H, s, CH3), 2.06 (3H, s, 
COCH3), 2.38 (1H, ddd, J = 16.9, 7.5, 3.7, C4HH), 2.56 (1H, dddd, J = 16.9, 6.1, 5.5, 1.0, 
C4HH), 4.20 (1H, d, J = 7.5, C6H), 4.39 (1H, app td, J = 7.5, 4.3, C5H), 5.93 (2H, s, OCH2O), 
6.00 (1H, ddd, J = 9.5, 5.5, 3.7, C3H), 6.40 (1H, ddd, J = 9.5, 2.5, 1.0, C2H), 6.72-6.81 (3H, 3 
× CArH); m/z (EI
+) 332 [(M)+•, 29%]. To a solution of diisopropylamine (8.77 mL, 62.42 
mmol) in THF (95 mL) was added n-BuLi (29.45 mL, 2.12 M in hexanes, 62.42 mmol) 
dropwise at -78 °C. The resultant solution was allowed to stir for 10 min at -78 °C and 
warmed to 0 °C for 10 min. This cooling and warming process was repeated 3 times to which 
the solution became a pale yellow colour. To a solution of crude acetate 41 (~ 12 g, ~ 35 
mmol) in THF (100 mL) at -78 °C was added LDA (0.5 M in THF, as described above) 
dropwise via cannula and allowed to stir for 20 min. After this time freshly distilled TMSCl 
(13.68 mL, 107.01 mmol) was added and the reaction mixture stirred at -78 °C for 30 min. 
After this time the reaction mixture was warmed to 0 °C over 30 min before being allowed to 
reflux for 16 h. The reaction mixture was quenched with 10% citric acid solution until pH 4 
was reached, brine (170 mL) was added, the phases separated and the aqueous phase 
extracted further with Et2O (3 × 100 mL). The combined organic phases were combined, 
washed with brine (25 mL), dried over Na2SO4 and concentrated in vacuo to give acid 45 (~ 
12 g); 1H NMR (400 MHz, CDCl3): δ 1.46 (3H, s, CH3), 1.50 (3H, s, CH3), 1.55 (1H, m, 
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C4HH), 2.04 (1H, ddd, J = 12.5, 4.9, 4.7, C4HH), 2.54 (1H, dd, J = 15.9, 7.5, C3HH), 2.59 
(1H, dd, J = 15.9, 7.2, C3HH), 2.76 (1H, m, C3aH), 4.36 (1H, ddd, J = 10.1, 5.1, 4.9, C5H), 
4.86 (1H, d, J = 5.1, C6H), 5.97 (2H, s, OCH2O), 6.13 (1H, d, J = 2.6, C2H), 6.80 (1H, d, J = 
8.6, CArH), 7.06 (2H, m, 2 × CArH), OH (absent); m/z (EI
+) 332 [(M+•), 52%]. To a solution 
of Diazald® (22.93 g, 107.01 mmol) in Et2O (240 mL), in diazomethane smooth-surface 
apparatus, was added a solution of KOH (7.0 g, 124.85 mmol) in carbitol/H2O/Et2O (135 mL, 
3:1:1) dropwise at 50 °C. The resulting diazomethane that formed was condensed and 
dropped into a separate flask containing a solution of acid 45 (~ 12 g, ~ 35 mmol) in Et2O 
(50 mL) cooled to 0 °C. The Diazald® solution was heated until no further diazomethane was 
seen to evolve and then cooled. The reaction mixture was allowed to stir at RT for 16 h. After 
this the reaction mixture was concentrated in vacuo and the crude residue purified by FC 
(SiO2, petrol/Et2O 4:1→3:1→2:1→1.5:1) to yield methylester 90 as a yellow oil (5.88 g, 
47%); 1H NMR (400 MHz, CDCl3): δ 1.41 (3H, s, CH3), 1.46 (3H, s, CH3), 1.48 (1H, m, 
C4HH), 1.96 (1H, app dt, J = 12.4, 6.7, C4HH), 2.48 (2H, m, C3H2), 2.72 (1H, m, C3aH), 3.70 
(3H, s, OCH3), 4.31 (1H, app p, J = 5.4, C5H), 4.78 (1H, d, J = 5.4, C6H), 5.93 (2H, s, 
OCH2O), 6.06 (1H, d, J = 2.6, C2H), 6.76 (1H, d, J = 8.9, CArH), 7.02-7.04 (2H, 2 × CArH); 
m/z (EI+) 346 [(M)+•, 55%]. 
(3aS
*
,5S
*
,6R
*
)-5,6-Di-O-isopropylidene-3-(2-oxoethyl)-1-(3,4-
methylenedioxyphenyl)cyclohex-1-ene (91)
46
 
 
To a solution of methylester 90 (100 mg, 0.29 mmol) in toluene (4 mL) at -78 °C was added 
via cannula (wrapped in aluminium foil containing crushed dry ice) a cooled solution of 
DIBAL (1.0 M in hexanes, 0.32 mL, 0.32 mmol). After 3 h, MeOH (1.5 mL) cooled to -78 
°C was added via cannula and the solution stirred for a further 30 min, before being warmed 
to RT. Solvents were removed in vacuo and the yellow/white solid was partitioned between 
sodium potassium tartrate (sat. aq., 6 mL) and EtOAc (6 mL). The phases were separated and 
the aqueous phase extracted further with EtOAc (5 × 6 mL). The combined organic phases 
were washed with brine (30 mL), dried over MgSO4 and concentrated in vacuo. The crude 
residue was purified by FC (SiO2, petrol/Et2O, 3:1→1:1→1:3) to yield aldehyde 91 as a pale 
yellow oil (37 mg, 40%); 1H NMR (400 MHz, CDCl3): δ 1.41 (3H, s, CH3), 1.45 (3H, s, 
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CH3), 1.50 (1H, m, C4HH), 1.98 (1H, app dt, J = 12.6, 5.3, C4HH), 2.67 (2H, m, C3H2), 2.84 
(1H, m, C3aH), 4.33 (1H, app p, J = 5.3, C5H), 4.78 (1H, d, J = 5.3, C6H), 5.93 (2H, s, 
OCH2O), 6.06 (1H, d, J = 2.8, C2H), 6.80 (1H, d, J = 8.7, CArH), 7.00-7.03 (2H, 2 × CArH), 
9.83 (1H, s, CHO); m/z (EI+) 316 [(M)+•, 76%]. 
(E)- and (Z)-(3aR*,5S*,6R*)-5,6-Di-O-isopropylidene-3-(2-hydroxyiminoethyl)-1-(3,4-
methylenedioxyphenyl)cyclohex-1-ene (46)
46 
 
To a stirred solution of methyl ester 90 (6.73 g, 19.43 mmol) in THF (150 mL) at 0 °C was 
added LiBH4 (68.01 mL, 2 M in THF, 136.01 mmol) over 41.5 h during which time the 
mixture warmed to RT. After stirring for a further 15 h the reaction mixture was quenched 
with H2O (50 mL), the phases were separated and the aqueous phase extracted further with 
EtOAc (4 × 100 ml). The combined organic phases were washed with brine (200 mL), dried 
over Na2SO4 and concentrated in vacuo to give alcohol 92 as a yellow oil (5.34 g, 86%). 
1H 
NMR (CDCl3, 400 MHz): δ 1.44 (1H, m, C4HH), 1.47 (3H, s, CH3), 1.52 (3H, s, CH3), 1.61 
(1H, br s, OH), 1.73 (1H, td, J = 13.9, 6.5, C3HH), 1.86 (1H, td, J = 13.5, 6.5, C3HH), 2.01 
(1H, app dt, J = 12.1, 4.7, C4HH), 2.45 (1H, m, C3aH), 3.84 (2H, m, C3bH2), 4.32 (1H, app dt, 
J = 10.5, 5.0, C5H), 4.83 (1H, d, J = 5.0, C6H), 5.98 (2H, s, OCH2O), 6.17 (1H, d, J = 2.3, 
C2H), 6.82 (1H, d, J = 8.3, CArH), 7.07-7.10 (2H, 2 × CArH); m/z (EI
+) 318 [(M+•), 57%]. To a 
suspension of Dess-Martin periodinane (21.4 g, 50.4 mmol) in CH2Cl2 (60 mL) at RT was 
added a solution of alcohol 92 (5.34 g, 16.8 mmol) in CH2Cl2 (20 mL) dropwise via cannula. 
After stirring for 23.5 h the reaction mixture was filtered through Celite® and the filtrate 
treated with NaHCO3 (sat. aq., 100 mL). The phases were separated and the aqueous phase 
extracted further with CH2Cl2 (2 × 50 mL). The combined organic phases were washed with 
NaHCO3 (sat. aq., 50 mL), dried over Na2SO4 and concentrated in vacuo to give aldehyde 91 
as a dark red oil (5.04 g, 95%, 1H NMR yield); Spectroscopic data as above. To a solution of 
aldehyde 91 (5.04 g, 15.93 mmol) in CH2Cl2 (40 mL) was added hydroxylamine (2.21 g, 
31.86 mmol), NaOAc (3.27 g, 39.83 mmol) and MeOH (7 mL) and the reaction mixture 
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allowed to stir open to the atmosphere at RT. After 2 h brine (50 mL) and EtOAc (200 mL) 
were added to the reaction mixture and the phases separated. The aqueous phase was 
extracted further with EtOAc (2 × 100 mL), the combined organic phases were washed with 
brine (100 mL), dried over NaSO4 and concentrated in vacuo. The crude residue was purified 
by FC (SiO2, petrol/Et2O, 2:1→1:1→1:2) to yield oxime 46 as a yellow foam (4.3 g, E:Z, 
1.2:1 by 1H NMR, 67% from methylester 90). (NB. Protocol only with intermediate yields for 
alcohol 92 and aldehyde 91). Samples of the two isomers were isolated on an analytical scale 
by FC (SiO2, petrol/Et2O 1:1) to give: 
(E)-oxime 46 as a white solid;1H NMR (400 MHz, CDCl3): δ 1.40-1.46 (1H, C4HH), 1.42 
(3H, s, CH3), 1.46 (3H, s, CH3), 1.96 (1H, app dt, J = 12.4, 4.5, C4HH), 2.36 (2H, m, C3H2), 
2.43 (1H, m, C3aH), 4.28 (1H, app p, J = 5.4, C5H), 4.78 (1H, d, J = 5.4, C6H), 5.92 (2H, s, 
OCH2O), 6.08 (1H, d, J = 2.0, C2H), 6.76 (1H, d, J = 8.0, CArH), 7.01-7.04 (2H, 2 × CArH), 
7.48 (1H, t, J = 6.1, NCH), 7.97 (1H, s, NOH); m/z (EI+) 331 [(M+•), 26%]. 
(Z)-oxime 46 as a white solid; 1H NMR (400 MHz, CDCl3): δ 1.41-1.47 (1H, C4HH), 1.42 
(3H, s, CH3), 1.47 (3H, s, CH3), 1.96 (1H, app dt, J = 12.5, 4.3, C4HH), 2.48 (2H, m, C3H2), 
2.64 (1H, m, C3aH), 4.28 (1H, app p, J = 5.4, C5H), 4.78 (1H, d, J = 5.4, C6H), 5.93 (2H, s, 
OCH2O), 6.06 (1H, d, J = 1.2, C2H), 6.77 (1H, d, J = 8.8, CArH), 6.82 (1H, t, J = 5.4, NCH), 
7.02-7.04 (2H, 2 × CArH), 7.97 (1H, s, NOH); m/z (EI
+) 331 [(M+•), 26%]. 
(3aR*,5S*,5aR*,11bS*,11cR*)-5,5a-Di-O-isopropylidene-1-hydroxylamino-11b-(3, 4-
methylenedioxyphenyl)-2, 3, 3a, 4, 5, 5a, 11b, 11c-octahydroindole (48)
46
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A stirred solution of oxime 46 (0.5 g, 1.51 mmol) and NaCNBH3 (0.19 g, 3.02 mmol) in 
MeOH (58 mL) was cooled to 0 °C and 15 drops methyl orange added. MeOH/HCl (10:1) 
(1.1 mL over 10 min) was added dropwise to this bright yellow solution to give an orange 
solution. The reaction mixture was then warmed to RT for 5 min to which the solution 
returned to yellow colour and was cooled back down to 0 °C. MeOH/HCl was added 
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dropwise until the solution remained orange and the reaction mixture was again warmed to 
RT. After 5 min the yellow solution was concentrated to approximately 10 mL, partitioned 
between Et2O (50 mL) and NaHCO3 (sat. aq., 50 mL) and the phases separated. The aqueous 
phase was extracted further with Et2O (5 × 50 mL), the combined organic phases were 
washed with brine (50 mL), dried over NaSO4 and concentrated in vacuo to give 
hydroxylamine 47 as a yellow foam. The hydroxylamine was immediately redissolved in 
toluene (100 mL), the solution was degassed (freeze-thaw × 4) and heated to 80 °C. After 14 
h the reaction mixture was concentrated in vacuo to give N-OH pyrrolidine 48 as a yellow 
solid (0.50 g, 94%); 1H NMR (400 MHz, CDCl3): δ 1.27 (3H, s, CH3), 1.42 (3H, s, CH3), 
1.42-1.58 (2H, C4H2), 2.10 (2H, m, C3H2), 2.31 (1H, m, C3aH), 2.73 (2H, m, C2H2), 3.00 (1H, 
app t, J = 10.8, C11bH), 3.15 (1H, m, C11cH), 4.16 (1H, dd, J = 10.8, 7.6, C5aH), 4.26 (1H, m, 
C5H), 5.91 (2H, s, OCH2O), 6.81 (2H, app s, 2 × CArH), 6.84 (1H, app s, CArH), OH (absent); 
m/z (ESI) 334 [(MH+), 100%]. 
(3aR*,5S*,5aR*,11bS*,11cR*)-5,5a-Di-O-isopropylidene-11b-(3,4-
methylenedioxyphenyl)-2, 3, 3a, 4, 5, 5a, 11b, 11c-octahydroindole (94)
46
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To a solution of N-OH pyrrolidine 48 (500 mg 1.51 mmol) in EtOH/H2O (10:1) (35 mL) was 
added an excess of Raney Ni (suspension in H2O) and the reaction mixture allowed to stir at 
RT under an atmosphere of H2. After 3 h the reaction mixture was filtered through Celite
® 
and concentrated in vacuo to give pyrrolidine 94 as a yellow foamy solid (430 mg, 90%); 1H 
NMR (400 MHz, CDCl3): δ 1.27 (3H, s, CH3), 1.42 (3H, s, CH3), 1.42-1.59 (2H, C4H2), 2.02-
2.20 (4H, C3H2, C3aH, NH), 2.60 (1H, app t, J = 10.9, C11bH), 2.66 (1H, ddd, J = 10.2, 9.9, 
6.4, C2HH), 2.98 (1H, ddd, J = 9.9, 6.8, 3.1, C2HH), 3.13 (1H, dd, J = 10.9, 9.3, C11cH), 4.15 
(1H, dd, J = 10.9, 7.5, C5aH), 4.29 (1H, ddd, J = 10.5, 7.5, 5.8, C5H), 5.90 (2H, s, OCH2O), 
6.75 (2H, app s, 2 × CArH), 6.78 (1H, app s, CArH); m/z (CI
+) 318 [(MH)+, 100%]. 
(3aR*,5S*,5aR*,11bS*,11cR*)-5,5a-Di-O-isopropylidene-1-formyl-11b-(3,4-
methylenedioxyphenyl)-2, 3, 3a, 4, 5, 5a, 11b, 11c-octahydroindole (95)
46
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Method 1: 
A solution of acetoformic anhydride was prepared according to the method of Prosperi139 by 
heating a solution of acetic anhydride (2.0 mL) and formic acid (2.0 mL) at 60 °C for 2 h. To 
a solution of pyrrolidine 94 (0.43 g, 1.36 mmol) in CH2Cl2 (15 mL) was added a solution of 
acetoformic anhydride (0.36 g, 4.08 mmol) (prepared as described above) in CH2Cl2 (5 mL) 
and the reaction mixture allowed to stir at RT for 2 h. After this time the reaction mixture 
was quenched with NaHCO3 (sat. aq., 20 mL), the phases were separated and the aqueous 
phase extracted further with CH2Cl2 (3 × 20 mL). The combined organic phases were washed 
with brine (20 mL), dried over NaSO4 and concentrated in vacuo. The crude residue was 
purified by FC (SiO2, petrol:Et2O, 1:2→1:4→100% Et2O→2% MeOH in Et2O→3% MeOH 
in Et2O→5% MeOH in Et2O→10% MeOH in Et2O) to give formamide 95 as a white foam 
(160 mg, 34%); 1H NMR (400 MHz, CDCl3): δ 1.27 (3H, s, CH3), 1.43 (3H, s, CH3), 1.79 
(2H, m, C4H2), 2.09 (2H, m, C3H2), 2.46 (1H, m, C3aH), 2.63 (1H, app t, J = 10.7, C11bH), 
3.23 (1H, app dt, J = 12.1, 7.7, C11cH), 3.75 (2H, m, C2H2), 4.25 (1H, dd, J = 10.3, 6.8, C5aH) 
4.31 (1H, m, C5H), 5.91 (2H, s, OCH2O), 6.62 (1H, dd, J = 7.9, 1.5, C7aH), 6.68 (1H, d, J = 
1.7, C8H), 6.79 (1H, d, J = 7.9, C11H), 7.26 (1H, s, NCHO); m/z (CI
+) 346 [(MH)+, 100%], 
363 [(MNH4)
+, 52%]. 
Method 2: 
A stirred solution of pyrrolidine 94 (121 mg, 0.38 mmol) in ethyl formate (20 mL) was 
heated to 60 °C and allowed to reflux for 16 h. After this time the reaction mixture was 
concentrated in vacuo to give formamide 95 as an off white foam (124 mg, 94%); 
Spectroscopic data as above. 
(3aR*,5S*,5aR*,11bS*,11cR*)-5,5a-Dihydroxy-2,3,3a,4,5,5a,11b,11c-octahydro-1H-
[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridinium chloride (38)
46
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To a solution of formamide 95 (361 mg, 1.05 mmol) in MeCN (20 mL) was added POCl3 
(0.15 mL, 1.58 mmol) dropwise and the reaction mixture refluxed for 30 min. After this time 
the reaction mixture was cooled to RT and treated with aqueous HCl (12 mL, 3 M). After 1 h 
the reaction mixture was concentrated in vacuo to give the crude product as a brown sticky 
oil. Purification by SPE using a WCX CBA ion exchange column followed by reverse phase 
C18 silica column gave the iminium salt 38 as a yellow oil (142 mg, 42 %). 1H NMR (400 
MHz, D2O): δ 1.74 (1H, m, C4HH), 1.98 (1H, m, C4HH), 2.12 (1H, app qd, J = 12.6, 6.9, 
C3HH), 2.46 (1H, app dt, J = 12.6, 6.1, C3HH), 2.77 (1H, m, C3aH), 3.16 (1H, dd, J = 17.4, 
8.5, C11bH), 3.88 (1H, m, C5H), 4.04 (1H, m, C11cH), 4.12 (1H, app dd, J = 17.7, 10.6, 
C2HH), 4.23 (1H, app dd, J = 12.7, 6.6, C2HH), 4.31 (1H, dd, J = 8.5, 5.3, C5aH), 6.19 (2H, s, 
OCH2O), 7.22 (1H, s, C8H), 7.33 (1H, s, C11H), 8.76 (1H, s, N=CH), 2 × OH (absent); m/z 
(ESI) 288 [(M-Cl-)+, 100%]. 
(±)-Clivonine (1)
9,13,46 
 
To a solution of iminium salt 38 (5 mg, 0.015 mmol) in DMSO-d6/D2O (0.5 mL:0.1 mL) in 
an NMR tube was added a solution of Cs2CO3 (25 µL, 0.77 M in D2O) and the solution 
sonicated for 5 min. By 1H NMR the iminium signal at δ 9.07 ppm had disappeared and the 
new benzylic proton signal of lactamol 50 at δ 4.92 ppm was observed. 1H NMR (400 MHz, 
DMSO-d6): δ 1.62-1.78 (4H, C2H2 & C4H2), 1.88 (1H, m, C3HH), 2.11 (1H, m, C3HH), 2.58 
(1H, dd, J = 15.8, 9.0, C11bH), 2.80 (1H, app t, J = 9.0, C11cH), 2.99 (1H, app dd, J = 15.8, 
10.5, C3aH), 3.65 (1H, m, C5aH), 3.72 (1H, m, C5H), 4.92 (1H, s, NCOH), 5.88 (2H, s, 
OCH2O), 6.87 (1H, s, C8H), 7.22 (1H, s, C11H) 3 × OH (absent); Immediately, MeI (0.03 
mmol dilute solution in DMSO-d6) was added and the reaction mixture sonicated for 5 min. 
Solvents were removed by freeze drying and the residue suspended in toluene (2.5 mL). 
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Freshly prepared Fetizon’s reagent61 (130 mg, 0.23 mmol) was added to the solution and the 
suspension was heated to 80 °C for 1 h. The reaction mixture was then cooled to RT, filtered 
through a pad of Celite®, washed with EtOAc (15 mL) and concentrated in vacuo. 
Purification by preparative TLC [pentane/Et2O/MeOH (sat. NH3), 50:45:5] gave (±)-
clivonine 1 as a white solid (1.5 mg, 32%). m.p. 198-200 °C (CHCl3) [Lit. 199-200 °C 
(EtOAc)]7; Rf 0.7 (CHCl3/MeOH, 9:1); 
1H NMR (400 MHz, CDCl3): δ 1.80 (1H, ddd, J = 
15.3, 6.3, 3.9, C4HH), 2.10 (1H, m, C4HH), 2.26 (2H, m, C2HH & C3HH), 2.48-2.58 (5H, 
NCH3, C3aH, C3HH), 2.89 (1H, dd, J = 10.0, 6.7, C11cH), 3.22 (1H, dd, J = 12.3, 10.0, C11bH), 
3.29 (1H, m, C2HH), 4.09 (1H, dd, J = 12.3, 2.7, C5aH), 4.24 (1H, dd, J = 6.3, 2.7, C5H), 6.02 
(2H, AB, J = 5.0, OCH2O), 7.46 (1H, s, C8H), 7.74 (1H, s, C11H), OH (absent); 
13C NMR 
(125 MHz, CDCl3): δ 28.73 (t), 30.82 (t), 33.12 (d), 33.43 (d), 45.22 (q), 52.95 (t), 67.41 (d), 
69.50 (d), 81.81 (d), 101.82 (t), 107.15 (d), 109.34 (d), 118.69 (s), 140.77 (s), 146.68 (s), 
152.67 (s), 164.68 (s); IR νmax (neat): 1036, 1274, 1477, 1710, 2924, 3420 cm 
-1; m/z (ESI+) 
318 [(MH)+, 28%], 282 (70); HRMS (CI+) calcd. for C17H20NO5 [(MH)
+] 318.1341, found 
318.1345 (∆ 1.3 ppm). A single crystal X-ray structure determination was performed on the 
hydrochloride of this product (See Appendix 2). 
N-[2-(3,4-Dimethoxyphenyl)ethyl]-N-methylformamide (98)
140
 
 
Ethyl formate (0.52 mL, 6.4 mmol) was added to 3,4-dimethoxyethylphenylamine (97) (0.47 
mL, 2.7 mL) and the neat mixture refluxed at 60 °C for 16 h. After this time the reaction 
mixture was concentrated in vacuo to give the formamide 98 as a yellow oil (603 mg, 100%); 
1H NMR (400 MHz, CDCl3): δ 2.83 (2H, m, NCH2CH2), 2.88 (3H, s, NCH3) and 2.92 (3H, s, 
NCH3), 3.47 (2H, t, J = 7.3, NCH2CH2) and 3.57 (2H, t, J = 7.3, NCH2CH2), 3.88-3.90 (6H, 
m, 2 × OCH3), 6.66 (1H, d, J = 1.9, CArH) and 6.69 (1H, d, J = 1.9, CArH), 6.71 (1H, d, J = 
1.9, CArH) and 6.78 (1H, m, CArH), 6.82 (1H, s, CArH) and 6.84 (1H, s, CArH), 7.85 (1H, s, 
CHO) and 8.05 (1H, s, CHO); m/z (EI+) 223 [(M)+, 27%]. 
6,7-Dimethoxy-2-methyl-3,4-dihydroisoquinolinium (96) 
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To a solution of formamide 98 (0.23 g, 1.03 mmol) in MeCN (4 mL) was added POCl3 (0.15 
mL, 1.65 mmol) dropwise and the reaction mixture allowed to reflux. After 1 h the reaction 
mixture was concentrated in vacuo to give the iminium salt 96 as a brown sticky oil/solid. 1H 
NMR (500 MHz, CD3OD): δ 3.27 (2H, t, J = 8.2, NCH2CH2), 3.77 (3H, s, NCH3), 3.90 (3H, 
s, OCH3), 3.99 (3H, s, OCH3), 4.03 (2H, t, J = 8.2, NCH2CH2), 7.13 (1H, s, CArH), 7.42 (1H, 
s, CArH), 8.94 (1H, s, N=CH); 
13C NMR (125 MHz, CD3OD): δ 26.07 (t), 47.62 (q), 50.76 
(t), 56.97 (q), 57.32 (q), 112.36 (d), 116.317 (d), 118.43 (s), 133.84 (s), 150.12 (s), 158.97 
(s), 166.35 (d); IR νmax (neat): 781, 986, 1010, 1124, 1158, 1242, 1339, 1395, 1520, 1603, 
2286, 3033, 3449 cm-1; m/z (ESI) 206 [(M-Cl-)+, 100%]; HRMS (ESI): calcd. for C12H16NO2 
[(M-Cl-)+] 206.1181, found 206.1177 (∆ -1.9 ppm). 
4.3. Experimental for Chapter 2 
(1R*,2S*,4S*,7R*)-3,8-Dioxa-tricyclo[5.1.0.02,4]octane (133)
141
 
 
Method 1: Polystyrene CoTPP 
Polystyrene CoTPP was prepared as according to the method of Griesbeck105 by adding a 
solution of CoTPP (14 mg, 0.021 mmol) in CH2Cl2 to a slurry of polystyrene beads (5 g, 75-
150 µm, 1% DVB cross-linked) in CH2Cl2. The dark pink/red slurry was poured onto a petri 
dish and the solvent allowed to evaporate. The dry resin was slurried in MeCN (10 mL) in a 
quick fit conical flask, sealed, cooled to 0 °C and purged with O2 for 10 min. To this slurry 
was then added 1,3-cyclohexadiene (0.1 mL, 1.05 mmol) and the reaction mixture irradiated 
with a 300 W lamp for 6 h at 0 °C. After this time 1H NMR analysis showed full conversion 
of starting material had occurred to give a mixture of endoperoxide 132 and bis-epoxide 133 
(ratio of 1:0.3 endoperoxide/bis-epoxide). Endoperoxide 13253; 1H NMR (400 MHz, MeCN-
d3): δ 1.41 (2H, d, J = 9.2, CH2), 2.10 (2H, m, CH2), 4.57 (2H, m, 2 × CHO), 6.62 (2H, dd, J 
= 4.3, 3.3, CH=CH); The reaction mixture was allowed to stir at RT for 20 h. After this time 
the reaction was filtered and the resin was washed with MeCN (20 mL). This solution of the 
crude bis-epoxide 133 was sealed and used directly in the next step (see below). An aliquot of 
the solution was taken and purified by FC (SiO2 100% hexane → 95:5 hexane/Et2O → 2:1 
hexane/Et2O); Rf 0.28 (Et2O/hexane, 2:1); 
1H NMR (400 MHz, CDCl3): δ 1.79 (4H, m, C5H2 
and C6H5), 3.09 (2H, m, C4H and C7H), 3.31 (2H, dd, J = 3.1, 0.9, C1H and C2H); 
13C NMR 
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(100 MHz, CDCl3): δ 19.65 (2 × t), 47.30 (2 × d), 47.94 (2 × d); IR νmax (neat): 761, 779, 
796, 888, 917, 938, 1267, 1415, 1440, 2935, 3004 cm -1; m/z (CI+) 130 [(MNH4)
+, 100%]; 
HRMS (CI+) calcd. for C6H12NO2 [(MNH4)
+] 130.0868, found 130.0870 (∆ 1.5 ppm). 
(1R*,2S*,3S*,6R*)-3,6-Dibromocyclohexane-1,2-diol (134)  
 
A solution of dilithium tetrabromocuprate (Li2CuBr4) was prepared according to the method 
of Ciaccio107 by dissolving CuBr2 (375 mg, 1.68 mmol) and LiBr (292 mg, 3.36 mmol) in 
MeCN (5 mL) at 0 °C and warming to 25 °C. To this dark purple solution was added a 
solution of bis-epoxide 133 (~ 1 mmol) in MeCN (~ 30 mL) via cannula and the reaction 
mixture allowed to stir at RT for 1.5 h. After this time the solvent was removed in vacuo and 
the crude mixture partitioned between H2O (40 mL) and Et2O (40 mL). The phases were 
separated and the aqueous phase extracted further with Et2O (3 × 40 mL). The combined 
organic phases were dried over Na2SO4, filtered and concentrated in vacuo. The crude 
residue was purified by FC (SiO2, petrol/Et2O, 2:1) to give diol 134 as a white solid (192 mg, 
67%). m.p. 80-82 °C (hexane); Rf 0.42 (Et2O/hexane, 2:1); 
1H NMR (400 MHz, CDCl3): δ 
2.10 (2H, unresolved m, CH2), 2.24 (2H, m, CH2), 3.06 (2H, s, 2 × OH), 4.21 (2H, m, C1H 
and C2H), 4.28 (2H, app br s, C3H and C6H); 
13C (100 MHz, CDCl3): δ 29.90 (2 × t), 52.59 
(broad peak, 2 × d), 72.90 (2 × d); IR νmax (neat): 675, 1040, 1077, 2946, 3395 cm 
-1; m/z 
(EI+) 276 [{M(81Br, 81Br)}+•, 21%], 274 [{M(81Br, 79Br)}+•, 45%)], 272 [{M(79Br, 79Br)}+•, 
22%]; HRMS (EI+) calcd. for C6H10O2
79Br2 [(M)
+•] 271.9048, found 271.9042 (∆ -2.0 ppm). 
Method 2: CoTPP in Solution 
A solution of CoTPP (71 mg, 0.11 mmol) in CCl4 (20 mL) was purged with O2 and 1,3-
cyclohexadiene (0.5 mL, 5.25 mmol) added. The solution was cooled to 0 °C and irradiated 
with a 300 W lamp at this temperature for 26 h. After this time the reaction mixture was 
added to a preformed solution of Li2CuBr4 in MeCN (10 mL) [prepared as described above, 
CuBr2 (1.88 g, 8.4 mmol), LiBr (1.46 g, 16.8 mmol)] and allowed to stir at 25 °C for 2 h. 
After this time solvent was removed in vacuo and the crude mixture partitioned between H2O 
(40 mL) and Et2O (40 mL). The phases were separated and the aqueous phase extracted 
further with Et2O (2 × 40 mL), the combined organic phases were dried over MgSO4, filtered 
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and concentrated in vacuo. The residue was purified by FC (SiO2, 100% hexane → 
hexane/Et2O, 95:5 → hexane/Et2O, 2:1 → hexane/Et2O, 1:1 → hexane/Et2O, 1:2) to give diol 
134 as a white solid (944 mg, 66%); Spectroscopic data as above. 
Method 3: TPP then CoTPP in solution 
A solution of TPP (65 mg, 0.11 mmol) in CCl4 (20 mL) was purged with O2 and 1,3-
cyclohexadiene (0.5 mL, 5.25 mmol) added. The solution was cooled to 0 °C and irradiated 
with a 300 W lamp at this temperature for 5.5 h. After this time full conversion to 
endoperoxide 132 was observed by 1H NMR analysis. Endoperoxide 13253; 1H NMR (400 
MHz, CDCl3): δ 1.46 (2H, d, J = 9.4, CH2), 2.27 (2H, d, J = 9.4, CH2), 4.63 (2H, m, 2 × 
CHO), 6.66 (2H, dd, J = 4.4, 3.3, CH=CH); CoTPP (71 mg, 0.11 mmol) was added to the 
solution and the reaction mixture stirred at RT under an inert atmosphere. After 2.5 h full 
conversion to bis-epoxide 133 was observed by TLC and the reaction mixture added via 
cannula to a preformed solution of Li2CuBr4 in MeCN (10 mL) [prepared as described above, 
CuBr2 (1.88 g, 8.4 mmol), LiBr (1.46 g, 16.8 mmol]. The flask was washed with MeCN (10 
mL) and cannulated likewise and the reaction mixture allowed to stir at RT for 1 h. The 
solvent was then removed in vacuo and the crude mixture partitioned between H2O (20 mL) 
and Et2O (20 mL). The phases were separated and the aqueous phase extracted further with 
Et2O (2 × 60 mL), the combined organic phases were dried over Na2SO4, filtered and 
concentrated in vacuo. The residue was purified by FC (SiO2, 100% hexane → hexane/Et2O, 
99:1 → hexane/Et2O, 97:3 → hexane/Et2O, 95:5 → hexane/Et2O, 2:1→ hexane/Et2O, 1:1→ 
hexane/Et2O, 1:2) to give diol 134 as a white solid (983 mg, 68%); Spectroscopic data as 
above. 
(3S*,6S*)-3,6-Dibromocyclohexene (164)
106
 
 
To a solution of CuBr2 (375 mg, 1.68 mmol) and LiBr (292 mg, 3.36 mmol) in MeCN (20 
mL) was added 1,3-cyclohexadiene (0.1 mL, 1.05 mmol) and the reaction mixture allowed to 
stir at 25 °C for 2 h. After this time solvent was removed in vacuo and the crude mixture 
partitioned between H2O (20 mL) and Et2O (20 mL). The phases were separated and the 
aqueous phase was extracted further with Et2O (2 × 10 mL). The combined organic phases 
Chapter 4                                                                                                                 Experimental 
114 
 
were dried over Na2SO4 and concentrated in vacuo to give dibromide 164 as a white 
crystalline solid (151 mg, 60%). m.p. 82-88 °C (hexane); Rf 0.77 (hexane/Et2O, 9:1);
 1H 
NMR (400 MHz, CDCl3): δ 2.15 (2H, app d, J = 10.2, CH2), 2.42 (2H, m, CH2), 4.88 (2H, 
app s, C3H and C6H), 5.97 (2H, d, J = 2.9, C1H and C2H); 
13C (100 MHz, CDCl3): δ 27.74 (2 
× t), 45.77 (2 × d), 130.35 (2 × d); IR νmax (neat): 556, 793, 885, 994, 1078, 1199, 1396, 1424 
cm -1; m/z (EI+) 242 [{M(81Br, 81Br)}+•, 20%], 240 [{M(81Br, 79Br)}+•, 45%], 238 [{M(79Br, 
79Br)}+•, 22%], 159 (35), 79 (100); HRMS (EI+) calcd. for C6H8
79Br2 [(M)
+•] 237.8993, found 
237.8981 (∆ -4.9 ppm). A single crystal X-ray structure determination was performed on the 
product to confirm the relative stereochemistry (See Appendix 2). 
(3aS*,4S*,7R*,7aR*)-4,7-Dibromo-2,2-dimethylhexahydro-1,3-benzodioxole (135)  
 
To a solution of diol 134 (1.52 g, 5.55 mmol) in CH2Cl2 (60 mL) was added a solution of 
DMP (4.10 mL, 33.30 mmol) and pTsOH·H2O (211 mg, 1.11 mmol) in CH2Cl2 (5 mL) at 0 
°C and the resultant solution allowed to stir at this temperature for 2 h. After this time the 
reaction mixture was quenched with aqueous NaOH (100 mL, 1 M). The phases were 
separated and the aqueous phase extracted further with CH2Cl2 (2 × 50 mL). The combined 
organic phases were dried over Na2SO4, filtered and concentrated in vacuo. The crude 
residue was purified by FC (SiO2, 100% hexane → hexane/Et2O, 99:1 → hexane/Et2O, 98:2 
→ hexane/Et2O, 97:3 → hexane/Et2O, 9:1) to give dibromide 135 as a white solid (1.53 g, 
88%). m.p. 74-77 °C (hexane); Rf 0.42 (hexane/Et2O, 9:1); 
1H NMR (400 MHz, CDCl3): δ 
1.34 (3H, s, CH3), 1.47 (3H, s, CH3), 2.13 (4H, m, C5H2 and C6H2), 4.21 (2H, m, C4H and 
C7H), 4.45 (2H, m, C3aH and C7aH); 
13C (100 MHz, CDCl3): δ 26.33 (q), 28.55 (q), 30.00 (2 
× t), 49.98 (2 × d), 79.26 (2 × d), 110.13 (s); IR νmax (neat): 864, 1050, 1063, 1220, 1211, 
1382, 2986 cm -1; m/z (CI+) 334 [{M(81Br, 81Br)NH4}
+, 23%], 332 [{M(81Br, 79Br)NH4}
+, 
46%], 330 [{M(79Br, 79Br)NH4}
+, 24%], 317 [{M(81Br, 81Br)H}+, 48%], 315 [{M(81Br, 
79Br)H}+, 100%], 313 [{M(79Br, 79Br) H}+, 50%]; HRMS (CI+) calcd. for C9H15O2
79Br2 
[(MH)+] 312.9439, found 312.9449 (∆ 3.3 ppm). A single crystal X-ray structure 
determination was performed on the product to confirm the relative stereochemistry (see 
Appendix 2). 
(1S*,2S*,3R*,4R*)-1,4-Dibromo-2,3-dibenzoylcyclohexane (166) 
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Following an adapted literature procedure by Ley75 benzoyl chloride (94 µL, 0.81 mmol) was 
added dropwise to a stirred solution of diol 134 (100 mg, 0.37 mmol) and DMAP (4.5 mg, 
0.037 mmol) in pyridine (5 mL) at 0 °C. The resultant solution was allowed to stir at 0 °C for 
0.5 h before being warmed to RT and stirred at this temperature for a further 17 h. After this 
time the reaction mixture was quenched with dilute aqueous CuSO4 solution (5 mL) and 
allowed to stir for 15 min. Et2O (5 mL) was added, the phases were separated and the 
aqueous phase was extracted further with Et2O (3 × 5 mL). The combined organic phases 
were washed with a dilute aqueous CuSO4 solution (2 × 5 mL), H2O (1 × 5 mL), brine (1 × 5 
mL) and finally 0.1 M HCl (1 × 5 mL), dried over MgSO4 and concentrated in vacuo. The 
residue was purified by FC (SiO2, hexane/Et2O, 7:3) to give dibromide 166 as a foamy pale 
yellow solid (137 mg, 77%). m.p. 124-130 °C (hexane); Rf 0.44 (hexane/Et2O, 2:1); 
1H NMR 
(400 MHz, CDCl3): δ 2.25-2.45 (4H, C5H2 and C6H2), 4.50 (2H, m, C1H and C4H), 5.88 (2H, 
d, J = 6.2, C2H and C3H), 7.40 (4H, app t, J = 7.6, 4 × CArH), 7.55 (2H, app t, J = 7.6, 2 × 
CArH), 7.96 (4H, dd, J = 1.2, 8.4, 4 × CArH); 
13C NMR (100 MHz, CDCl3): δ 30.49 (2 × t), 
46.94 (2 × d), 72.77 (2 × d), 128.56 (4 × d), 129.26 (2 × s), 129.80 (4 × d), 133.53 (2 × d), 
164.92 (2 × s); IR νmax (neat): 670, 685, 704, 755, 1025, 1067, 1088, 1257, 1601, 1722, 2957 
cm -1; m/z (CI+) 502 [{M(81Br, 81Br)NH4}
+, 65%], 500 [{M(81Br, 79Br)NH4}
+, 100%], 498 
[{M(79Br, 79Br)NH4}
+, 65%]; HRMS (CI+) calcd. for C20H22NO4
79Br2 [(MNH4)
+] 497.9916, 
found 497.9928 (∆ 2.5 ppm). 
cis-1,2-(Isopropylidenedioxy)cyclohexa-3,5-diene (77) 
 
Into a dry 2-necked flask containing TBAI (3.87 g, 9.75 mmol) was cannulated a solution of 
dibromide 135 (1.53 g, 4.87 mmol) in CH2Cl2 (10 mL), the flask was washed with CH2Cl2 
(3.6 mL) and cannulated likewise. To this solution was added DBU (7.28 mL, 48.70 mmol) 
and the solution heated to 45 °C. After 2 h the reaction mixture was quenched with a citric 
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acid monohydrate solution (15.40 g, 73.05 mmol in 20 mL H2O) and allowed to stir for 10 
min. The phases were separated and the aqueous phase extracted further with CH2Cl2 (3 × 15 
mL). The combined organic phases were washed with brine (3 × 50 mL), H2O (2 × 50 mL), 
dried over Na2SO4 and filtered. The crude product was isolated by distillation at 55 °C to 
give acetonide 77 as a yellow oil (617 mg, 83%). Spectroscopic data as described in Section 
4.2, Chapter 1 Experimental. 
4.4. Experimental for Chapter 3 
5-Nitropent-1-ene (177) 
 
To a solution of NaNO2 (6.40 g, 92.85 mmol) in DMF (60 ml) was added 5-bromopent-1-ene 
(178) (10 mL, 84.4 mmol) and the resultant mixture allowed to stir at RT for 8 h. After this 
time the reaction mixture was quenched with ice cold H2O (50 mL) and Et2O (50 ml) added. 
The phases were separated and the aqueous phase extracted further with Et2O (3 × 50 mL). 
The combined organic phases were washed with brine (5 × 100 mL), dried over Na2SO4 and 
concentrated by distillation. The crude residue was purified by FC (SiO2, pentane/Et2O, 9:1) 
and 5-nitropent-1-ene (177) isolated by distillation as pale yellow oil (3.12 g, 32%). Rf 0.49 
(hexane/Et2O, 9:1); 
1H NMR (400 MHz, CDCl3): δ 2.12 (4H, m, C3H2 and C4H2), 4.37 (2H, t, 
J = 6.7, C5H2), 5.07 (2H, m, 2 × C2H), 5.74 (1H, ddt, J = 17.0, 10.3, 6.5, C1H); 
13C NMR 
(100 MHz, CDCl3): δ 26.35 (t), 30.18 (t), 74.77 (t), 116.87 (d), 135.75 (d); IR νmax (neat): 
917, 995, 1381, 1435, 1547, 2930, 3081 cm -1; m/z (CI+) 133 [(MNH4)
+, 82%]; HRMS (CI+) 
calcd. for C5H13N2O2 [(MNH4)
+] 133.0977, found 133.0973 (∆ -3.0 ppm). 
[(1E)-5-Nitropent-1-en-1-yl]benzene (179a)
130
 
 
To a stirred solution of 5-nitropent-1-ene (177) (0.11 mL, 0.96 mmol) and styrene (0.4 mL, 
3.46 mmol) in CH2Cl2 (15 mL) was added Grubbs 2
nd generation catalyst (40 mg, 5 mol%) 
and the resultant mixture allowed to heat at 45 °C. After 17 h more styrene (0.4 mL, 3.46 
mmol) and Grubbs catalyst (9 mg, 1.1 mol%) were added and the reaction mixture heated at 
45 °C for a further 4 h. The reaction mixture was then concentrated in vacuo and the crude 
residue purified by FC (SiO2, hexane 100% → hexane/Et2O, 95:5) to give nitroalkene 179a 
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as a pale yellow oil (119 mg, inseparable mixture of isomers, ratio Z/E 0.14:1 by 1H NMR, 
65%, data reported on major isomer only). Rf 0.24 (hexane/Et2O, 9:1); 
1H NMR (400 MHz, 
CDCl3): δ 2.18 (2H, app p, J = 7.0, C4H2), 2.32 (2H, app q, J = 7.1, C3H2), 4.41 (2H, t, J = 
6.9, C5H2), 6.12 (1H, dt, J = 15.8, 7.0, C2H), 6.43 (1H, d, J = 15.8, C1H), 7.21 (1H, m, CArH), 
7.27-7.34 (4H, 4 × CArH); 
13C NMR (100 MHz, CDCl3): δ 26.91 (t), 29.53 (t), 74.80 (t), 
126.10 (2 × d), 127.28 (d), 127.43 (d), 128.60 (2 × d), 132.18 (d), 137.00 (s); IR νmax (neat): 
695, 752, 1352, 1383, 1496, 1549, 2925, 3031 cm -1; m/z (EI+) 191 [(M)+•, 25%]; HRMS 
(EI+) calcd. for C11H13NO2 [(M)
+•] 191.0946, found 191.0945 (∆ -0.7 ppm). 
1-Methyl-4-[(1E)-5-nitropent-1-en-1-yl]benzene (179b) 
 
To a stirred solution of 5-nitropent-1-ene (177) (0.63 mL, 5.50 mmol) in CH2Cl2 (40 mL) 
was added Grubbs 2nd generation catalyst (233 mg, 5 mol%). To this solution was added 4-
methylstyrene (2.6 mL, 19.76 mmol) in four portions over 6 h whilst being heated at 45 °C. 
After the complete addition of 4-methylstyrene the resultant mixture was allowed to stir at 45 
°C for a further 15.5 h. After this time more 4-methylstyrene was added (2.60 mL, 19.76 
mmol) in four portions over 6 h. The reaction mixture was then concentrated in vacuo and the 
crude residue purified by FC (SiO2, 1% Et2O in hexane → 3% Et2O in hexane) to give 
nitroalkene 179b as a dark yellow oil (513 mg, inseparable mixture of isomers, ratio Z/E 
0.22:1 by 1H NMR, 45%, data reported on major isomer only). Rf 0.53 (hexane/Et2O, 2:1); 
1H 
NMR (400 MHz, CDCl3): δ 2.22 (2H, app q, J = 7.1, C4H2), 2.33-2.39 (5H, C3H2 and CH3), 
4.46 (2H, t, J = 7.0, C5H2), 6.12 (1H, dt, J = 15.8, 6.9, C2H), 6.45 (1H, d, J = 15.8, C1H), 7.16 
(2H, d, J = 8.0, 2 × CArH), 7.28 (2H, d, J = 8.0, 2 × CArH); 
13C NMR (100 MHz, CDCl3): δ 
21.71 (q), 26.99 (t), 29.52 (t), 74.82 (t), 126.01 (2 × d), 126.26 (d), 129.31 (2 × d), 132.01 (d), 
134.27 (s), 137.22 (s); IR νmax (neat): 796, 967, 1379, 1432, 1512, 1547, 2922, 3024 cm 
-1; 
m/z (EI+) 205 [(M)+•, 74%]; HRMS (EI+) calcd. for C12H15NO2 [(M)
+•] 205.1103, found 
205.1100 (∆ -1.4 ppm). 
1-Methoxy-4-[(1E)-5-nitropent-1-en-1-yl]benzene (179c) 
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To a stirred solution of 5-nitropent-1-ene (177) (0.63 mL, 5.50 mmol) in CH2Cl2 (40 mL) 
was added Grubbs 2nd generation catalyst (233 mg, 5 mol%). To this solution was added 4-
vinylanisole (2.63 mL, 19.78 mmol) in four portions over 6 h whilst being heated at 45 °C. 
After the complete addition of 4-vinylanisole the resultant mixture was allowed to stir at 45 
°C for a further 15.5 h. After this time more 4-vinylanisole was added (1.47 mL, 11.05 
mmol) in three portions over 6 h. The reaction mixture was then concentrated in vacuo and 
the crude residue purified by FC (SiO2, 1% Et2O in hexane → 3% Et2O in hexane) to give 
nitroalkene 179c as a yellow oil (576 mg, inseparable mixture of isomers, ratio Z/E 0.20:1 by 
1H NMR, 47%, data reported on major isomer only). Rf 0.36 (hexane/Et2O, 2:1); 
1H NMR 
(400 MHz, CDCl3): δ 2.20 (2H, app p, J = 6.9, C4H2), 2.33 (2H, app q, J = 7.1, C3H2), 3.83 
(3H, s, OCH3), 4.45 (2H, t, J = 6.9, C5H2), 6.01 (1H, dt, J = 15.8, 7.0, C2H), 6.40 (1H, d, J = 
15.8, C1H), 6.83 (2H, m, 2 × CArH), 7.25 (2H, m, 2 × CArH); 
13C NMR (100 MHz, CDCl3): δ 
27.06 (t), 29.51 (t), 55.32 (q), 74.84 (t), 114.03 (2 × d), 125.07 (d), 127.24 (2 × d), 129.86 (s), 
131.53 (d), 159.10 (s); IR νmax (neat): 805, 840, 967, 1174, 1243, 1379, 1463, 1509, 1547, 
1606, 2837, 2955 cm -1; m/z (EI+) 221 [(M)+•, 86%]; HRMS (EI+) calcd. for C12H15NO3 
[(M)+•] 221.1052, found 221.1045 (∆ -3.1 ppm). 
1-[(1E)-5-Nitropent-1-en-1-yl]-4-(trifluoromethyl)benzene (179d) 
 
To a stirred solution of 5-nitropent-1-ene (177) (0.18 mL, 1.61 mmol) in CH2Cl2 (12 mL) 
was added Grubbs 2nd generation catalyst (68 mg, 5 mol%). To this solution was added 4-
trifluoromethylstyrene (0.86 mL, 5.81 mmol) via syringe pump over 4 h whilst being heated 
at 45 °C. After complete addition of 4-trifluoromethylstyrene the resultant mixture was 
allowed to stir at 45 °C for a further 17 h. After this time more Grubbs catalyst was added (34 
mg, 2.5 mol%) and the reaction mixture stirred at 45 °C for a further 7 h before being 
concentrated in vacuo. The crude residue was purified by FC (SiO2, 1% Et2O in hexane) to 
give nitroalkene 179d as a dark yellow oil (209 mg, inseparable mixture of isomers, ratio Z/E 
0.04:1 by 1H NMR, 50%, data reported on major isomer only). Rf 0.20 (hexane/Et2O, 9:1); 
1H 
NMR (400 MHz, CDCl3): δ 2.25 (2H, app p, J = 6.9, C4H2), 2.40 (2H, app q, J = 7.0, C3H2), 
4.47 (2H, t, J = 6.8, C5H2), 6.28 (1H, dt, J = 15.8, 6.9, C2H), 6.51 (1H, d, J = 15.8, C1H), 7.46 
(2H, d, J = 8.2, 2 × CArH), 7.59 (2H, d, J = 8.2, 2 × CArH); 
13C NMR (100 MHz, CDCl3): δ 
26.66 (t), 29.59 (t), 74.74 (t), 120.46 (s) and 122.84 (s) and 125.37 (s) and 127.60 (s), 125.50 
(2 × d) and 125.54 (2 × d) and 125.58 (2 × d) and 125.62 (2 × d), 126.25 (2 × d), 128.75 (s) 
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and 129.0 (s) and 129.39 (s) and 129.70 (s), 130.13 (d), 130.92 (d), 140.43 (s); 19F NMR (376 
MHz, CDCl3): δ -62.50 (3F, s, CF3); IR νmax (neat): 854, 969, 1015, 1065, 1110, 1161, 1321, 
1550, 1615 2934 cm -1; m/z (EI+) 259 [(M)+•, 66%]; HRMS (EI+) calcd for C12H12F3NO2 
[(M)+•] 259.0820, found 259.0819 (∆ -0.4 ppm). 
1-Chloro-4-[(1E)-5-nitropent-1-en-1-yl]benzene (179e) 
O2N
Cl
Chemical Formula: C11H12ClNO2
Exact Mass: 225.06
Molecular Weight: 225.67
179e
 
To a stirred solution of 5-nitropent-1-ene (177) (0.60 mL, 5.25 mmol) in CH2Cl2 (40 mL) 
was added Grubbs 2nd generation catalyst (223 mg, 5 mol%). To this solution was added 4-
chlorostyrene (2.27 mL, 18.90 mmol) via syringe pump over 6 h whilst being heated at 45 
°C. After complete addition of 4-chlorostyrene the resultant mixture was allowed to stir at 45 
°C for a further 14.5 h. After this time more Grubbs catalyst was added (112 mg, 2.5 mol%) 
and the reaction mixture stirred at 45 °C for a further 4 h before being concentrated in vacuo. 
The crude residue was purified by FC (SiO2, 1% Et2O in hexane → 2% Et2O in hexane) to 
give nitroalkene 179e as a pale yellow oil (411 mg, inseparable mixture of isomers, ratio E/Z 
0.05:1 by 1H NMR, 35%, data reported on major isomer only). Rf 0.27 (hexane/Et2O, 9:1); 
1H 
NMR (400 MHz, CDCl3): δ 2.23 (2H, app p, J = 7.1, C4H2), 2.36 (2H, app q, J = 7.1, C3H2), 
4.46 (2H, t, J = 6.9, C5H2), 6.15 (1H, dt, J = 15.7, 6.9, C2H), 6.43 (1H, dt, J = 15.7, 1.3, C1H), 
7.30 (4H, app s, 4 × CArH); 
13C NMR (100 MHz, CDCl3): δ 26.80 (t), 29.52 (t), 74.77 (t), 
127.31 (2 × d), 128.03 (d), 128.74 (2 × d), 130.98 (d), 133.03 (s), 135.51 (s); IR νmax (neat): 
802, 846, 966, 1011, 1089, 1379, 1432, 1489, 1546 2927, 3029 cm -1; m/z (EI+) 227 
[{M(37Cl)}+•, 15%], 225 [{M(35Cl)}+•, 45%]; HRMS (EI+) calcd. for C11H12
35ClNO2 [(M)
+•] 
225.0557, found 225.0553 (∆ -1.6 ppm). 
1-Fluoro-4-[(1E)-5-nitropent-1-en-1-yl]benzene (179f)
130
 
 
To a stirred solution of 5-nitropent-1-ene (177) (0.60 mL, 5.25 mmol) in CH2Cl2 (40 mL) 
was added Grubbs 2nd generation catalyst (223 mg, 5 mol%). To this solution was added 4-
fluorostyrene (2.25 mL, 18.90 mmol) via syringe pump over 4 h whilst being heated at 45 °C. 
After complete addition of 4-fluorostyrene the resultant mixture was allowed to stir at 45 °C 
for a further 16 h. After this time more Grubbs catalyst (112 mg, 2.5 mol%) and 4-
fluorostyrene (1.13 mL, 9.45 mmol) were added and the reaction mixture stirred at 45 °C for 
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a further 3 h before being concentrated in vacuo. The crude residue was purified by FC (SiO2, 
1% Et2O in hexane) to give nitroalkene 179f as a dark yellow oil (631 mg, inseparable 
mixture of isomers, ratio E/Z 0.15:1 by 1H NMR, 57%, data reported on major isomer only). 
Rf 0.41 (hexane/Et2O, 9:1); 
1H NMR (400 MHz, CDCl3): δ 2.22 (2H, app p, J = 7.1, C4H2), 
2.35 (2H, app q, J = 7.0, C3H2), 4.46 (2H, t, J = 6.9, C5H2), 6.08 (1H, dt, J = 15.8, 7.0, C2H), 
6.43 (1H, d, J = 15.8, C1H), 6.98 (2H, m, 2 × CArH), 7.28 (2H, m, 2 × CArH); 
13C NMR (100 
MHz, CDCl3): δ 26.88 (t), 29.49 (t), 74.79 (t), 115.37 (2 × d) and 115.59 (2 × d), 127.03 (d), 
127.53 (2 × d) and 127.61 (2 × d), 130.97 (d), 132.91 (s) and 133.15 (s), 160.93 (s) and 
163.42 (s); 19F NMR (376 MHz, CDCl3): δ -114.8 (1F, s, ArF); IR νmax (neat): 807, 845, 967, 
1158, 1223, 1380, 1433, 1506, 1547, 1601, 2933 cm -1; m/z (EI+) 210 [{M(20F)}+•, 10%], 209 
[{M(19F)}+•, 48%]; HRMS (EI+) calcd. for C11H12
19FNO2 [(M)
+•] 209.0852, found 209.0852 
(∆ 0.00 ppm). 
(1Z,4E)-5-Phenylpent-4-enal oxime (180a)
142
 
 
General Method A: To a stirred solution of nitroalkene 179a (288 mg, 1.51 mmol) in THF 
(10 mL) was added KOH (89 mg, 1.59 mmol) and TBAI (84 mg, 15 mol%) as solids. To this 
mixture was added benzylbromide (198 µL, 1.66 mmol) and the resultant suspension allowed 
to stir at RT. After 6 h a 75% conversion was observed by 1H NMR analysis and more KOH 
(25 mg, 0.45 mmol) was added and the reaction mixture stirred at RT for a further 16 h. After 
this time full conversion was observed by TLC analysis and H2O (10 mL) and Et2O (10 mL) 
were added to the reaction mixture. The phases were separated and the aqueous phase was 
extracted further with Et2O (4 × 10 mL). The combined organic phases were dried over 
Na2SO4, filtered and concentrated in vacuo. The crude residue was purified by FC (SiO2, 
hexane/Et2O, 9:1) to give oxime 180a as an off white solid (132 mg, inseparable mixture of 
isomers, ratio Z/E 1:0.9 by 1H NMR, 50%, data reported on major isomer only). m.p. 82-88 
°C, (Et2O/pentane), [Lit., 104-106 °C, (Et2O/pentane)]
142; Rf 0.37 (hexane/Et2O, 2:1); 
1H 
NMR (400 MHz, CDCl3): δ 2.47 (2H, app q, J = 7.1, C3H2), 2.63 (2H, app dd, J = 13.5, 5.9, 
C2H2), 6.25 (1H, dt, J = 15.8, 6.9, C4H), 6.49 (1H, d, J = 15.8, C5H), 6.84 (1H, t, J = 5.9, 
NCH), 7.27 (1H, app q, J = 7.1, CArH), 7.36 (4H, m, 4 × CArH), 9.24 (1H, br s, OH); 
13C 
NMR (100 MHz, CDCl3): δ 24.63 (t), 29.32 (t), 126.10 (2 × d), 127.19 (d), 128.55 (2 × d), 
128.77 (d), 131.03 (d), 137.39 (s), 151.90 (d); IR νmax (neat): 741, 965, 1320, 1666, 1446, 
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2879, 3027, 3083, 3192 cm -1; m/z (EI+) 175 [(M)+•, 22%]; HRMS (EI+) calcd. for C11H13NO 
[(M)+•] 175.0997, found 175.0999 (∆ 1.1 ppm). 
(1Z,4E)-5-(4-methylphenyl)pent-4-enal oxime (180b) 
 
Using general method A nitroalkene 179b (513 mg, 2.50 mmol), KOH (147 mg, 2.63 mmol), 
TBAI (140 mg, 15 mol%), benzylbromide (327 µL, 2.75 mmol) in THF (30 mL) after 14 h at 
RT gave a 78% conversion, more KOH (42 mg, 0.75 mmol) was added. After a further 3.5 h 
full conversion was observed. The crude residue was purified by FC (SiO2, hexane/Et2O, 4:1) 
to give oxime 180b as an off white crystalline solid (242 mg, inseparable mixture of isomers, 
ratio Z/E 1:0.42 by 1H NMR, 52%, data reported on major isomer only). m.p. 110-117 °C 
(Et2O/pentane); Rf 0.62 (hexane/Et2O); 
1H NMR (400 MHz, CDCl3): δ 2.31 (3H, s, CH3), 
2.38 (2H, app q, J = 7.1, C3H2), 2.54 (2H, app dd, J = 13.5, 7.1, C2H2), 6.13 (1H, dt, J = 15.9, 
7.0, C4H), 6.40 (1H, d, J = 15.9, C5H), 6.76 (1H, t, J = 5.3, NCH), 7.09 (2H, d, J = 8.0, 2 × 
CArH), 7.22 (2H, d, J = 8.0, 2 × CArH), 7.71 (1H, br s, OH); 
13C NMR (100 MHz, CDCl3): δ 
21.15 (q), 24.56 (t), 29.39 (t), 125.97 (2 × d), 127.52 (d), 129.22 (2 × d), 130.96 (d), 134.60 
(s), 136.92 (s), 151.68 (d); IR νmax (neat): 795, 834, 916, 964, 1443, 1512, 1663, 2859, 3027, 
3082, 3185 cm -1; m/z (EI+) 189 [(M)+•, 28%]; HRMS (EI+) calcd. for C12H15NO [(M)
+•] 
189.1154, found 189.1154 (∆ 0.2 ppm). 
(1Z,4E)-5-(4-Methoxyphenyl)pent-4-enal oxime (180c) 
 
Using general method A nitroalkene 179c (576 mg, 2.60 mmol), KOH (153 mg, 2.73 mmol), 
TBAI (144 mg, 15 mol%), benzylbromide (340 µL, 2.86 mmol) in THF (30 mL) after 14 h at 
RT gave a 76% conversion, more KOH (44 mg, 0.78 mmol) was added. After a further 3.5 h 
full conversion was observed. The crude residue was purified by FC (SiO2, hexane/Et2O, 4:1 
→ 2:1) to give oxime 180c as an off white crystalline solid (233 mg, inseparable mixture of 
isomers, ratio Z/E 1:0.34 by 1H NMR, 44%, data reported on major isomer only). m.p. 112-
118 °C (Et2O/hexane); Rf 0.36 (hexane/Et2O, 2:1); 
1H NMR (400 MHz, CDCl3): δ 2.43 (2H, 
app q, J = 7.1, C3H2), 2.59 (2H, m, C2H2), 3.83 (3H, s, CH3), 6.09 (1H, dt, J = 6.8, 15.9, 
C4H), 6.42 (1H, d, J = 15.9, C5H), 6.81 (1H, t, J = 5.3, NCH), 6.87 (2H, m, 2 × CArH), 7.31 
(2H, m, 2 × CArH), 7.68 (1H, br s, OH); 
13C NMR (100 MHz, CDCl3): δ 24.60 (t), 29.33 (t), 
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55.31 (q), 113.96 (2 × d), 126.56 (d), 127.17 (2 × d), 130.36 (d), 151.72 (s), 152.28 (d), 
158.91 (s); IR νmax (neat): 700, 803, 839, 962, 1031, 1174, 1246, 1452, 1509, 1606, 2836, 
3028, 3216 cm -1; m/z (EI+) 205 [(M)+•, 23%]; HRMS (EI+) calcd. for C12H15NO2 [(M)
+•] 
205.1103, found 205.1095 (∆ -3.8 ppm). 
(1Z,4E)-5-[4-(Trifluoromethyl)phenyl]pent-4-enal oxime (180d) and (1E,4E)-5-[4-
(trifluoromethyl)phenyl]pent-4-enal oxime (180d) 
 
Using general method A nitroalkene 179d (209 mg, 0.81 mmol), KOH (48 mg, 0.85 mmol), 
TBAI (45 mg, 15 mol%), benzylbromide (106 µL, 0.89 mmol) in THF (15 mL) after 15.5 h 
at RT gave a 70% conversion, more KOH (14 mg, 0.24 mmol) was added. After a further 3 h 
full conversion was observed. The crude residue was purified by FC (SiO2, hexane/Et2O, 4:1) 
to give oxime 180d as an off white crystalline solid (90.5 mg, inseparable mixture of isomers, 
ratio Z/E 1:0.45 by 1H NMR, 46%, data reported on the mixture of isomers). m.p. 91-94 °C 
(pentane/Et2O); Rf 0.63 (Et2O/hexane, 2:1); 
1H NMR (400 MHz, CDCl3): δ 2.42-2.51 (2.62H, 
E C2H2, E C3H2 and Z C3H2), 2.63 (1.38H, app q, J = 7.0, Z C2H2), 6.34 (1H, dt, J = 15.9, 
6.7, E and Z C4H), 6.50 (0.31H, d, J = 15.9, E C5H), 6.51 (0.69H, d, J = 15.9, Z C5H), 6.81 
(0.69H, t, J = 5.2, Z NCH), 7.46 (2H, d, J = 8.1, E and Z 2 × CArH), 7.52 (0.31H, t, J = 5.5, E 
NCH), 7.58 (2H, d, J = 8.1, E and Z 2 × CArH), 8.08 (0.31H, br s, E OH), 8.54 (1H, br s Z 
OH); 13C NMR (100 MHz, CDCl3): δ 24.35 (Z t), 29.03 (Z t), 29.22 (E t), 29.83 (E t), 120.16 
(s) and 122.86 (s) and 125.56 (s) and 128.26 (s), 125.37(2 × d) and 125.40 (2 × d) and 125.43 
(2 × d) and 125.46 (2 × d), 126.16 (2 × d), 128.45 (s) and 128.77 (s) and 129.09 (s) and 
129.41 (s), 129.74, (Z d), 129.92 (E d), 131.27 (Z d), 131.49 (E d), 140.75 (s), 151.14 (E d), 
151.52 (Z d); 19F (376 MHz, CDCl3): δ -62.46 (3F, s, CF3); IR νmax (neat): 860, 1069, 1111, 
1121, 1167, 1324, 1415, 1443, 1615, 2877, 3207 cm -1; m/z (EI+) 244 [{M(20F)}+•, 3%], 243 
[{M(19F)}+•, 16%]; HRMS (EI+) calcd. for C12H12F3NO [(M)
+•] 243.0871, found 243.0870 (∆ 
-0.4 ppm). 
(1Z,4E)-5-(4-Chlorophenyl)pent-4-enal oxime (180e) 
 
Using general method A nitroalkene 179e (411 mg, 1.82 mmol), KOH (107 mg, 1.91 mmol), 
TBAI (101 mg, 15 mol%), benzylbromide (238 µL, 2.00 mmol) in THF (30 mL) after 4 h at 
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RT gave a 64% conversion, more KOH (31 mg, 0.54 mmol) was added. After a further 11.5 h 
full conversion was observed. The crude residue was purified by FC (SiO2, hexane/Et2O, 4:1) 
to give oxime 180e as a white crystalline solid (222 mg, inseparable mixture of isomers, ratio 
Z/E 1:0.12 by 1H NMR, 58%, data reported on major isomer only). m.p. 125-132 °C 
(Et2O/pentane); Rf 0.22 (Et2O/hexane, 2:1); 
1H NMR (400 MHz, CDCl3): δ 2.45 (2H, app q, 
J = 7.1, C3H2), 2.60 (2H, m, C2H2), 6.21 (1H, dt, J = 15.9, 6.6, C4H), 6.43 (1H, dt, J = 15.9, 
1.4, C5H), 6.80 (1H, t, J = 5.4, NCH), 7.29 (4H, app s, 4 × CArH), 8.06 (1H, br s, OH); 
13C 
NMR (100 MHz, CDCl3): δ 24.39 (t), 29.30 (t), 127.28 (2 × d), 128.67 (2 × d), 129.48 (d), 
129.83 (d), 132.75 (s), 135.86 (s), 151.90 (d); IR νmax (neat): 967, 1091, 1445, 1490, 1665, 
2868, 3036, 3091, 3182 cm -1; m/z (EI+) 211 [{M(37Cl)}+•, 8%], 210 [{M(36Cl)}+•, 3%], 209 
[{M(35Cl)}+•, 28%]; HRMS (EI+) calcd. for C11H12
35ClNO [(M)+•] 209.0607, found 209.0605 
(∆ -1.2 ppm). 
(1Z,4E)-5-(4-Fluorophenyl)pent-4-enal oxime (180f) 
 
Using general method A nitroalkene 179f (631 mg, 3.02 mmol), KOH (178 mg, 3.17 mmol), 
TBAI (167 mg, 15 mol%), benzylbromide (395 µL, 3.32 mmol) in THF (30 mL) after 4 h at 
RT gave a 65% conversion, more KOH (51 mg, 0.91 mmol) was added. After a further 2 h 
full conversion was observed. The crude residue was purified by FC (SiO2, hexane/Et2O, 4:1) 
to give oxime 180f as a white crystalline solid (399 mg, inseparable mixture of isomers, ratio 
Z/E 1:0.23 by 1H NMR, 68%, data reported on major isomer only). m.p. 96-102 °C 
(Et2O/pentane); Rf 0.25 (pentane/Et2O, 2:1); 
1H NMR (400 MHz, CDCl3): δ 2.44 (2H, app q, 
J = 7.1, C3H2), 2.60 (2H, m, C2H2), 6.15 (1H, dt, J = 15.9, 6.7, C4H), 6.44 (1H, d, J = 15.9, 
C5H), 6.81 (1H, t, J = 5.3, NCH), 7.02 (2H, m, 2 × CArH), 7.33 (2H, m, 2 × CArH), 8.74 (1H, 
br s, OH); 13C NMR (100MHz, CDCl3): δ 24.53 (t), 29.25 (t), 115.28 (2 × d) and 115.50 (2 × 
d), 127.48 (2 × d) and 127.55 (2 × d), 128.48 (d) and 128.49 (d), 129.84 (d), 133.51 (s) and 
133.54 (s), 151.87 (d), 160.86 (s) and 163.31 (s); 19F NMR (376 MHz, CDCl3): δ -115.23 
(1F, s, ArF); IR νmax (neat): 969, 1226, 1319, 1446, 1507, 1599, 1666, 2868, 3085, 3190 cm 
-
1; m/z (EI+) 194 [{M(20F)}+•, 4%], 193 [{M(19F)}+•, 22%]; HRMS (EI+) calcd. for 
C11H12
19FNO [(M)+•] 193.0903, found 193.0905 (∆ 1.1 ppm). 
(4E)-7-Phenylhept-4-enal (183)
134
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To a stirred solution of 4-pentenal (181) (587 µL, 5.94 mmol) and 4-phenylbut-1-ene (182) 
(3.2 mL, 21.38 mmol) in CH2Cl2 (15 mL) was added Grubbs 2
nd generation catalyst (204 mg, 
4 mol%) and the resultant mixture heated to 45 °C for 3 h 15 min. After this time the solvent 
was removed under a stream of N2 and the crude residue purified by FC (SiO2, 1% Et2O in 
hexane → 5% Et2O in hexane) to give aldehyde 183 as a pale yellow oil (195 mg, 17%). Rf 
0.34 (hexane/Et2O, 9:1); 
1H NMR (400 MHz, CDCl3): δ 2.30 (4H, m, C3H2 and C6H2), 2.45 
(2H, m, C2H2), 2.65 (2H, m, C7H2), 5.44 (2H, m, C4H and C5H), 7.13-7.18 (4H, 4 × CArH), 
7.26-7.29 (1H, CArH), 9.72 (1H, t, J = 1.7, CHO); 
13C NMR (100 MHz, CDCl3): δ 24.14 (t), 
34.29 (t), 35.86 (t), 43.42 (t), 125.79 (d), 128.27 (d), 28.48 (4 × d), 130.98 (d), 141.87 (s), 
202.42 (s); IR νmax (neat): 697, 746, 968, 1453, 1495, 1722, 2853, 2926, 3027 cm 
-1; m/z (CI+) 
206 [(MNH4)
+, 100%]; HRMS (CI+) calcd. for C13H20NO [(MNH4)
+] 206.1545, found 
206.1551 (∆ 3.0 ppm). 
(1Z,4E)-7-Phenylhept-4-enal oxime (180g) and (1E,4E)-7-phenylhept-4-enal oxime 
(180g) 
N
OH
Chemical Formula: C13H17NO
Exact Mass: 203.13
Molecular Weight: 203.28
180g  
To a stirred solution of aldehyde 183 (195 mg, 1.04 mmol) in CH2Cl2 (15 mL) was added 
NH2OH·HCl (273 mg, 3.93 mmol) and NaOAc (404 mg, 4.93 mmol) as solids followed by 
MeOH (2.5 mL) and the resultant mixture allowed to stir at RT open to the atmosphere for 1 
h. After this time brine (40 mL) was added and the reaction mixture and stirred until two 
clear phases had formed. The phases were separated and the aqueous phase extracted further 
with CH2Cl2 (2 × 40 mL). The combined organic phases were dried over Na2SO4, filtered and 
concentrated in vacuo. The crude residue was purified by FC (SiO2, hexane/Et2O, 4:1) to give 
oxime 180g as a colourless oil (207 mg, inseparable mixture of isomers, ratio Z/E 1:1.1 by 1H 
NMR, 98%, data reported on the mixture of isomers). Rf 0.38 (hexane/Et2O, 2:1); 
1H NMR 
(400 MHz, CDCl3): δ 2.26 (2H, app q, J = 6.8, E and Z C3H2), 2.33 (0.94H, m, Z C2H2), 
2.36-2.45 (2H, E and Z C6H2), 2.52 (1.06H, td, J = 7.3, 5.4, E C2H2), 2.76 (2H, app t, J = 7.6, 
E and Z C7H2), 5.50 (1H, dt, J = 15.3, 6.3, E and Z C5H), 5.60 (1H, m, E and Z C4H), 6.77 
(0.47H, t, J = 5.3, Z NCH), 7.24-7.29 (3H, 3 × CArH), 7.36 (2H, m, 2 × CArH), 7.49 (0.53H, t, 
J = 5.8, E NCH), 9.24 (0.53H, br s, E OH), 9.66 (0.47H, br s, Z OH); 13C NMR (100 MHz, 
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CDCl3): δ 24.75 (Z t), 29.50 (t), 29.64(E t), 34.41 (t), 35.99 (t), 125.85 (d), 128.34 (2 × d), 
128.54 (2 × d), 128.90 (Z d), 129.17 (E d), 130.93 (Z d), 131.07 (E d), 142.01 (s), 151.79 (E 
d), 152.23 (Z d); IR νmax (neat): 698, 746, 968, 1076, 1335, 1453, 1495, 2853, 2917, 3027, 
3236 cm -1; m/z (EI+) 203 [(M)+•, 5%]; HRMS (EI+) calcd. for C13H17NO [(M)
+•] 203.1310, 
found 203.1302 (∆ -0.4 ppm). 
(4E)-N-Hydroxy-5-phenylpent-4-en-1-amine (176a)
142
 
 
General Method B: A solution of oxime 180a (47.2 mg, 0.27 mmol) and NaCNBH3 (34 mg, 
0.54 mmol) in MeOH (10.4 mL) was cooled to 0 °C and 14 drops methyl orange added. 
MeOH/HCl (10:1) (0.29 mL over 10 min) was added dropwise to this bright yellow solution 
to give an orange solution. The reaction mixture was then warmed to RT for 10 min to which 
the solution returned to yellow colour and was cooled back down to 0 °C. MeOH/HCl (10:1) 
(0.05 mL over 10 min) was added dropwise until the solution remained orange and the 
reaction mixture was again warmed to RT for 10 min. After this time the reaction mixture 
was quenched with NaOH (2 mL, 2 M) and allowed to stir for 10 min before Et2O (10 mL) 
was added and the phases separated. The aqueous phase was extracted further with Et2O (3 × 
10 mL), the combined organic phases were washed with brine (20 mL), dried over Na2SO4, 
filtered and concentrated in vacuo to give hydroxylamine 176a as a yellow oil (43.4 mg, 
91%). Rf 0.57 (Et2O/hexane, 9:1); 
1H NMR (400 MHz, CDCl3): δ 1.78 (2H, tt, J = 14.0, 7.1, 
C2H2), 2.31 (2H, app dd, J = 14.0, 6.8, C3H2), 3.04 (2H, t, J = 7.1, C1H2), 6.25 (1H, dt, J = 
15.8, 6.8, C4H), 6.45 (1H, d, J = 15.8, C5H), 7.22-7.26 (1H, m, CArH), 7.32-7.39 (4H, 4 × 
CArH), NH and OH (absent); 
13C NMR (100 MHz, CDCl3): δ 26.53 (t), 30.45 (t), 53.20 (t), 
125.91 (2 × d), 126.89 (d), 128.43 (2 × d), 129.89 (d), 130.39 (d), 137.57 (s); IR νmax (neat): 
692, 745, 697, 1031, 1451, 1497, 1599, 2859, 2928, 3026, 3243 cm -1; m/z (ESI) 178 [(MH)+, 
60 %]; HRMS (ESI) calcd. for C11H16NO [(MH)
+] 178.1232, found 178.1236 (∆ 2.2 ppm). 
(4E)-N-Hydroxy-5-(4-methylphenyl)pent-4-en-1-amine (176b) 
 
Using general method B oxime 180b (50 mg, 0.26 mmol), NaCNBH3 (33 mg, 0.53 mmol) in 
MeOH (10 mL) after the addition of MeOH/HCl (10:1) (0.32 mL over 10 min) then (0.4 mL 
over 10 min) gave hydroxylamine 176b as a white solid (47.5 mg, 96%). m.p. 54-62 °C; Rf 
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0.35 (Et2O/hexane, 9:1); 
1H NMR (400 MHz, CDCl3): δ 1.72 (2H, app q, J = 7.3, C2H2), 2.25 
(2H, app q, J = 6.9, C3H2), 2.32 (3H, s, CH3), 2.98 (2H, t, J = 7.2, C1H2), 6.14 (1H, dt, J = 
15.8, 6.9, C4H), 6.36 (1H, d, J = 15.8, C4H), 7.08 (2H, d, J = 8.0, 2 × CArH), 7.22 (2H, d, J = 
8.0, 2 × CArH), NH and OH (absent); 
13C NMR (100 MHz, CDCl3): δ 21.06 (q), 26.50 (t), 
30.42 (t), 53.16 (t), 125.77 (2 × d), 128.79 (d), 129.11 (2 × d), 130.16 (d), 134.71 (s), 136.57 
(s); IR νmax (neat): 791, 966, 1437, 1512, 2858, 2920, 3262 cm 
-1; m/z (ESI) 192 [(MH)+, 
100%]; HRMS (ESI) calcd for C12H18NO [(MH)
+] 192.1388, found 192.1380 (∆ -4.2 ppm). 
(4E)-N-Hydroxy-5-(4-methoxyphenyl)pent-4-en-1-amine (176c) 
 
Using general method B oxime 180c (50 mg, 0.24 mmol), NaCNBH3 (31 mg, 0.49 mmol) in 
MeOH (9.2 mL) after the addition of MeOH/HCl (10:1) (0.31 mL over 10 min) then (0.1 mL 
over 10 min) gave hydroxylamine 176c as an off white solid (43 mg, 86%); m.p. 61-66 °C; Rf 
0.57 (Et2O/hexane, 9:1); 
1H NMR (400 MHz, CDCl3): δ 1.75 (2H, app q, J = 7.3, C2H2), 2.27 
(2H, app q, J = 7.2, C3H2), 3.02 (2H, t, J = 7.2, C1H2), 3.82 (3H, s, CH3), 6.09 (1H, dt, J = 
15.8, 6.9, C4H), 6.37 (1H, d, J = 15.8, C5H), 6.86 (2H, m, 2 × CArH), 7.30 (2H, m, 2 × CArH), 
NH and OH (absent); 13C NMR (125 MHz, CDCl3): δ 26.64 (t), 30.42 (t), 53.23 (t), 55.20 
(q), 113.86 (2 × d), 126.97 (2 × d), 127.70 (d), 129.70 (d), 130.40 (s), 158.67 (s); IR νmax 
(neat): 840, 966, 1033, 1067, 1120, 1174, 1245, 1325, 1510, 1607, 2836, 2936, 3274 cm -1; 
m/z (ESI) 208 [(MH)+, 100%]; HRMS (EI+) calcd. for C12H17NO2 [(MH)
+•] 207.1259, found 
207.1253 (∆ -3.0 ppm). 
(4E)-N-Hydroxy-5-[4-(trifluoromethyl)phenyl]pent-4-en-1-amine (176d) 
 
Using general method B oxime 180d (48 mg, 0.20 mmol), NaCNBH3 (25 mg, 0.40 mmol) in 
MeOH (7.7 mL) after the addition of MeOH/HCl (10:1) (0.29 mL over 10 min) then (0.4 mL 
over 10 min) gave hydroxylamine 176d as a yellow semi-solid (49 mg, 100%). Rf 0.37 
(Et2O/hexane. 9:1); 
1H NMR (400 MHz, CDCl3): δ 1.79 (2H, app p, J = 7.3, C2H2), 2.32 (2H, 
app q, J = 7.1, C3H2), 3.02 (2H, t, J = 7.2, C1H2), 6.12 (1H, br s, OH), 6.33 (1H, dt, J = 15.9, 
6.7, C4H), 6.45 (1H, d, J = 15.9, C5H), 7.42 (2H, d, J = 8.1, 2 × CArH), 7.55 (2H, d, J = 8.1, 2 
× CArH), NH (absent); 
13C NMR (125 MHz, CDCl3): δ 26.37 (t), 30.47 (t), 53.15 (t), 120.98 
(s) and 123.14 (s) and 125.31 (s) and 127.46 (s), 125.34 (2 × d) and 125.37 (2 × d) and 
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125.40 (2 × d) and 125.43 (2 × d), 126.01 (2 × d), 128.35 (s) and 128.60 (s) and 128.86 (s) 
and 129.12 (s), 129.21 (s), 132.76 (d), 141.01 (s); 19F NMR (376 MHz, CDCl3): δ -62.38 (3F, 
s, CF3); IR νmax (neat): 855, 967, 1016, 1065, 1111, 1161, 1322, 1415, 1615, 2851, 2933, 
3230 cm -1; m/z (ESI) 246 [(MH)+, 54%]; HRMS (ESI) calcd. for C12H15F3NO [(MH)
+] 
246.1106, found 246.1106 (∆ 0.0 ppm). 
(4E)-N-Hydroxy-7-phenylhept-4-en-1-amine (176g) 
 
Using general method B oxime 180g (80 mg, 0.39 mmol), NaCNBH3 (50 mg, 0.79 mmol) in 
MeOH (15 mL) after the addition of MeOH/HCl (10:1) (0.45 mL over 10 min) then (0.05 mL 
over 10 min) gave hydroxylamine 176g as a yellow oil (75.5 mg, 94%). Rf 0.43 
(Et2O/hexane, 9:1); 
1H NMR (400 MHz, CDCl3): δ 1.65 (2H, app q, J = 7.3, C2H2), 2.10 (2H, 
m, C3H2), 2.38 (2H, m, C6H2), 2.73 (2H, app t, J = 7.8, C7H2), 2.95 (2H, t, J = 7.3, C1H2), 
5.50 (2H, m, C4H and C5H), 7.24 (3H, app t, J = 7.2, 3 × CArH), 7.32 (2H, m, 2 × CArH), NH 
and OH (absent); 13C NMR (100 MHz, CDCl3): δ 26.63 (t), 30.07 (t), 34.43 (t), 36.06 (t), 
53.21 (t), 125.77 (d), 128.29 (2 × d), 128.51 (2 × d), 130.14 (d), 130.21 (d), 142.06 (s); IR 
νmax (neat): 697, 745, 967, 1030, 1453, 1495, 2850, 2918, 3026, 3251 cm 
-1; m/z (ESI) 206 
[(MH)+, 42%], 204 [{(MH)+ - H2}, 48%]; HRMS (ESI) calcd. for C13H20NO [(MH)
+] 
206.1545, found 206.1549 (∆ 1.9 ppm), calcd. for C13H18NO [{(MH)
+ - H2}] 204.1388, 
found 204.1388 (∆ 0.0 ppm). 
(±)-2-Benzylpyrrolidin-1-ol (184a) 
 
General Method C: Hydroxylamine 176a (10.85 mg, 0.06 mmol) in MeOH (4.3 mL) or 
CHCl3 (4.3 mL) or toluene (4.3 mL) was degassed (3 × freeze/thaw) and then stirred at RT 
for 3 h before being heated to 40 °C for 2.5 h and then 60 °C for 16 h. After this time 
reactions were combined and the solvent removed in vacuo. The crude residue was purified 
by FC (SiO2, hexane/Et2O, 2:1) to give pyrrolidine 184a as an off white solid. m.p. 51-52 °C, 
[Lit., 67-68 °C, (hexane/ether)]143; Rf 0.26 (Et2O/hexane, 2:1); 
1H NMR (400 MHz, CDCl3): 
δ 1.50 (1H, m, C3HH), 1.73-1.87 (3H, C4H2 and C3HH), 2.61 (1H, dd, J = 12.7, 9.7, 
PhCHH), 2.83 (1H, dd, J = 18.7, 9.7, C5HH), 3.02 (1H, m, C2H), 3.19 (1H, dd, J = 12.7, 4.9, 
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PhCHH), 3.34 (1H, app p, J = 5.3, C5HH), 7.20-7.32 (5H, 5 × CArH), OH (absent); 
13C NMR 
(100 MHz, CDCl3): δ 19.57 (t), 27.10 (t), 39.65 (t), 57.67 (t), 69.95 (d), 126.11 (d), 128.38 (2 
× d), 129.07 (2 × d), 139.65 (s); IR νmax (neat): 698, 745, 1029, 1365, 1453, 1495, 1603, 
2856, 2925, 3216 cm -1; m/z (ESI) 178 [(MH)+, 100%]; HRMS (ESI) calcd. for C11H16NO 
[(MH)+] 178.1232, found 178.1230 (∆ -1.1 ppm). 
(±)-2-(4-Methylbenzyl)pyrrolidin-1-ol (184b)  
 
Using general method C hydroxylamine 176b (11.9 mg, 0.062 mmol) in MeOH (4.3 mL) or 
CHCl3 (4.3 mL) or toluene (4.3 mL) after 16 h at 60 °C gave pyrrolidine 184b as an off white 
solid. m.p. 50-57 °C; Rf 0.38 (Et2O/hexane, 2:1); 
1H NMR (400 MHz, CDCl3); δ 1.45 (1H, 
m, C3HH), 1.75-1.89 (3H, C4H2 and C3HH), 2.35 (3H, s, CH3), 2.59 (1H, m, MePhCHH), 
2.85 (1H, app q, J = 9.3, C5HH), 3.03 (1H, m, C2H), 3.17 (1H, dd, J = 13.2, 3.7, MePhCHH), 
3.35 (1H, app p, J = 5.3, C5HH), 7.13 (4H, app s, 4 × CArH), OH (absent); 
13C NMR (125 
MHz, CDCl3): δ 19.63 (t), 21.01 (q), 27.10 (t), 39.19 (t), 57.62 (t), 70.04 (d), 128.94 (2 × d), 
129.06 (2 × d), 135.57 (s), 136.41 (s); IR νmax (neat): 802, 1209, 1364, 1447, 1515, 1607, 
2856, 2923, 3220 cm -1; m/z (ESI) 192 [(MH)+, 100%]; HRMS (ESI) calcd. for C12H18NO 
[(MH)+] 192.1388, found 192.1384 (∆ -2.1 ppm). 
(±)-2-(4-Methoxybenzyl)pyrrolidin-1-ol (184c) 
 
Using general method C hydroxylamine 176c (10 mg, 0.048 mmol) toluene (3.4 mL) or 
toluene and MeOH (3.4 mL, 10 µL) after 8 h at 60 °C gave pyrrolidine 184c as an off white 
solid. m.p. 64-69 °C; Rf 0.19 (Et2O/hexane, 2:1); 
1H NMR (400 MHz, CDCl3): δ 1.43 (1H, 
m, C3HH), 1.67-1.82 (3H, C4H2 and C3HH), 2.52 (1H, m, O-MePhCHH), 2.79 (1H, app q, J 
= 9.2, C5HH), 2.94 (1H, m, C2H), 3.11 (1H, dd, J = 13.2, 4.8, O-MePhCHH), 3.30 (1H, app 
p, J = 5.3, C5HH), 3.77 (3H, s, CH3), 6.80 (2H, d, J = 8.6, 2 × CArH), 7.11 (2H, d, J = 8.6, 2 × 
CArH), OH (absent); 
13C NMR (125 MHz, CDCl3): δ 19.54 (t), 27.06 (t), 38.81 (t), 55.23 (q), 
57.66 (t), 70.09 (d), 113.79 (2 × d), 129.93 (2 × d), 131.66 (s), 157.97 (s); IR νmax (neat): 816, 
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1035, 1177, 1245, 1462, 1511, 1611, 2834, 2933, 3195 cm -1; m/z (ESI) 208 [(MH)+, 85%]; 
HRMS (ESI) calcd. for C12H18NO2 [(MH)
+] 208.1338, found.208.1325 (∆ -6.2 ppm). 
(±)-2-[4-(Trifluoromethyl)benzyl]pyrrolidin-1-ol (184d) 
 
Using general method C hydroxylamine 176d (13 mg, 0.053 mmol) in MeOH (3.8 mL) or 
CHCl3 (3.8 mL) or toluene (3.8 mL) after 1 h at 60 °C gave pyrrolidine 184d as an off white 
solid. m.p. 67-70 °C; Rf 0.33 (Et2O/hexane, 2:1); 
1H NMR (400 MHz, CDCl3): δ 1.43 (1H, 
m, C3HH), 1.76-1.87 (3H, C4H2 and C3HH), 2.63 (1H, m, CF3PhCHH), 2.86 (1H, dd, J = 
18.5, 9.5, C5HH), 2.99 (1H, m, C2H), 3.26 (1H, dd, J = 13.2, 4.9, CF3PhCHH), 3.35 (1H, m, 
C5HH), 7.35 (2H, d, J = 8.1, 2 × CArH), 7.57 (2H, d, J = 8.1, 2 × CArH), OH (absent); 
13C 
NMR (125 MHz, CDCl3): δ 19.66 (t), 27.01 (t), 39.40 (d), 57.66 (t), 69.51 (t), 121.05 (s) and 
123.21 (s) and 125.37 (s) and 127.53 (s), 125.22 (2 × d) and 125.25 (2 × d) and 125.28 (2 × 
d) and 125.31 (2 × d), 128.12 (s) and 128.38 (s) and 128.64 (s) and 128.90 (s), 129.32 (2 × d), 
143.70 (s); IR νmax (neat): 755, 818, 854, 1018, 1065, 1111, 1161, 1322, 1418, 1618, 2862, 
2975, 3201 cm -1; m/z (ESI) 246 [(MH)+, 75%]; HRMS (ESI) calcd. for C12H15F3NO [(MH)
+] 
246.1106, found 246.1104 (∆ 0.4 ppm). 
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Appendix 1 
Loading Level (LL) Calculation. 
 Start with 25 g of aminomethylated resin of which the LL = 0.9 mmolg-1, therefore, 
the mmol of the resin = 22.5 mmol 
 Assume all available resin reacts with the isothiocyanate and so 1.8 g has been added 
to the overall mass. 
 The total mass is now: 25 g + 1.8 g = 26.8 g and the mmol of the resin remains the 
same at 22.5 mmol. Therefore the LL = mmol/g = 22.5/26.8 = 0.84 mmolg-1. 
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Appendix 2 
Single Crystal X-Ray Structure Determinations 
Clivonine·HCl (1) 
 
 
Crystal data and structure refinement for compound 1 
 
Identification code AS0906 
Empirical formula (C17 H20 N O5)(Cl) . CHCl3 
Formula weight 473.16 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Monoclinic, P2(1)/n 
Unit cell dimensions a = 8.4338(2) Å α = 90° 
 b = 22.7228(6) Å β = 97.729(2)° 
 c = 10.7268(3) Å γ = 90° 
Volume, Z 2037.00(9) Å3, 4 
Density (calculated) 1.543 Mg/m3 
Absorption coefficient 0.612 mm-1 
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F(000) 976 
Crystal colour / morphology Colourless tablets 
Crystal size 0.44 x 0.20 x 0.07 mm3 
θ range for data collection 2.89 to 32.18° 
Index ranges -12<=h<=12, -33<=k<=32, -15<=l<=15 
Reflns collected / unique 18968 / 6530 [R(int) = 0.0232] 
Reflns observed [F>4σ(F)] 4519 
Absorption correction Analytical 
Max. and min. transmission 0.957 and 0.831 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6530 / 33 / 294 
Goodness-of-fit on F2 1.008 
Final R indices [F>4σ(F)] R1 = 0.0467, wR2 = 0.1111 
R indices (all data) R1 = 0.0781, wR2 = 0.1206 
Largest diff. peak, hole 0.419, -0.186 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
 
Bond lengths [Å] and angles [°] for compound 1
O(1)-C(2) 1.350(2) 
O(1)-C(20) 1.4534(19) 
C(2)-O(2) 1.205(2) 
C(2)-C(3) 1.482(2) 
C(3)-C(11) 1.394(2) 
C(3)-C(4) 1.408(2) 
C(4)-C(5) 1.360(2) 
C(5)-O(6) 1.3716(19) 
C(5)-C(9) 1.384(2) 
O(6)-C(7) 1.414(2) 
C(7)-O(8) 1.447(2) 
O(8)-C(9) 1.3685(19) 
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C(9)-C(10) 1.375(2) 
C(10)-C(11) 1.410(2) 
C(11)-C(12) 1.5195(19) 
C(12)-C(20) 1.5193(19) 
C(12)-C(13) 1.538(2) 
C(13)-N(14) 1.5123(19) 
C(13)-C(17) 1.558(2) 
N(14)-C(21) 1.490(2) 
N(14)-C(15) 1.501(2) 
C(15)-C(16) 1.518(3) 
C(16)-C(17) 1.540(3) 
C(17)-C(18) 1.533(2) 
C(18)-C(19) 1.513(3) 
C(19)-O(22) 1.422(2) 
C(19)-C(20) 1.515(2) 
C(30)-Cl(3) 1.734(9) 
C(30)-Cl(2) 1.746(9) 
C(30)-Cl(4) 1.748(9) 
C(30')-Cl(2') 1.746(10) 
C(30')-Cl(3') 1.750(10) 
C(30')-Cl(4') 1.771(10) 
C(2)-O(1)-C(20) 119.75(12) 
O(2)-C(2)-O(1) 118.07(15) 
O(2)-C(2)-C(3) 124.78(15) 
O(1)-C(2)-C(3) 117.14(14) 
C(11)-C(3)-C(4) 122.97(14) 
C(11)-C(3)-C(2) 120.98(14) 
C(4)-C(3)-C(2) 116.05(14) 
C(5)-C(4)-C(3) 116.26(15) 
C(4)-C(5)-O(6) 128.22(15) 
C(4)-C(5)-C(9) 121.81(14) 
O(6)-C(5)-C(9) 109.94(14) 
C(5)-O(6)-C(7) 106.47(13) 
O(6)-C(7)-O(8) 108.05(13) 
C(9)-O(8)-C(7) 105.75(13) 
O(8)-C(9)-C(10) 127.54(15) 
O(8)-C(9)-C(5) 109.78(14) 
C(10)-C(9)-C(5) 122.68(15) 
C(9)-C(10)-C(11) 117.21(14) 
C(3)-C(11)-C(10) 118.98(13) 
C(3)-C(11)-C(12) 116.93(13) 
C(10)-C(11)-C(12) 124.09(13) 
C(20)-C(12)-C(11) 106.67(12) 
C(20)-C(12)-C(13) 110.79(12) 
C(11)-C(12)-C(13) 115.11(12) 
N(14)-C(13)-C(12) 109.71(12) 
N(14)-C(13)-C(17) 102.93(12) 
C(12)-C(13)-C(17) 117.78(12) 
C(21)-N(14)-C(15) 113.48(14) 
C(21)-N(14)-C(13) 111.42(13) 
C(15)-N(14)-C(13) 104.89(12) 
N(14)-C(15)-C(16) 104.63(14) 
C(15)-C(16)-C(17) 106.04(13) 
C(18)-C(17)-C(16) 114.34(15) 
C(18)-C(17)-C(13) 114.90(13) 
C(16)-C(17)-C(13) 106.00(13) 
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C(19)-C(18)-C(17) 113.41(13) 
O(22)-C(19)-C(18) 113.30(15) 
O(22)-C(19)-C(20) 107.77(12) 
C(18)-C(19)-C(20) 107.24(14) 
O(1)-C(20)-C(19) 107.00(12) 
O(1)-C(20)-C(12) 110.43(12) 
C(19)-C(20)-C(12) 112.83(13) 
Cl(3)-C(30)-Cl(2) 111.2(5) 
Cl(3)-C(30)-Cl(4) 110.4(6) 
Cl(2)-C(30)-Cl(4) 112.1(5) 
Cl(2')-C(30')-Cl(3') 108.8(6) 
Cl(2')-C(30')-Cl(4') 106.7(6) 
Cl(3')-C(30')-Cl(4') 111.7(7) 
(3S,6S)-3,6-Dibromocyclohexene (164) 
 
Crystal data and structure refinement for compound 164 
 
Identification code AS0909 
Empirical formula C6 H8 Br2 
Formula weight 239.94 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Monoclinic, P2(1)/n 
Unit cell dimensions a = 6.9532(3) Å α = 90° 
 b = 5.63370(18) Å β = 109.729(6)° 
 c = 10.1488(5) Å γ = 90° 
Volume, Z 374.22(3) Å3, 2 
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Density (calculated) 2.129 Mg/m3 
Absorption coefficient 10.729 mm-1 
F(000) 228 
Crystal colour / morphology Colourless blocky needles 
Crystal size 0.42 x 0.21 x 0.10 mm3 
θ range for data collection 4.20 to 32.74° 
Index ranges -5<=h<=10, -8<=k<=7, -15<=l<=15 
Reflns collected / unique 3823 / 1268 [R(int) = 0.0247] 
Reflns observed [F>4σ(F)] 851 
Absorption correction Analytical 
Max. and min. transmission 0.404 and 0.094 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1268 / 0 / 55 
Goodness-of-fit on F2 0.825 
Final R indices [F>4σ(F)] R1 = 0.0220, wR2 = 0.0406 
R indices (all data) R1 = 0.0433, wR2 = 0.0424 
Largest diff. peak, hole 0.612, -0.563 eÅ-3 
Mean and maximum shift/error 0.001 and 0.002 
 
Bond lengths [Å] and angles [°] for compound 164
Br(1)-C(1) 1.9928(18) 
C(1)-C(3)#1 1.366(10) 
C(1)-C(2) 1.391(10) 
C(1)-C(3')#1 1.601(9) 
C(1)-C(2') 1.612(10) 
C(2)-C(3) 1.528(13) 
C(3)-C(1)#1 1.366(10) 
C(2')-C(3') 1.295(16) 
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C(3')-C(1)#1 1.601(9) 
C(3)#1-C(1)-C(2) 103.9(5) 
C(2)-C(1)-C(3')#1 112.6(6) 
C(3)#1-C(1)-C(2') 113.3(6) 
C(3')#1-C(1)-C(2') 118.5(6) 
C(3)#1-C(1)-Br(1) 117.8(3) 
C(2)-C(1)-Br(1) 116.6(3) 
C(3')#1-C(1)-Br(1) 102.2(3) 
C(2')-C(1)-Br(1) 101.3(3) 
C(1)-C(2)-C(3) 113.8(7) 
C(1)#1-C(3)-C(2) 113.8(7) 
C(3')-C(2')-C(1) 120.0(8) 
C(2')-C(3')-C(1)#1 121.4(8) 
Symmetry transformations used to generate equivalent atoms: 
#1 -x+1,-y+1,-z+1 
 
(3aS,4S,7R,7aR)-4,7-Dibromo-2,2-dimethylhexahydro-1,3-benzodioxole (135) 
 
Crystal data and structure refinement for compound 135 
 
Identification code AS1001 
Empirical formula C9 H14 Br2 O2 
Formula weight 314.02 
Temperature 296(2) K 
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Triclinic, P-1 
Unit cell dimensions a = 7.0842(10) Å α = 95.640(8)° 
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 b = 9.0032(13) Å β = 97.798(9)° 
 c = 9.5389(6) Å β = 110.869(13)° 
Volume, Z 556.12(13) Å3, 2 
Density (calculated) 1.875 Mg/m3 
Absorption coefficient 7.256 mm-1 
F(000) 308 
Crystal colour / morphology Colourless blocks 
Crystal size 0.53 x 0.40 x 0.28 mm3 
θ range for data collection 3.01 to 32.83° 
Index ranges -10<=h<=10, -13<=k<=13, -11<=l<=14 
Reflns collected / unique 6459 / 3660 [R(int) = 0.0261] 
Reflns observed [F>4σ(F)] 1964 
Absorption correction Analytical 
Max. and min. transmission 0.232 and 0.118 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3660 / 0 / 119 
Goodness-of-fit on F2 0.839 
Final R indices [F>4σ(F)] R1 = 0.0315, wR2 = 0.0602 
R indices (all data) R1 = 0.0727, wR2 = 0.0635 
Extinction coefficient 0.207(3) 
Largest diff. peak, hole 0.615, -0.597 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
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Bond lengths [Å] and angles [°] for compound 135
O(1)-C(9) 1.429(2) 
O(1)-C(2) 1.444(3) 
C(2)-O(3) 1.431(3) 
C(2)-C(11) 1.506(4) 
C(2)-C(10) 1.514(3) 
O(3)-C(4) 1.425(3) 
C(4)-C(5) 1.517(3) 
C(4)-C(9) 1.521(3) 
C(5)-C(6) 1.505(3) 
C(5)-Br(5) 1.969(2) 
C(6)-C(7) 1.515(4) 
C(7)-C(8) 1.513(3) 
C(8)-C(9) 1.512(3) 
C(8)-Br(8) 1.964(2) 
C(9)-O(1)-C(2) 108.65(15) 
O(3)-C(2)-O(1) 105.28(16) 
O(3)-C(2)-C(11) 108.8(2) 
O(1)-C(2)-C(11) 110.04(19) 
O(3)-C(2)-C(10) 110.7(2) 
O(1)-C(2)-C(10) 108.7(2) 
C(11)-C(2)-C(10) 113.0(2) 
C(4)-O(3)-C(2) 105.34(17) 
O(3)-C(4)-C(5) 108.71(18) 
O(3)-C(4)-C(9) 101.26(17) 
C(5)-C(4)-C(9) 116.66(18) 
C(6)-C(5)-C(4) 113.83(19) 
C(6)-C(5)-Br(5) 110.67(17) 
C(4)-C(5)-Br(5) 106.86(16) 
C(5)-C(6)-C(7) 111.7(2) 
C(8)-C(7)-C(6) 108.7(2) 
C(9)-C(8)-C(7) 113.40(19) 
C(9)-C(8)-Br(8) 109.48(15) 
C(7)-C(8)-Br(8) 110.16(16) 
O(1)-C(9)-C(8) 111.69(18) 
O(1)-C(9)-C(4) 101.09(16) 
C(8)-C(9)-C(4) 112.14(18) 
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